action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,,189700,[],CHEMBL640256,Inhibition of [3H]-DPCPX binding to adenosine A1 receptor (AR).,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2nc(C3CCCCC3)[nH]c2n(Cc2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1133597,J Med Chem,2000.0,"{'bei': '15.12', 'le': '0.30', 'lle': '3.73', 'sei': '6.35'}",CHEMBL359066,,CHEMBL359066,6.78,0,http://www.openphacts.org/units/Nanomolar,285152,=,1,1,=,,IC50,nM,,165.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,165.0
,,191011,[],CHEMBL640255,Inhibition of [3H]-DPCPX binding to adenosine A1 receptor (AR).,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2nc(C3CCCC3)[nH]c2n(CCCOC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1133597,J Med Chem,2000.0,"{'bei': '15.65', 'le': '0.31', 'lle': '5.07', 'sei': '5.96'}",CHEMBL327708,,CHEMBL327708,7.93,0,http://www.openphacts.org/units/Nanomolar,285147,=,1,1,=,,IC50,nM,,11.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,11.8
,,200340,[],CHEMBL640256,Inhibition of [3H]-DPCPX binding to adenosine A1 receptor (AR).,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2nc(C3CCCCC3)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1133597,J Med Chem,2000.0,"{'bei': '14.63', 'le': '0.29', 'lle': '4.78', 'sei': '5.59'}",CHEMBL144360,,CHEMBL144360,7.60,0,http://www.openphacts.org/units/Nanomolar,285150,=,1,1,=,,IC50,nM,,24.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,24.9
,,203984,[],CHEMBL640256,Inhibition of [3H]-DPCPX binding to adenosine A1 receptor (AR).,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2nc(C3CCCCC3)[nH]c2n(CCCc2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1133597,J Med Chem,2000.0,"{'bei': '14.59', 'le': '0.29', 'lle': '3.31', 'sei': '6.51'}",CHEMBL147156,,CHEMBL147156,6.95,0,http://www.openphacts.org/units/Nanomolar,285151,=,1,1,=,,IC50,nM,,112.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,112.0
,,213402,[],CHEMBL640256,Inhibition of [3H]-DPCPX binding to adenosine A1 receptor (AR).,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2nc(C3CCCC3)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1133597,J Med Chem,2000.0,"{'bei': '15.19', 'le': '0.30', 'lle': '5.25', 'sei': '5.65'}",CHEMBL321218,,CHEMBL321218,7.68,0,http://www.openphacts.org/units/Nanomolar,285149,=,1,1,=,,IC50,nM,,21.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,21.0
,,218229,[],CHEMBL640256,Inhibition of [3H]-DPCPX binding to adenosine A1 receptor (AR).,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2nc(C3CCCCC3)[nH]c2n(CCCCCc2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1133597,J Med Chem,2000.0,"{'bei': '13.86', 'le': '0.27', 'lle': '2.58', 'sei': '6.55'}",CHEMBL148098,,CHEMBL148098,7.00,0,http://www.openphacts.org/units/Nanomolar,285148,=,1,1,=,,IC50,nM,,101.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,101.0
,,346054,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(CCCNC(=O)CBr)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '15.02', 'le': '0.34', 'lle': '5.07', 'sei': '6.11'}",CHEMBL92906,,CHEMBL92906,6.22,0,http://www.openphacts.org/units/Nanomolar,167230,=,1,1,=,,IC50,nM,,600.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.6
,,346059,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(CCCNC(=O)c3cccc(S(=O)(=O)F)c3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '11.65', 'le': '0.23', 'lle': '3.86', 'sei': '4.11'}",CHEMBL90720,,CHEMBL90720,5.58,0,http://www.openphacts.org/units/Nanomolar,167232,=,1,1,=,,IC50,nM,,2600.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,2.6
,,346098,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CCC(OC(=O)c4cccc(S(=O)(=O)F)c4)C3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '14.01', 'le': '0.28', 'lle': '4.24', 'sei': '5.33'}",CHEMBL314539,,CHEMBL314539,7.10,0,http://www.openphacts.org/units/Nanomolar,167246,=,1,1,=,,IC50,nM,,80.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.08
,,348695,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(NCCCl)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '25.80', 'le': '0.53', 'lle': '6.74', 'sei': '9.56'}",CHEMBL328953,,CHEMBL328953,8.10,0,http://www.openphacts.org/units/Nanomolar,167238,=,1,1,=,,IC50,nM,,8.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.008
,,348697,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(CCCCCN3C(=O)C=CC3=O)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '14.09', 'le': '0.27', 'lle': '4.32', 'sei': '5.14'}",CHEMBL446355,,CHEMBL446355,5.66,0,http://www.openphacts.org/units/Nanomolar,167239,=,1,1,=,,IC50,nM,,2200.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,2.2
,,348699,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(NC(=O)c3ccc(S(=O)(=O)F)cc3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '12.29', 'le': '0.24', 'lle': '3.76', 'sei': '3.96'}",CHEMBL90745,,CHEMBL90745,5.38,0,http://www.openphacts.org/units/Nanomolar,167231,=,1,1,=,,IC50,nM,,4200.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,4.2
,,350092,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(-c3cccnc3Cl)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '16.11', 'le': '0.32', 'lle': '3.18', 'sei': '6.55'}",CHEMBL90037,,CHEMBL90037,5.60,0,http://www.openphacts.org/units/Nanomolar,167243,=,1,1,=,,IC50,nM,,2500.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,2.5
,,354387,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(N(CCCl)CCCl)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '18.72', 'le': '0.40', 'lle': '5.06', 'sei': '9.28'}",CHEMBL90024,,CHEMBL90024,7.05,0,http://www.openphacts.org/units/Nanomolar,167242,=,1,1,=,,IC50,nM,,90.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.09
,,358714,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(CCCCCNC(=O)CBr)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '13.38', 'le': '0.30', 'lle': '3.99', 'sei': '5.82'}",CHEMBL91505,,CHEMBL91505,5.92,0,http://www.openphacts.org/units/Nanomolar,167236,=,1,1,=,,IC50,nM,,1200.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,1.2
,,361309,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CCC(OC(=O)c4ccc(S(=O)(=O)F)cc4)C3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '14.26', 'le': '0.28', 'lle': '4.36', 'sei': '5.43'}",CHEMBL94105,,CHEMBL94105,7.22,0,http://www.openphacts.org/units/Nanomolar,167255,=,1,1,=,,IC50,nM,,60.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.06
,,364252,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(CCNC(=O)CBr)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '13.49', 'le': '0.31', 'lle': '4.64', 'sei': '5.30'}",CHEMBL93674,,CHEMBL93674,5.40,0,http://www.openphacts.org/units/Nanomolar,167237,=,1,1,=,,IC50,nM,,4000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,4.0
,,365716,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(CCNC(=O)c3cccc(S(=O)(=O)F)c3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '13.22', 'le': '0.26', 'lle': '4.81', 'sei': '4.53'}",CHEMBL330335,,CHEMBL330335,6.16,0,http://www.openphacts.org/units/Nanomolar,167233,=,1,1,=,,IC50,nM,,700.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.7
,,365758,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)n(CCCOC(=O)c2ccc(S(=O)(=O)F)cc2)c(=O)c2[nH]c(C3CCCC3)nc21,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '13.94', 'le': '0.28', 'lle': '4.20', 'sei': '5.30'}",CHEMBL90702,,CHEMBL90702,7.06,0,http://www.openphacts.org/units/Nanomolar,167249,=,1,1,=,,IC50,nM,,87.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.087
,,367238,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CCCC3)[nH]c2n(CCCOC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '15.79', 'le': '0.31', 'lle': '5.14', 'sei': '6.01'}",CHEMBL327708,,CHEMBL327708,8.00,0,http://www.openphacts.org/units/Nanomolar,167253,=,1,1,=,,IC50,nM,,10.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.01
,,368564,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(CNC(=O)c3ccccc3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '14.08', 'le': '0.26', 'lle': '3.56', 'sei': '5.11'}",CHEMBL90298,,CHEMBL90298,5.20,0,http://www.openphacts.org/units/Nanomolar,167250,=,1,1,=,,IC50,nM,,6300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,6.3
,,369991,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(-c3ccc(Cl)c([N+](=O)[O-])c3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '13.16', 'le': '0.26', 'lle': '2.22', 'sei': '4.45'}",CHEMBL90937,,CHEMBL90937,5.16,0,http://www.openphacts.org/units/Nanomolar,167229,=,1,1,=,,IC50,nM,,7000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,7.0
,,370033,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(CNC(=O)c3ccc(S(=O)(=O)F)cc3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '12.62', 'le': '0.25', 'lle': '4.41', 'sei': '4.19'}",CHEMBL91284,,CHEMBL91284,5.70,0,http://www.openphacts.org/units/Nanomolar,167244,=,1,1,=,,IC50,nM,,2000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,2.0
,,372786,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(CCCNC(=O)c3ccc(S(=O)(=O)F)cc3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '12.71', 'le': '0.25', 'lle': '4.37', 'sei': '4.49'}",CHEMBL89920,,CHEMBL89920,6.10,0,http://www.openphacts.org/units/Nanomolar,167245,=,1,1,=,,IC50,nM,,800.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.8
,,375547,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(NC(=O)c3cccc(S(=O)(=O)F)c3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '12.47', 'le': '0.25', 'lle': '3.84', 'sei': '4.01'}",CHEMBL93600,,CHEMBL93600,5.46,0,http://www.openphacts.org/units/Nanomolar,167235,=,1,1,=,,IC50,nM,,3500.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,3.5
,,375665,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCCCn1c(=O)c2nc(C3CCCC3)[nH]c2n(CCCOC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O)c1ccc(S(=O)(=O)F)cc1,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '7.70', 'le': '0.16', 'lle': '2.11', 'sei': '2.82'}",CHEMBL328033,,CHEMBL328033,5.46,0,http://www.openphacts.org/units/Nanomolar,167252,=,1,1,=,,IC50,nM,,3500.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,3.5
,,381233,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)C2NC(C3CCCC3)NC2N(CCCOC(=O)CBr)C1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '18.07', 'le': '0.41', 'lle': '6.66', 'sei': '8.84'}",CHEMBL329774,,CHEMBL329774,8.05,0,http://www.openphacts.org/units/Nanomolar,167254,=,1,1,=,,IC50,nM,,9.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.009
,,382672,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CCC(OC(=O)CBr)C3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '17.44', 'le': '0.39', 'lle': '5.42', 'sei': '7.78'}",CHEMBL88128,,CHEMBL88128,7.70,0,http://www.openphacts.org/units/Nanomolar,167256,=,1,1,=,,IC50,nM,,20.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.02
,,384089,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(CCNC(=O)c3ccc(S(=O)(=O)F)cc3)[nH]c2n(CCC)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '13.22', 'le': '0.26', 'lle': '4.81', 'sei': '4.53'}",CHEMBL329810,,CHEMBL329810,6.16,0,http://www.openphacts.org/units/Nanomolar,167257,=,1,1,=,,IC50,nM,,700.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.7
,,384092,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CCCC3)[nH]c2n(CCCOC(=O)c2cccc(S(=O)(=O)F)c2)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '15.20', 'le': '0.30', 'lle': '4.84', 'sei': '5.78'}",CHEMBL90627,,CHEMBL90627,7.70,0,http://www.openphacts.org/units/Nanomolar,167248,=,1,1,=,,IC50,nM,,20.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.02
,,390049,[],CHEMBL640253,Inhibition of specific binding of [3H]CPX to the A1 adenosine receptor in DDT1 MF-2 (DDT) cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CCCC3)[nH]c2n(CC(C)OC(=O)CBr)c1=O,,,CHEMBL1127726,J Med Chem,1994.0,"{'bei': '18.03', 'le': '0.40', 'lle': '5.68', 'sei': '8.04'}",CHEMBL91604,,CHEMBL91604,7.96,0,http://www.openphacts.org/units/Nanomolar,167247,=,1,1,=,,IC50,nM,,11.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.011
,,488796,[],CHEMBL643299,Inhibition of cAMP formation in CHO cells expressing adenosine A1 receptor,B,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O,,,CHEMBL1136764,J Med Chem,2003.0,"{'bei': '24.03', 'le': '0.49', 'lle': '8.44', 'sei': '7.08'}",CHEMBL284969,,CHEMBL284969,8.89,0,http://www.openphacts.org/units/Nanomolar,57526,=,1,1,=,,IC50,nM,,1.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1.3
,,511459,[],CHEMBL643300,Inhibition of cAMP formation in CHO cells expressing human adenosine A1 receptor,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N/N=N/c1nc(NC2CCCC2)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)Nc1ccccc1,,,CHEMBL1136764,J Med Chem,2003.0,"{'bei': '17.74', 'le': '0.33', 'lle': '7.21', 'sei': '4.61'}",CHEMBL2113457,,CHEMBL2113457,8.82,0,http://www.openphacts.org/units/Nanomolar,57517,=,1,1,=,,IC50,nM,,1.5,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1.5
,,685582,[],CHEMBL640254,Inhibitory concentration against [3H]DPCPX binding to Adenosine A1 receptor from DDT1 MF2 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CCCC3)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1134949,Bioorg Med Chem Lett,2002.0,"{'bei': '15.19', 'le': '0.30', 'lle': '5.25', 'sei': '5.65'}",CHEMBL321218,,CHEMBL321218,7.68,1,http://www.openphacts.org/units/Nanomolar,203074,=,1,1,=,,IC50,nM,,21.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,21.0
,,686842,[],CHEMBL640254,Inhibitory concentration against [3H]DPCPX binding to Adenosine A1 receptor from DDT1 MF2 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CC4CCC3C4)[nH]c2n(CCCCC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1134949,Bioorg Med Chem Lett,2002.0,"{'bei': '15.85', 'le': '0.31', 'lle': '4.50', 'sei': '6.79'}",CHEMBL107646,,CHEMBL107646,8.41,0,http://www.openphacts.org/units/Nanomolar,203073,=,1,1,=,,IC50,nM,,3.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3.9
,,692086,[],CHEMBL640254,Inhibitory concentration against [3H]DPCPX binding to Adenosine A1 receptor from DDT1 MF2 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CCCCC3)[nH]c2n(CCCCC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1134949,Bioorg Med Chem Lett,2002.0,"{'bei': '14.99', 'le': '0.29', 'lle': '3.71', 'sei': '6.28'}",CHEMBL108552,,CHEMBL108552,7.78,0,http://www.openphacts.org/units/Nanomolar,203072,=,1,1,=,,IC50,nM,,16.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,16.8
,,702745,[],CHEMBL640254,Inhibitory concentration against [3H]DPCPX binding to Adenosine A1 receptor from DDT1 MF2 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CCCC3)[nH]c2n(CCCCC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1134949,Bioorg Med Chem Lett,2002.0,"{'bei': '15.97', 'le': '0.31', 'lle': '4.39', 'sei': '6.51'}",CHEMBL107499,,CHEMBL107499,8.06,0,http://www.openphacts.org/units/Nanomolar,203075,=,1,1,=,,IC50,nM,,8.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,8.7
,,704154,[],CHEMBL640254,Inhibitory concentration against [3H]DPCPX binding to Adenosine A1 receptor from DDT1 MF2 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2nc(C3CCCC3)[nH]c2n(CCCOC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,,CHEMBL1134949,Bioorg Med Chem Lett,2002.0,"{'bei': '15.65', 'le': '0.31', 'lle': '5.07', 'sei': '5.96'}",CHEMBL327708,,CHEMBL327708,7.93,1,http://www.openphacts.org/units/Nanomolar,203071,=,1,1,=,,IC50,nM,,11.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,11.8
,,827917,[],CHEMBL642660,Inhibitory activity against membranes from yeast cells transformed with human A1 receptor (hA1),B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)NCCNc1[nH]c(-c2ccccc2)nc2nc(C)c(C)c1-2,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '23.56', 'le': '0.43', 'lle': '4.88', 'sei': '9.21'}",CHEMBL81616,,CHEMBL81616,7.62,0,http://www.openphacts.org/units/Nanomolar,142913,=,1,1,=,,IC50,nM,,24.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,24.0
,,827919,[],CHEMBL640188,Inhibitory activity against binding of [3H]DPCPX to human A1 receptor (hA1) using competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCCNc1[nH]c(-c2ccccc2)nc2nc(C)c(C)c1-2,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '23.56', 'le': '0.43', 'lle': '4.88', 'sei': '9.21'}",CHEMBL81616,,CHEMBL81616,7.62,0,http://www.openphacts.org/units/Nanomolar,142913,=,1,1,=,,IC50,nM,,24.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,24.0
,,832475,[],CHEMBL640189,Inhibitory activity against human A1 receptor (hA1) on membranes from yeast cells,B,,,BAO_0000190,BAO_0000019,assay format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '25.91', 'le': '0.49', 'lle': '5.53', 'sei': '10.85'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,7.89,0,http://www.openphacts.org/units/Nanomolar,142910,=,1,1,=,,IC50,nM,,13.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,13.0
,,832477,[],CHEMBL646675,Binding affinity against human A1 receptor (hA1) was measured through displacement of [3H]DPCPX using yeast cell membranes,B,,,BAO_0000190,BAO_0000019,assay format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '25.80', 'le': '0.49', 'lle': '5.49', 'sei': '10.81'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,7.85,0,http://www.openphacts.org/units/Nanomolar,142910,=,1,1,=,,IC50,nM,,14.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,14.0
,,834848,[],CHEMBL642660,Inhibitory activity against membranes from yeast cells transformed with human A1 receptor (hA1),B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2nc(-c3ccccc3)nc(N[C@@H]3CCCCNC3=O)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '16.89', 'le': '0.31', 'lle': '2.58', 'sei': '7.14'}",CHEMBL312503,,CHEMBL312503,5.90,0,http://www.openphacts.org/units/Nanomolar,142919,=,1,1,=,,IC50,nM,,1256.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1256.0
,,834850,[],CHEMBL640188,Inhibitory activity against binding of [3H]DPCPX to human A1 receptor (hA1) using competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1[nH]c2nc(-c3ccccc3)nc(N[C@@H]3CCCCNC3=O)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '16.64', 'le': '0.31', 'lle': '2.49', 'sei': '7.03'}",CHEMBL312503,,CHEMBL312503,5.81,0,http://www.openphacts.org/units/Nanomolar,142919,=,1,1,=,,IC50,nM,,1535.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1535.0
,,836029,[],CHEMBL642660,Inhibitory activity against membranes from yeast cells transformed with human A1 receptor (hA1),B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2nc(-c3ccccc3)nc(NCCN3CCNC3=O)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '18.19', 'le': '0.33', 'lle': '3.69', 'sei': '7.42'}",CHEMBL82197,,CHEMBL82197,6.38,0,http://www.openphacts.org/units/Nanomolar,142916,=,1,1,=,,IC50,nM,,422.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,422.0
,,836031,[],CHEMBL640188,Inhibitory activity against binding of [3H]DPCPX to human A1 receptor (hA1) using competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1[nH]c2nc(-c3ccccc3)nc(NCCN3CCNC3=O)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '18.37', 'le': '0.34', 'lle': '3.76', 'sei': '7.49'}",CHEMBL82197,,CHEMBL82197,6.44,0,http://www.openphacts.org/units/Nanomolar,142916,=,1,1,=,,IC50,nM,,364.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,364.0
,,845860,[],CHEMBL642660,Inhibitory activity against membranes from yeast cells transformed with human A1 receptor (hA1),B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccccc3)[nH]c(N[C@H](CO)CC(C)C)c-2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '17.01', 'le': '0.31', 'lle': '1.75', 'sei': '7.80'}",CHEMBL78659,,CHEMBL78659,5.76,0,http://www.openphacts.org/units/Nanomolar,142914,=,1,1,=,,IC50,nM,,1754.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1754.0
,,845862,[],CHEMBL640188,Inhibitory activity against binding of [3H]DPCPX to human A1 receptor (hA1) using competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2nc(-c3ccccc3)[nH]c(N[C@H](CO)CC(C)C)c-2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '16.90', 'le': '0.31', 'lle': '1.71', 'sei': '7.75'}",CHEMBL78659,,CHEMBL78659,5.72,0,http://www.openphacts.org/units/Nanomolar,142914,=,1,1,=,,IC50,nM,,1910.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1910.0
,,845867,[],CHEMBL642660,Inhibitory activity against membranes from yeast cells transformed with human A1 receptor (hA1),B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2nc(-c3ccccc3)nc(NCc3ccncc3)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '20.20', 'le': '0.36', 'lle': '2.40', 'sei': '10.01'}",CHEMBL81863,,CHEMBL81863,6.65,0,http://www.openphacts.org/units/Nanomolar,142915,=,1,1,=,,IC50,nM,,222.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,222.0
,,845869,[],CHEMBL640188,Inhibitory activity against binding of [3H]DPCPX to human A1 receptor (hA1) using competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1[nH]c2nc(-c3ccccc3)nc(NCc3ccncc3)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '19.98', 'le': '0.36', 'lle': '2.33', 'sei': '9.90'}",CHEMBL81863,,CHEMBL81863,6.58,0,http://www.openphacts.org/units/Nanomolar,142915,=,1,1,=,,IC50,nM,,262.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,262.0
,,849362,[],CHEMBL642660,Inhibitory activity against membranes from yeast cells transformed with human A1 receptor (hA1),B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2nc(-c3ccccc3)nc(NCCCN3CCCC3=O)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '14.44', 'le': '0.27', 'lle': '1.58', 'sei': '7.10'}",CHEMBL78377,,CHEMBL78377,5.25,0,http://www.openphacts.org/units/Nanomolar,142918,=,1,1,=,,IC50,nM,,5647.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5647.0
,,850533,[],CHEMBL642660,Inhibitory activity against membranes from yeast cells transformed with human A1 receptor (hA1),B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccccc3)[nH]c(N[C@H](C)c3ccccc3)c-2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '16.92', 'le': '0.30', 'lle': '0.42', 'sei': '10.81'}",CHEMBL81336,,CHEMBL81336,5.79,0,http://www.openphacts.org/units/Nanomolar,142911,=,1,1,=,,IC50,nM,,1607.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1607.0
,,850535,[],CHEMBL640188,Inhibitory activity against binding of [3H]DPCPX to human A1 receptor (hA1) using competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2nc(-c3ccccc3)[nH]c(N[C@H](C)c3ccccc3)c-2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '16.65', 'le': '0.30', 'lle': '0.33', 'sei': '10.64'}",CHEMBL81336,,CHEMBL81336,5.70,0,http://www.openphacts.org/units/Nanomolar,142911,=,1,1,=,,IC50,nM,,1981.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1981.0
,,852673,[],CHEMBL642660,Inhibitory activity against membranes from yeast cells transformed with human A1 receptor (hA1),B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2nc(-c3ccccc3)nc(N[C@H]3CC[C@H](O)CC3)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '21.99', 'le': '0.40', 'lle': '3.44', 'sei': '10.02'}",CHEMBL78595,,CHEMBL78595,7.40,0,http://www.openphacts.org/units/Nanomolar,142912,=,1,1,=,,IC50,nM,,40.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,40.0
,,852675,[],CHEMBL640188,Inhibitory activity against binding of [3H]DPCPX to human A1 receptor (hA1) using competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1[nH]c2nc(-c3ccccc3)nc(N[C@H]3CC[C@H](O)CC3)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '21.73', 'le': '0.40', 'lle': '3.35', 'sei': '9.90'}",CHEMBL78595,,CHEMBL78595,7.31,0,http://www.openphacts.org/units/Nanomolar,142912,=,1,1,=,,IC50,nM,,49.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,49.0
,,856024,[],CHEMBL642660,Inhibitory activity against membranes from yeast cells transformed with human A1 receptor (hA1),B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2nc(-c3ccccc3)nc(N[C@@H]3Cc4ccccc4[C@H]3O)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '15.58', 'le': '0.28', 'lle': '1.46', 'sei': '7.82'}",CHEMBL441806,,CHEMBL441806,5.77,0,http://www.openphacts.org/units/Nanomolar,142917,=,1,1,=,,IC50,nM,,1696.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1696.0
,,856026,[],CHEMBL640188,Inhibitory activity against binding of [3H]DPCPX to human A1 receptor (hA1) using competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1[nH]c2nc(-c3ccccc3)nc(N[C@@H]3Cc4ccccc4[C@H]3O)c2c1C,,,CHEMBL1131846,Bioorg Med Chem Lett,1999.0,"{'bei': '15.50', 'le': '0.28', 'lle': '1.43', 'sei': '7.78'}",CHEMBL441806,,CHEMBL441806,5.74,0,http://www.openphacts.org/units/Nanomolar,142917,=,1,1,=,,IC50,nM,,1810.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1810.0
,,960144,[],CHEMBL646674,Binding affinity against A1 adenosine receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCCn1c(O)nc2ccccc21)OCc1cc2c(cc1Cl)OCO2,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '16.01', 'le': '0.32', 'lle': '3.02', 'sei': '6.82'}",CHEMBL333843,,CHEMBL333843,6.46,0,http://www.openphacts.org/units/Nanomolar,216634,=,1,1,=,,IC50,nM,,344.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,344.0
,,986575,[],CHEMBL646674,Binding affinity against A1 adenosine receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(OCc1cc2c(cc1Cl)OCO2)N1CCC(n2c(O)nc3ccccc32)CC1,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '12.98', 'le': '0.25', 'lle': '1.48', 'sei': '6.48'}",CHEMBL115444,,CHEMBL115444,5.58,0,http://www.openphacts.org/units/Nanomolar,216585,=,1,1,=,,IC50,nM,,2640.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2640.0
,,1035850,[],CHEMBL640187,Displacement of specific [3H]DPCPX binding at human adenosine A1 receptor expressed in CHO cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCc1nc2[nH]ncc2c2nc(-c3ccc(F)cc3)nn12,,,CHEMBL1146808,Bioorg Med Chem Lett,2004.0,"{'bei': '20.03', 'le': '0.37', 'lle': '3.06', 'sei': '8.66'}",CHEMBL339218,,CHEMBL339218,6.21,0,http://www.openphacts.org/units/Nanomolar,236284,=,1,1,=,,IC50,nM,,610.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,610.0
,,1035854,[],CHEMBL640187,Displacement of specific [3H]DPCPX binding at human adenosine A1 receptor expressed in CHO cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCc1nc2ccccc2c2nc(-c3ccccc3)nn12,,,CHEMBL1146808,Bioorg Med Chem Lett,2004.0,"{'bei': '18.47', 'le': '0.33', 'lle': '1.30', 'sei': '12.96'}",CHEMBL340580,,CHEMBL340580,5.58,0,http://www.openphacts.org/units/Nanomolar,236309,=,1,1,=,,IC50,nM,,2600.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2600.0
,,1038158,[],CHEMBL640187,Displacement of specific [3H]DPCPX binding at human adenosine A1 receptor expressed in CHO cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1nc2[nH]ncc2c2nc(-c3ccccc3)nn12,,,CHEMBL1146808,Bioorg Med Chem Lett,2004.0,"{'bei': '28.64', 'le': '0.52', 'lle': '5.34', 'sei': '10.55'}",CHEMBL340221,,CHEMBL340221,7.57,0,http://www.openphacts.org/units/Nanomolar,236280,=,1,1,=,,IC50,nM,,27.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,27.0
,,1049072,[],CHEMBL640187,Displacement of specific [3H]DPCPX binding at human adenosine A1 receptor expressed in CHO cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCc1nc2[nH]ncc2c2nc(-c3ccc(Cl)cc3)nn12,,,CHEMBL1146808,Bioorg Med Chem Lett,2004.0,"{'bei': '18.12', 'le': '0.35', 'lle': '2.26', 'sei': '8.25'}",CHEMBL122037,,CHEMBL122037,5.92,0,http://www.openphacts.org/units/Nanomolar,236285,=,1,1,=,,IC50,nM,,1200.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1200.0
,,1051441,[],CHEMBL640187,Displacement of specific [3H]DPCPX binding at human adenosine A1 receptor expressed in CHO cells.,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCc1nc2[nH]ncc2c2nc(-c3ccc(C)cc3)nn12,,,CHEMBL1146808,Bioorg Med Chem Lett,2004.0,"{'bei': '18.03', 'le': '0.33', 'lle': '2.20', 'sei': '7.70'}",CHEMBL124725,,CHEMBL124725,5.52,0,http://www.openphacts.org/units/Nanomolar,236282,=,1,1,=,,IC50,nM,,3000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3000.0
,,1286218,[],CHEMBL642661,Inhibitory activity against cyclic AMP production in human Adenosine A1 receptor assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)C1=C2C=CN(C)C=C2c2nc(-c3ccccc3)nn2C1,,,CHEMBL1134604,J Med Chem,2001.0,"{'bei': '16.47', 'le': '0.30', 'lle': '3.05', 'sei': '8.76'}",CHEMBL52735,,CHEMBL52735,5.28,0,http://www.openphacts.org/units/Nanomolar,85294,=,1,1,=,,IC50,nM,,5300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,5.3
,,1303931,[],CHEMBL884114,Binding Affinity for Adenosine A1 receptor expressed in CHO-K1 cells compared to [3H]CCPA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)c2nc(-c3ccccc3)[nH]c2n(C)c1=O,,,CHEMBL1134604,J Med Chem,2001.0,"{'bei': '22.92', 'le': '0.42', 'lle': '5.24', 'sei': '8.08'}",CHEMBL62350,8-PHENYL THEOPHYLLINE,CHEMBL62350,5.87,0,http://www.openphacts.org/units/Nanomolar,85297,=,1,1,=,,IC50,nM,,1340.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,1.34
,,1712920,[],CHEMBL866942,Activity against human adenosine A1 receptor in CHO cells assessed by the antagonizing effect of 100 nM CPA on forskolin-induced cAMP production,F,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2nc(-c3ccccc3)c3nc(C4CCCCC4)nc-3[nH]2)cc1,,,CHEMBL1147670,J Med Chem,2006.0,,CHEMBL207529,,CHEMBL207529,6.32,0,http://www.openphacts.org/units/Nanomolar,471122,=,1,1,=,,IC50,nM,,477.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,477.0
,,1740002,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)n(C)c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccc6c(c5)OCO6)CC4)cc3)cc21,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '12.36', 'le': '0.24', 'lle': '4.65', 'sei': '5.88'}",CHEMBL211071,,CHEMBL211071,6.99,0,http://www.openphacts.org/units/Nanomolar,520199,=,1,1,=,,IC50,nM,,102.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,102.0
,,1740009,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCc4ccc(OC)cn4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '16.38', 'le': '0.32', 'lle': '5.93', 'sei': '6.18'}",CHEMBL212528,,CHEMBL212528,7.92,0,http://www.openphacts.org/units/Nanomolar,520197,=,1,1,=,,IC50,nM,,12.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,12.0
,,1740015,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCc4ccccn4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '14.78', 'le': '0.29', 'lle': '4.89', 'sei': '5.81'}",CHEMBL212464,,CHEMBL212464,6.91,0,http://www.openphacts.org/units/Nanomolar,520196,=,1,1,=,,IC50,nM,,123.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,123.0
,,1740021,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccc(C#N)cc5)CC4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '11.77', 'le': '0.23', 'lle': '3.95', 'sei': '5.18'}",CHEMBL212416,,CHEMBL212416,6.43,0,http://www.openphacts.org/units/Nanomolar,520195,=,1,1,=,,IC50,nM,,370.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,370.0
,,1740029,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NC4CCN(Cc5ccccc5)CC4)cc3)cc2n(CCC)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '12.82', 'le': '0.25', 'lle': '3.31', 'sei': '6.62'}",CHEMBL209944,,CHEMBL209944,7.23,0,http://www.openphacts.org/units/Nanomolar,520194,=,1,1,=,,IC50,nM,,59.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,59.0
,,1740037,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCc4ccccn4)cc3)cc2n(CC)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '14.66', 'le': '0.28', 'lle': '4.74', 'sei': '5.77'}",CHEMBL378527,,CHEMBL378527,6.85,0,http://www.openphacts.org/units/Nanomolar,520193,=,1,1,=,,IC50,nM,,140.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,140.0
,,1740045,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NC4CCN(Cc5ccc(F)cc5)CC4)cc3)cc2n(CC)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '12.08', 'le': '0.23', 'lle': '3.41', 'sei': '6.12'}",CHEMBL210969,,CHEMBL210969,6.69,0,http://www.openphacts.org/units/Nanomolar,520192,=,1,1,=,,IC50,nM,,205.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,205.0
,,1740050,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5cccc(F)c5)CC4)cc3)cc2n(CC)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '11.96', 'le': '0.23', 'lle': '3.62', 'sei': '6.43'}",CHEMBL210931,,CHEMBL210931,6.46,0,http://www.openphacts.org/units/Nanomolar,520191,=,1,1,=,,IC50,nM,,350.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,350.0
,,1740066,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccc(Cl)s5)CC4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '13.09', 'le': '0.27', 'lle': '4.54', 'sei': '6.96'}",CHEMBL211813,,CHEMBL211813,6.99,0,http://www.openphacts.org/units/Nanomolar,520189,=,1,1,=,,IC50,nM,,102.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,102.0
,,1740081,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccc(Br)cc5)CC4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '11.77', 'le': '0.26', 'lle': '4.24', 'sei': '6.71'}",CHEMBL437309,,CHEMBL437309,6.74,0,http://www.openphacts.org/units/Nanomolar,520188,=,1,1,=,,IC50,nM,,183.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,183.0
,,1740085,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccc(F)cc5F)CC4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '13.03', 'le': '0.25', 'lle': '4.88', 'sei': '6.87'}",CHEMBL210088,,CHEMBL210088,6.90,0,http://www.openphacts.org/units/Nanomolar,520187,=,1,1,=,,IC50,nM,,126.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,126.0
,,1740098,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5cccc(F)c5)CC4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '13.33', 'le': '0.26', 'lle': '4.94', 'sei': '6.79'}",CHEMBL210383,,CHEMBL210383,6.82,0,http://www.openphacts.org/units/Nanomolar,520185,=,1,1,=,,IC50,nM,,152.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,152.0
,,1740107,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccccc5)CC4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '12.93', 'le': '0.25', 'lle': '4.64', 'sei': '6.36'}",CHEMBL209019,,CHEMBL209019,6.38,0,http://www.openphacts.org/units/Nanomolar,520183,=,1,1,=,,IC50,nM,,415.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,415.0
,,1740125,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCOc4ccccn4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '14.06', 'le': '0.27', 'lle': '5.42', 'sei': '5.00'}",CHEMBL209208,,CHEMBL209208,6.40,0,http://www.openphacts.org/units/Nanomolar,520180,=,1,1,=,,IC50,nM,,396.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,396.0
,,1740130,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCc4ccccn4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '15.53', 'le': '0.30', 'lle': '5.67', 'sei': '5.74'}",CHEMBL211762,,CHEMBL211762,6.82,0,http://www.openphacts.org/units/Nanomolar,520179,=,1,1,=,,IC50,nM,,150.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,150.0
,,1740142,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(NS(=O)(=O)c2ccc(-c3cc4c([nH]3)c(=O)n(C)c(=O)n4C)cc2)cn1,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '16.46', 'le': '0.32', 'lle': '5.83', 'sei': '5.67'}",CHEMBL210456,,CHEMBL210456,7.27,0,http://www.openphacts.org/units/Nanomolar,520177,=,1,1,=,,IC50,nM,,54.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,54.0
,,1740148,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)Nc4ccccn4)cc3)cc2n(C)c1=O,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '17.42', 'le': '0.34', 'lle': '5.74', 'sei': '6.03'}",CHEMBL208705,,CHEMBL208705,7.17,0,http://www.openphacts.org/units/Nanomolar,520176,=,1,1,=,,IC50,nM,,68.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,68.0
,,1740199,[],CHEMBL864808,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(CNS(=O)(=O)c2ccc(-c3cc4c([nH]3)c(=O)n(C)c(=O)n4C)cc2)nc1,,,CHEMBL1138926,Bioorg Med Chem Lett,2006.0,"{'bei': '15.36', 'le': '0.30', 'lle': '5.89', 'sei': '5.46'}",CHEMBL210457,,CHEMBL210457,7.00,0,http://www.openphacts.org/units/Nanomolar,520178,=,1,1,=,,IC50,nM,,101.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,101.0
,,1802694,[],CHEMBL909521,Inhibition of adenosine A1 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2,,,CHEMBL1139839,J Med Chem,2007.0,"{'bei': '17.34', 'le': '0.33', 'lle': '1.79', 'sei': '12.13'}",CHEMBL217899,TOFIMILAST,CHEMBL217899,5.89,0,http://www.openphacts.org/units/Nanomolar,621579,=,1,1,=,,IC50,nM,,1300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,1.3
,,1802697,[],CHEMBL853711,Inhibition of human adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2,,,CHEMBL1139839,J Med Chem,2007.0,"{'bei': '15.57', 'le': '0.30', 'lle': '1.18', 'sei': '10.89'}",CHEMBL217899,TOFIMILAST,CHEMBL217899,5.28,0,http://www.openphacts.org/units/Nanomolar,621579,=,1,1,=,,IC50,nM,,5200.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,5.2
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",Antagonist,1818173,[],CHEMBL907374,Activity at human adenosine A1 receptor in CHO cells assessed as effect on CPA induced inhibition of forskolin-stimulated cAMP production,F,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc(-c3ccccc3)c3nc(C4CCCCC4)[nH]c3n2)cc1,,,CHEMBL1141417,J Med Chem,2007.0,,CHEMBL219160,,CHEMBL219160,5.77,0,http://www.openphacts.org/units/Nanomolar,625411,=,1,1,=,,IC50,nM,,1700.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,1.7
,,1880943,[],CHEMBL904695,Displacement of [3H]DPCPX from human A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,c1coc(-c2nc(Nc3cncnc3)ncc2-c2ccncn2)c1,,,CHEMBL1143065,J Med Chem,2007.0,"{'bei': '23.15', 'le': '0.42', 'lle': '4.62', 'sei': '7.17'}",CHEMBL225972,,CHEMBL225972,7.35,0,http://www.openphacts.org/units/Nanomolar,638154,=,1,1,=,,IC50,nM,,45.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,45.0
,,2003333,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCOC4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL392149,TECADENOSON,CHEMBL392149,8.09,0,http://www.openphacts.org/units/Nanomolar,666601,=,1,1,=,,IC50,nM,,8.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,8.2
,,2003346,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccccc1Br)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL430374,,CHEMBL430374,8.05,0,http://www.openphacts.org/units/Nanomolar,666611,=,1,1,=,,IC50,nM,,9.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,9.0
,,2003347,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccccc1Cl)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL392720,,CHEMBL392720,6.59,0,http://www.openphacts.org/units/Nanomolar,666610,=,1,1,=,,IC50,nM,,254.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,254.0
,,2003348,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccccc1)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL240487,,CHEMBL240487,7.17,0,http://www.openphacts.org/units/Nanomolar,666609,=,1,1,=,,IC50,nM,,68.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,68.0
,,2003349,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)OC(=O)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL240279,,CHEMBL240279,8.60,0,http://www.openphacts.org/units/Nanomolar,666608,=,1,1,=,,IC50,nM,,2.5,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.5
,,2003350,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(NC4CC5CCC4N5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL391031,,CHEMBL391031,7.46,0,http://www.openphacts.org/units/Nanomolar,666607,=,1,1,=,,IC50,nM,,35.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,35.0
,,2003351,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccccc1)N1CC[C@@H](Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL240278,,CHEMBL240278,8.49,0,http://www.openphacts.org/units/Nanomolar,666606,=,1,1,=,,IC50,nM,,3.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3.2
,,2003352,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CC[C@@H](Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL391030,,CHEMBL391030,7.07,0,http://www.openphacts.org/units/Nanomolar,666605,=,1,1,=,,IC50,nM,,85.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,85.0
,,2003353,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)OC(=O)N1CC[C@@H](Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL240277,,CHEMBL240277,6.42,0,http://www.openphacts.org/units/Nanomolar,666604,=,1,1,=,,IC50,nM,,380.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,380.0
,,2003354,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CC[Se]C4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL240065,,CHEMBL240065,8.72,0,http://www.openphacts.org/units/Nanomolar,666603,=,1,1,=,,IC50,nM,,1.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1.9
,,2003355,[],CHEMBL901889,Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCSC4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1138285,Bioorg Med Chem Lett,2007.0,,CHEMBL391029,,CHEMBL391029,8.28,0,http://www.openphacts.org/units/Nanomolar,666602,=,1,1,=,,IC50,nM,,5.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.3
,,2134833,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL68738,N6-CYCLOPENTYLADENOSINE,CHEMBL68738,8.57,0,http://www.openphacts.org/units/Nanomolar,704446,=,1,1,=,,IC50,nM,,2.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.7
,,2134855,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,C[Se]C[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL412104,,CHEMBL412104,7.92,0,http://www.openphacts.org/units/Nanomolar,704466,=,1,1,=,,IC50,nM,,12.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,12.0
,,2134856,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL410288,,CHEMBL410288,9.05,0,http://www.openphacts.org/units/Nanomolar,704465,=,1,1,=,,IC50,nM,,0.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.9
,,2134857,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,O[C@@H]1[C@H](O)[C@@H](CCl)O[C@H]1n1cnc2c(N[C@H]3C[C@@H]4C[C@@H]3C3SC34)ncnc21,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL258759,,CHEMBL258759,9.52,0,http://www.openphacts.org/units/Nanomolar,704464,=,1,1,=,,IC50,nM,,0.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.3
,,2134858,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL411245,,CHEMBL411245,9.92,0,http://www.openphacts.org/units/Nanomolar,704463,=,1,1,=,,IC50,nM,,0.12,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.12
,,2134859,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=S)O[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL411859,,CHEMBL411859,6.15,0,http://www.openphacts.org/units/Nanomolar,704462,=,1,1,=,,IC50,nM,,710.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,710.0
,,2134860,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)O[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL279161,,CHEMBL279161,6.39,0,http://www.openphacts.org/units/Nanomolar,704461,=,1,1,=,,IC50,nM,,410.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,410.0
,,2134861,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL411463,,CHEMBL411463,5.37,0,http://www.openphacts.org/units/Nanomolar,704460,=,1,1,=,,IC50,nM,,4279.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,4279.0
,,2134862,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)NC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL262850,,CHEMBL262850,6.22,0,http://www.openphacts.org/units/Nanomolar,704459,=,1,1,=,,IC50,nM,,605.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,605.0
,,2134863,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCNC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL411279,,CHEMBL411279,5.30,0,http://www.openphacts.org/units/Nanomolar,704458,=,1,1,=,,IC50,nM,,4950.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,4950.0
,,2134864,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CNC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL442468,,CHEMBL442468,6.06,0,http://www.openphacts.org/units/Nanomolar,704457,=,1,1,=,,IC50,nM,,867.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,867.0
,,2134865,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,NC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL265947,,CHEMBL265947,6.46,0,http://www.openphacts.org/units/Nanomolar,704456,=,1,1,=,,IC50,nM,,351.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,351.0
,,2134866,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,C[Se]C[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL262876,,CHEMBL262876,7.32,0,http://www.openphacts.org/units/Nanomolar,704455,=,1,1,=,,IC50,nM,,48.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,48.0
,,2134867,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,O[C@@H]1[C@H](O)[C@@H](CSc2ccccc2F)O[C@H]1n1cnc2c(N[C@H]3C[C@H]4CC[C@H]3C4)ncnc21,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL258760,,CHEMBL258760,7.68,0,http://www.openphacts.org/units/Nanomolar,704454,=,1,1,=,,IC50,nM,,21.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,21.0
,,2134868,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL258972,,CHEMBL258972,7.82,0,http://www.openphacts.org/units/Nanomolar,704453,=,1,1,=,,IC50,nM,,15.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,15.0
,,2134869,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CCSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL260631,,CHEMBL260631,7.55,0,http://www.openphacts.org/units/Nanomolar,704452,=,1,1,=,,IC50,nM,,28.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,28.0
,,2134870,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL258489,,CHEMBL258489,7.17,0,http://www.openphacts.org/units/Nanomolar,704451,=,1,1,=,,IC50,nM,,68.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,68.0
,,2134871,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,O[C@@H]1[C@H](O)[C@@H](CS)O[C@H]1n1cnc2c(N[C@H]3C[C@H]4CC[C@H]3C4)ncnc21,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL260205,,CHEMBL260205,6.65,0,http://www.openphacts.org/units/Nanomolar,704450,=,1,1,=,,IC50,nM,,224.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,224.0
,,2134872,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,O[C@@H]1[C@H](O)[C@@H](CCl)O[C@H]1n1cnc2c(N[C@H]3C[C@H]4CC[C@H]3C4)ncnc21,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL427737,,CHEMBL427737,8.59,0,http://www.openphacts.org/units/Nanomolar,704449,=,1,1,=,,IC50,nM,,2.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.6
,,2134873,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,O[C@@H]1[C@H](O)[C@@H](CF)O[C@H]1n1cnc2c(N[C@H]3C[C@H]4CC[C@H]3C4)ncnc21,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL262604,,CHEMBL262604,8.15,0,http://www.openphacts.org/units/Nanomolar,704448,=,1,1,=,,IC50,nM,,7.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,7.0
,,2134874,[],CHEMBL922121,Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CCSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL1144002,Bioorg Med Chem,2008.0,,CHEMBL263643,,CHEMBL263643,7.68,0,http://www.openphacts.org/units/Nanomolar,704447,=,1,1,=,,IC50,nM,,21.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,21.0
,,2142207,[],CHEMBL923880,Activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CPA-induced decrease in forskolin-stimulated cAMP production by TR-FRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1c(-c2ccccc2)nc(NC(=O)C2CCCC2)nc1-c1ccccc1,,,CHEMBL1143999,Bioorg Med Chem,2008.0,,CHEMBL259704,,CHEMBL259704,6.82,0,http://www.openphacts.org/units/Nanomolar,704340,=,1,1,=,,IC50,nM,,150.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.15
,,2142208,[],CHEMBL923880,Activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CPA-induced decrease in forskolin-stimulated cAMP production by TR-FRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1c(NC(=O)C2CCCC2)nc(-c2ccccc2)nc1-c1ccc2c(c1)OCO2,,,CHEMBL1143999,Bioorg Med Chem,2008.0,,CHEMBL260396,,CHEMBL260396,5.85,0,http://www.openphacts.org/units/Nanomolar,704359,=,1,1,=,,IC50,nM,,1400.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,1.4
,,2401854,[],CHEMBL953119,Displacement of radiolabeled DPCPX from human adenosine A1 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL1140203,J Med Chem,2008.0,"{'bei': '26.85', 'le': '0.51', 'lle': '5.81', 'sei': '11.25'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,8.17,0,http://www.openphacts.org/units/Nanomolar,1311157,=,1,1,=,,IC50,nM,,6.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,10'-9M,UO_0000065,,6.7
,,2573313,[],CHEMBL982003,Inhibition of human adenosine A1 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL1155111,J Med Chem,2008.0,"{'bei': '25.91', 'le': '0.49', 'lle': '5.53', 'sei': '10.85'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,7.89,1,http://www.openphacts.org/units/Nanomolar,742948,=,1,1,=,,IC50,nM,,13.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,13.0
,,2626997,[],CHEMBL995342,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells assessed as ratio of IC50 in presence of GTP to absence of GTP by GTP shift assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)[O-])c2)c2c1C(=O)c1ccccc1C2=O.[Na+].[Na+],,,CHEMBL1136967,J Med Chem,2009.0,"{'bei': '10.78', 'le': '0.21', 'lle': '3.31', 'sei': '2.80'}",CHEMBL499428,,CHEMBL1208129,6.12,0,http://www.openphacts.org/units/Nanomolar,785658,=,1,1,=,,IC50,nM,,760.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.76
,,3498235,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc(C(C)=O)cc3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1257702,,CHEMBL1257702,7.40,0,http://www.openphacts.org/units/Nanomolar,962611,=,1,1,=,,IC50,nM,,40.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,40.0
,,3498236,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc(C)cc3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1257703,,CHEMBL1257703,8.50,0,http://www.openphacts.org/units/Nanomolar,962612,=,1,1,=,,IC50,nM,,3.16,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3.16
,,3498237,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc(C)c(C)c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1257825,,CHEMBL1257825,6.25,0,http://www.openphacts.org/units/Nanomolar,962740,=,1,1,=,,IC50,nM,,568.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,568.0
,,3498238,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc(F)cc3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1257826,,CHEMBL1257826,8.86,0,http://www.openphacts.org/units/Nanomolar,962741,=,1,1,=,,IC50,nM,,1.39,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1.39
,,3498239,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc(F)c(F)c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1257941,,CHEMBL1257941,6.53,0,http://www.openphacts.org/units/Nanomolar,962870,=,1,1,=,,IC50,nM,,294.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,294.0
,,3498240,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(-c2c(C)nn(-c3ccccc3C)c2Nc2ccc(OC)cc2C(=O)O)cc1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1257942,,CHEMBL1257942,6.51,0,http://www.openphacts.org/units/Nanomolar,962871,=,1,1,=,,IC50,nM,,306.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,306.0
,,3498241,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc(OC)c(OC)c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258052,,CHEMBL1258052,6.63,0,http://www.openphacts.org/units/Nanomolar,962995,=,1,1,=,,IC50,nM,,233.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,233.0
,,3498242,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc4c(c3)OCO4)c(C)nn2-c2ccccc2C)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258053,,CHEMBL1258053,6.64,0,http://www.openphacts.org/units/Nanomolar,962996,=,1,1,=,,IC50,nM,,231.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,231.0
,,3498243,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc4c(c3)OCCO4)c(C)nn2-c2ccccc2C)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258169,,CHEMBL1258169,7.57,0,http://www.openphacts.org/units/Nanomolar,963122,=,1,1,=,,IC50,nM,,27.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,27.0
,,3498244,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258170,,CHEMBL1258170,8.49,0,http://www.openphacts.org/units/Nanomolar,963123,=,1,1,=,,IC50,nM,,3.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3.2
,,3498245,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccc(Cl)cc1C(=O)O,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258283,,CHEMBL1258283,7.80,0,http://www.openphacts.org/units/Nanomolar,963248,=,1,1,=,,IC50,nM,,16.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,16.0
,,3498246,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258284,,CHEMBL1258284,8.29,0,http://www.openphacts.org/units/Nanomolar,963249,=,1,1,=,,IC50,nM,,5.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.1
,,3498247,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258396,,CHEMBL1258396,8.10,0,http://www.openphacts.org/units/Nanomolar,963371,=,1,1,=,,IC50,nM,,8.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,8.0
,,3498248,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258397,,CHEMBL1258397,8.55,0,http://www.openphacts.org/units/Nanomolar,963372,=,1,1,=,,IC50,nM,,2.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.8
,,3498249,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2C2CCCCC2)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258505,,CHEMBL1258505,6.36,0,http://www.openphacts.org/units/Nanomolar,963497,=,1,1,=,,IC50,nM,,435.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,435.0
,,3498250,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2Cl)c(C(=O)O)c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258506,,CHEMBL1258506,8.14,0,http://www.openphacts.org/units/Nanomolar,963498,=,1,1,=,,IC50,nM,,7.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,7.3
,,3498251,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CCc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccc(OC)cc1C(=O)O,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258621,,CHEMBL1258621,8.19,0,http://www.openphacts.org/units/Nanomolar,963626,=,1,1,=,,IC50,nM,,6.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,6.4
,,3498252,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1-n1nc(C(F)(F)F)c(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258622,,CHEMBL1258622,8.05,0,http://www.openphacts.org/units/Nanomolar,963627,=,1,1,=,,IC50,nM,,9.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,9.0
,,3498253,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CCc1nn(-c2ccccc2C)c(Nc2ccccc2C(=O)O)c1-c1ccc2nccnc2c1,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258730,,CHEMBL1258730,7.89,0,http://www.openphacts.org/units/Nanomolar,963753,=,1,1,=,,IC50,nM,,13.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,13.0
,,3498254,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1-n1ncc(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258731,,CHEMBL1258731,6.56,0,http://www.openphacts.org/units/Nanomolar,963754,=,1,1,=,,IC50,nM,,277.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,277.0
,,3498255,[],CHEMBL1259522,Antagonist activity at adenosine A1 receptor by cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1-n1nc(C)c(-c2cc(F)c3nccnc3c2)c1Nc1ccccc1C(=O)O,,,CHEMBL1255521,Bioorg Med Chem Lett,2010.0,,CHEMBL1258850,,CHEMBL1258850,9.22,0,http://www.openphacts.org/units/Nanomolar,963879,=,1,1,=,,IC50,nM,,0.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.6
,,5165956,[],CHEMBL1663571,Inhibition of human adenosine A1 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL1649335,Bioorg Med Chem,2010.0,"{'bei': '24.97', 'le': '0.47', 'lle': '5.24', 'sei': '10.46'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,7.60,0,http://www.openphacts.org/units/Nanomolar,1323886,=,1,1,=,,IC50,nM,,25.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,25.0
,,6159077,[],CHEMBL1763710,Inhibition of Adenosine receptor A1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cn2c(=O)[nH]c3c(N)nc(-c4ncco4)cc32)cn1,,,CHEMBL1759966,Bioorg Med Chem Lett,2011.0,"{'bei': '18.66', 'le': '0.34', 'lle': '4.30', 'sei': '5.20'}",CHEMBL1760580,,CHEMBL1760580,6.01,0,http://www.openphacts.org/units/Nanomolar,1412635,=,1,1,=,,IC50,nM,,970.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,970.0
,,6159079,[],CHEMBL1763710,Inhibition of Adenosine receptor A1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cn2c(=O)[nH]c3c(N)nc(-c4nc(C)co4)cc32)cn1,,,CHEMBL1759966,Bioorg Med Chem Lett,2011.0,"{'bei': '17.23', 'le': '0.32', 'lle': '3.78', 'sei': '5.01'}",CHEMBL1760581,,CHEMBL1760581,5.80,0,http://www.openphacts.org/units/Nanomolar,1412636,=,1,1,=,,IC50,nM,,1600.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1600.0
,,6159081,[],CHEMBL1763710,Inhibition of Adenosine receptor A1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cn2c(=O)[nH]c3c(N)nc(-n4nccn4)cc32)cn1,,,CHEMBL1759966,Bioorg Med Chem Lett,2011.0,"{'bei': '17.75', 'le': '0.33', 'lle': '5.08', 'sei': '4.76'}",CHEMBL1760582,,CHEMBL1760582,5.72,0,http://www.openphacts.org/units/Nanomolar,1412637,=,1,1,=,,IC50,nM,,1900.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1900.0
,,6159083,[],CHEMBL1763710,Inhibition of Adenosine receptor A1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cn2c(=O)[nH]c3c(N)nc(-n4cccn4)cc32)cn1,,,CHEMBL1759966,Bioorg Med Chem Lett,2011.0,"{'bei': '17.28', 'le': '0.32', 'lle': '4.31', 'sei': '5.17'}",CHEMBL1760583,,CHEMBL1760583,5.55,0,http://www.openphacts.org/units/Nanomolar,1412638,=,1,1,=,,IC50,nM,,2800.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2800.0
,,7635548,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,,,CHEMBL1909046,,,"{'bei': '9.81', 'le': '0.38', 'lle': '2.44', 'sei': '6.88'}",CHEMBL1544,LIOTHYRONINE,CHEMBL1544,6.39,0,http://www.openphacts.org/units/Nanomolar,1539438,=,15,1,=,,IC50,nM,,410.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.4109
,,7636104,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12,,,CHEMBL1909046,,,"{'bei': '21.84', 'le': '0.39', 'lle': '1.34', 'sei': '19.68'}",CHEMBL283196,ALPHA-NAPHTHOFLAVONE,CHEMBL283196,5.95,0,http://www.openphacts.org/units/Nanomolar,1539471,=,15,1,=,,IC50,nM,,1132.5,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,1.1325
,,7702626,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1,,,CHEMBL1909046,,,"{'bei': '20.66', 'le': '0.38', 'lle': '0.71', 'sei': '13.70'}",CHEMBL411,DIETHYLSTILBESTROL,CHEMBL411,5.54,0,http://www.openphacts.org/units/Nanomolar,1539695,=,15,1,=,,IC50,nM,,2856.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,2.856
,,7739749,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],,,CHEMBL1909046,,,"{'bei': '14.76', 'le': '0.28', 'lle': '2.93', 'sei': '4.74'}",CHEMBL193,NIFEDIPINE,CHEMBL193,5.11,0,http://www.openphacts.org/units/Nanomolar,1539987,=,15,1,=,,IC50,nM,,7701.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,7.701
,,7804912,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2,,,CHEMBL1909046,,,"{'bei': '18.10', 'le': '0.33', 'lle': '2.08', 'sei': '7.88'}",CHEMBL115769,,CHEMBL115769,6.05,0,http://www.openphacts.org/units/Nanomolar,1540128,=,15,1,=,,IC50,nM,,887.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.887
,,7815961,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,,,CHEMBL1909046,,,"{'bei': '12.28', 'le': '0.24', 'lle': '4.22', 'sei': '5.14'}",CHEMBL192,SILDENAFIL,CHEMBL192,5.83,0,http://www.openphacts.org/units/Nanomolar,1540147,=,15,1,=,,IC50,nM,,1493.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,1.493
,,7822149,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL1909046,,,"{'bei': '14.65', 'le': '0.28', 'lle': '0.85', 'sei': '8.56'}",CHEMBL10,SB-203580,CHEMBL10,5.53,0,http://www.openphacts.org/units/Nanomolar,1540140,=,15,1,=,,IC50,nM,,2950.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,2.95
,,7929400,[],CHEMBL1918027,Inhibition of adenosine A1 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCCOCCn1c(=O)nc(NC2CCC(O)CC2)c2nnc(-c3ccc(OC)nc3)cc21,,,CHEMBL1914420,Bioorg Med Chem Lett,2011.0,"{'bei': '13.98', 'le': '0.26', 'lle': '3.96', 'sei': '5.11'}",CHEMBL1916475,,CHEMBL1916475,6.36,0,http://www.openphacts.org/units/Nanomolar,1558913,=,1,1,=,,IC50,nM,,440.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,440.0
,,7938908,[],CHEMBL1919362,Inhibition of adenosine A1 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(F)cc2c1nc(C)c1c(C)nc(-c3ccncc3C)n12,,,CHEMBL1914403,J Med Chem,2011.0,"{'bei': '20.29', 'le': '0.37', 'lle': '2.80', 'sei': '13.05'}",CHEMBL1916113,,CHEMBL1916113,6.82,0,http://www.openphacts.org/units/Nanomolar,1558494,=,1,1,=,,IC50,nM,,150.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,150.0
,,10925281,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(F)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042297,,CHEMBL2042297,9.44,0,http://www.openphacts.org/units/Nanomolar,1649925,=,1,1,=,,IC50,nM,,0.36,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.36
,,10925282,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccccc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042298,,CHEMBL2042298,6.95,0,http://www.openphacts.org/units/Nanomolar,1649926,=,1,1,=,,IC50,nM,,112.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,112.0
,,10925283,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(N)cc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042299,,CHEMBL2042299,6.49,0,http://www.openphacts.org/units/Nanomolar,1649927,=,1,1,=,,IC50,nM,,326.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,326.0
,,10925284,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(Br)cc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042300,,CHEMBL2042300,5.68,0,http://www.openphacts.org/units/Nanomolar,1649928,=,1,1,=,,IC50,nM,,2082.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2082.0
,,10925285,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)cc(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042301,,CHEMBL2042301,5.63,0,http://www.openphacts.org/units/Nanomolar,1649929,=,1,1,=,,IC50,nM,,2324.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2324.0
,,10925286,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)c(O)c(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042302,,CHEMBL2042302,5.40,0,http://www.openphacts.org/units/Nanomolar,1649930,=,1,1,=,,IC50,nM,,3990.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3990.0
,,10925287,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)CCCC[C@H]5CCSS5)cc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042303,,CHEMBL2042303,5.67,0,http://www.openphacts.org/units/Nanomolar,1649931,=,1,1,=,,IC50,nM,,2136.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2136.0
,,10925288,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(F)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042304,,CHEMBL2042304,8.00,0,http://www.openphacts.org/units/Nanomolar,1649932,=,1,1,=,,IC50,nM,,10.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,10.0
,,10925289,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccccc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042305,,CHEMBL2042305,6.00,0,http://www.openphacts.org/units/Nanomolar,1649933,=,1,1,=,,IC50,nM,,1007.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1007.0
,,10925290,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(N)cc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042306,,CHEMBL2042306,5.93,0,http://www.openphacts.org/units/Nanomolar,1649934,=,1,1,=,,IC50,nM,,1184.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1184.0
,,10925291,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(Br)cc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042307,,CHEMBL2042307,6.37,0,http://www.openphacts.org/units/Nanomolar,1649935,=,1,1,=,,IC50,nM,,428.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,428.0
,,10925292,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)cc(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042308,,CHEMBL2042308,5.66,0,http://www.openphacts.org/units/Nanomolar,1649936,=,1,1,=,,IC50,nM,,2208.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2208.0
,,10925293,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)c(O)c(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042309,,CHEMBL2042309,5.28,0,http://www.openphacts.org/units/Nanomolar,1649937,=,1,1,=,,IC50,nM,,5251.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5251.0
,,10925294,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)CCCC[C@H]5CCSS5)cc4)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042310,,CHEMBL2042310,5.41,0,http://www.openphacts.org/units/Nanomolar,1649938,=,1,1,=,,IC50,nM,,3914.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3914.0
,,10925295,[],CHEMBL2044691,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(F)nc32)[C@H](O)[C@@H]1O,,,CHEMBL2040819,J Med Chem,2012.0,,CHEMBL2042311,,CHEMBL2042311,6.91,0,http://www.openphacts.org/units/Nanomolar,1649939,=,1,1,=,,IC50,nM,,122.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,122.0
,,13336219,[],CHEMBL2395779,Binding affinity to human adenosine A1 receptor by radioligand displacement assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL2390917,Bioorg Med Chem,2013.0,"{'bei': '29.77', 'le': '0.56', 'lle': '6.70', 'sei': '12.47'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,9.06,0,http://www.openphacts.org/units/Nanomolar,1898814,=,1,1,=,,IC50,nM,,0.87,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.87
,,13340407,[],CHEMBL2395290,Displacement of [3H]DPCPX from human recombinant adenosine receptor A1 expressed in CHO cells after 90 mins,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Cc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,,CHEMBL2390918,Bioorg Med Chem Lett,2013.0,"{'bei': '15.78', 'le': '0.30', 'lle': '5.60', 'sei': '4.84'}",CHEMBL139000,(R)-PIA,CHEMBL139000,6.08,0,http://www.openphacts.org/units/Nanomolar,1899730,=,1,1,=,,IC50,nM,,830.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.83
,,13342124,[],CHEMBL2395714,Binding affinity to human adenosine A1 receptor by radioligand displacement assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL2390830,Eur J Med Chem,2013.0,"{'bei': '29.73', 'le': '0.56', 'lle': '6.69', 'sei': '12.45'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,9.05,1,http://www.openphacts.org/units/Nanomolar,1900372,=,1,1,=,,IC50,nM,,0.89,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,10'-10M,UO_0000065,,8.9
,,13398747,[],CHEMBL2417045,Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response after 1 hr by SPAP reporter gene assay in presence of forskolin,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCCCCNC(=O)CCC4=CC5Cc6c(C)cc(C)n6[B-](F)(F)[N+]5=C4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL2412992,Bioorg Med Chem Lett,2013.0,,CHEMBL2414812,,CHEMBL2414812,6.57,0,http://www.openphacts.org/units/Nanomolar,1912790,=,1,1,=,,IC50,nM,,269.15,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,6.57
,,13398799,[],CHEMBL2417044,Agonist activity at human adenosine A1 receptor expressed in CHO cells by scintillation counting analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCCCCNS(=O)(=O)c4cccc5c(N(C)C)cccc45)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL2412992,Bioorg Med Chem Lett,2013.0,"{'bei': '9.96', 'le': '0.19', 'lle': '3.38', 'sei': '3.85'}",CHEMBL2413110,,CHEMBL2413110,7.08,0,http://www.openphacts.org/units/Nanomolar,1910660,=,1,1,=,,IC50,nM,,83.18,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,7.08
,,13398800,[],CHEMBL2417044,Agonist activity at human adenosine A1 receptor expressed in CHO cells by scintillation counting analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCCCCCCNS(=O)(=O)c4cccc5c(N(C)C)cccc45)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL2412992,Bioorg Med Chem Lett,2013.0,"{'bei': '8.81', 'le': '0.17', 'lle': '4.21', 'sei': '3.12'}",CHEMBL2413109,,CHEMBL2413109,6.64,0,http://www.openphacts.org/units/Nanomolar,1910659,=,1,1,=,,IC50,nM,,229.09,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,6.64
,,13398801,[],CHEMBL2417044,Agonist activity at human adenosine A1 receptor expressed in CHO cells by scintillation counting analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCNS(=O)(=O)c4cccc5c(N(C)C)cccc45)ncnc32)[C@H](C)[C@@H]1C,,,CHEMBL2412992,Bioorg Med Chem Lett,2013.0,"{'bei': '8.95', 'le': '0.17', 'lle': '0.87', 'sei': '4.15'}",CHEMBL2413106,,CHEMBL2413106,5.95,0,http://www.openphacts.org/units/Nanomolar,1910656,=,1,1,=,,IC50,nM,,1122.02,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,5.95
,,13398802,[],CHEMBL2417045,Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response after 1 hr by SPAP reporter gene assay in presence of forskolin,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCC4=[N+]5C(=Cc6c(C)cc(C)n6[B-]5(F)F)C=C4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL2412992,Bioorg Med Chem Lett,2013.0,,CHEMBL2413236,,CHEMBL2413236,6.03,0,http://www.openphacts.org/units/Nanomolar,1910815,=,1,1,=,,IC50,nM,,933.25,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,6.03
,,13489781,[],CHEMBL2438813,Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-mediated reduction of intracellular [3H]-cAMP accumulation incubated for 15 mins prior to NECA induction measured after 30 mins by liquid scintillation spectrometric analysis in presence of forskolin,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(C(=O)c1cn(Cc2ccccc2)c2ccccc12)c1ccco1,,,CHEMBL2434872,Eur J Med Chem,2013.0,,CHEMBL2435537,,CHEMBL2435537,6.54,0,http://www.openphacts.org/units/Nanomolar,1923880,=,1,1,=,,IC50,nM,,291.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,291.4
,,13489782,[],CHEMBL2438813,Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-mediated reduction of intracellular [3H]-cAMP accumulation incubated for 15 mins prior to NECA induction measured after 30 mins by liquid scintillation spectrometric analysis in presence of forskolin,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(C(=O)c1cn(Cc2ccccc2)c2ccccc12)c1ccccc1,,,CHEMBL2434872,Eur J Med Chem,2013.0,,CHEMBL2435536,,CHEMBL2435536,6.39,0,http://www.openphacts.org/units/Nanomolar,1923879,=,1,1,=,,IC50,nM,,404.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,404.2
,,14533569,[],CHEMBL3223308,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3217410,Medchemcomm,2012.0,,CHEMBL464859,NECA,CHEMBL464859,9.10,0,http://www.openphacts.org/units/Nanomolar,2076766,=,1,1,=,,IC50,nM,,0.7943,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,9.1
,,14533570,[],CHEMBL3223308,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3217410,Medchemcomm,2012.0,,CHEMBL2413230,,CHEMBL2413230,8.69,0,http://www.openphacts.org/units/Nanomolar,2076767,=,1,1,=,,IC50,nM,,2.042,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.69
,,14533571,[],CHEMBL3223308,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3217410,Medchemcomm,2012.0,,CHEMBL2413231,,CHEMBL2413231,9.31,0,http://www.openphacts.org/units/Nanomolar,2076768,=,1,1,=,,IC50,nM,,0.4898,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,9.31
,,14533572,[],CHEMBL3223308,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3217410,Medchemcomm,2012.0,,CHEMBL2413232,,CHEMBL2413232,8.28,0,http://www.openphacts.org/units/Nanomolar,2076769,=,1,1,=,,IC50,nM,,5.248,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.28
,,14533573,[],CHEMBL3223308,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3217410,Medchemcomm,2012.0,,CHEMBL2413233,,CHEMBL2413233,7.57,0,http://www.openphacts.org/units/Nanomolar,2076770,=,1,1,=,,IC50,nM,,26.92,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,7.57
,,14533574,[],CHEMBL3223308,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3217410,Medchemcomm,2012.0,,CHEMBL2413234,,CHEMBL2413234,6.89,0,http://www.openphacts.org/units/Nanomolar,2076771,=,1,1,=,,IC50,nM,,128.82,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,6.89
,,14533575,[],CHEMBL3223308,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCOCCOCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3217410,Medchemcomm,2012.0,,CHEMBL2413235,,CHEMBL2413235,7.13,0,http://www.openphacts.org/units/Nanomolar,2076772,=,1,1,=,,IC50,nM,,74.13,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,7.13
,,14533576,[],CHEMBL3223308,Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCOCCOCCOCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3217410,Medchemcomm,2012.0,,CHEMBL3221341,,CHEMBL3221341,6.72,0,http://www.openphacts.org/units/Nanomolar,2076773,=,1,1,=,,IC50,nM,,190.55,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,6.72
,,14744285,[],CHEMBL3296314,Inhibition of adenosine A1 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ncc(C(=O)N2CCC(Nc3cc(=O)n(C)c4ccccc34)CC2)c1Cl,,,CHEMBL3286182,J Med Chem,2014.0,"{'bei': '12.75', 'le': '0.25', 'lle': '2.46', 'sei': '7.06'}",CHEMBL3290772,,CHEMBL3290772,5.10,0,http://www.openphacts.org/units/Nanomolar,2118847,=,1,1,=,,IC50,nM,,8000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,8.0
,,14744286,[],CHEMBL3296314,Inhibition of adenosine A1 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1onc(C(=O)N2CCC(Nc3cc(=O)n(C)c4cc(F)c(F)cc34)CC2)c1C,,,CHEMBL3286182,J Med Chem,2014.0,"{'bei': '12.24', 'le': '0.23', 'lle': '1.96', 'sei': '6.34'}",CHEMBL3291056,,CHEMBL3291056,5.10,0,http://www.openphacts.org/units/Nanomolar,2119174,=,1,1,=,,IC50,nM,,8000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,8.0
,,14744287,[],CHEMBL3296314,Inhibition of adenosine A1 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1onc(C(=O)N2[C@@H]3CC[C@H]2C[C@@H](Nc2cc(=O)n(C)c4cc(F)c(F)cc24)C3)c1C,,,CHEMBL3286182,J Med Chem,2014.0,"{'bei': '11.52', 'le': '0.22', 'lle': '1.43', 'sei': '6.34'}",CHEMBL3291062,,CHEMBL3291062,5.10,0,http://www.openphacts.org/units/Nanomolar,2119180,=,1,1,=,,IC50,nM,,8000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,8.0
,,14744288,[],CHEMBL3296314,Inhibition of adenosine A1 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ncc(C(=O)N2[C@@H]3CC[C@H]2C[C@@H](Nc2n[nH]c4ccc(F)cc24)C3)c1Cl,,,CHEMBL3286182,J Med Chem,2014.0,"{'bei': '12.65', 'le': '0.25', 'lle': '1.76', 'sei': '6.46'}",CHEMBL3291063,,CHEMBL3291063,5.10,0,http://www.openphacts.org/units/Nanomolar,2119181,=,1,1,=,,IC50,nM,,8000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,8.0
,,14994329,[],CHEMBL3383140,Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins by liquid scintillation spectrometry,F,,,BAO_0000190,BAO_0000219,cell-based format,CCc1nc2c(=O)n(Cc3ccccc3)nc(C3CCC3)c2c2cc(-c3ccccc3)nn12,,,CHEMBL3351777,Eur J Med Chem,2015.0,,CHEMBL3359414,,CHEMBL3359414,8.54,0,http://www.openphacts.org/units/Nanomolar,2267084,=,1,1,=,,IC50,nM,,2.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.9
,,14994330,[],CHEMBL3383140,Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins by liquid scintillation spectrometry,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2c(=O)n(Cc3ccccc3)nc(C3CCCC3)c2c2cc(-c3ccccc3)nn12,,,CHEMBL3351777,Eur J Med Chem,2015.0,,CHEMBL379204,,CHEMBL379204,8.29,0,http://www.openphacts.org/units/Nanomolar,2267080,=,1,1,=,,IC50,nM,,5.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.1
,,15029625,[],CHEMBL3379791,Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc(CCCc2ccccc2)nc2cn(-c3ccccc3)nc12,,,CHEMBL3352340,Eur J Med Chem,2014.0,,CHEMBL3317574,,CHEMBL3317574,7.37,0,http://www.openphacts.org/units/Nanomolar,2272023,=,1,1,=,,IC50,nM,,43.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,43.0
,,15029626,[],CHEMBL3379791,Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1CCCc1nc(N)c2nn(-c3ccccc3)cc2n1,,,CHEMBL3352340,Eur J Med Chem,2014.0,,CHEMBL3317575,,CHEMBL3317575,7.92,0,http://www.openphacts.org/units/Nanomolar,2272024,=,1,1,=,,IC50,nM,,12.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,12.0
,,15029627,[],CHEMBL3379791,Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(CCCc2nc(N)c3nn(-c4ccccc4)cc3n2)c1,,,CHEMBL3352340,Eur J Med Chem,2014.0,,CHEMBL3317576,,CHEMBL3317576,8.62,0,http://www.openphacts.org/units/Nanomolar,2272025,=,1,1,=,,IC50,nM,,2.41,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.41
,,15029628,[],CHEMBL3379791,Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc(CCCc2ccccc2O)nc2cn(-c3ccccc3)nc12,,,CHEMBL3352340,Eur J Med Chem,2014.0,,CHEMBL3317578,,CHEMBL3317578,8.37,0,http://www.openphacts.org/units/Nanomolar,2272027,=,1,1,=,,IC50,nM,,4.26,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,4.26
,,15029629,[],CHEMBL3379791,Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc(CCCc2cccc(O)c2)nc2cn(-c3ccccc3)nc12,,,CHEMBL3352340,Eur J Med Chem,2014.0,,CHEMBL3317579,,CHEMBL3317579,8.54,0,http://www.openphacts.org/units/Nanomolar,2272028,=,1,1,=,,IC50,nM,,2.87,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.87
,,16486665,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL464859,NECA,CHEMBL464859,9.68,0,http://www.openphacts.org/units/Nanomolar,2760548,=,1,1,=,,IC50,nM,,0.2089,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,9.68
,,16486666,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL477,ADENOSINE,CHEMBL477,8.63,0,http://www.openphacts.org/units/Nanomolar,2760549,=,1,1,=,,IC50,nM,,2.344,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.63
,,16486667,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL284969,,CHEMBL284969,9.30,0,http://www.openphacts.org/units/Nanomolar,2760550,=,1,1,=,,IC50,nM,,0.5012,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,9.3
,,16486668,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL3771290,,CHEMBL3771290,7.72,0,http://www.openphacts.org/units/Nanomolar,2760552,=,1,1,=,,IC50,nM,,19.05,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,7.72
,,16486669,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL3771208,,CHEMBL3771208,9.17,0,http://www.openphacts.org/units/Nanomolar,2760553,=,1,1,=,,IC50,nM,,0.6761,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,9.17
,,16486670,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL116903,,CHEMBL116903,8.36,0,http://www.openphacts.org/units/Nanomolar,2760554,=,1,1,=,,IC50,nM,,4.365,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.36
,,16486671,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL3770664,,CHEMBL3770664,8.54,0,http://www.openphacts.org/units/Nanomolar,2760556,=,1,1,=,,IC50,nM,,2.884,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.54
,,16486672,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(O)(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL3769641,,CHEMBL3769641,7.43,0,http://www.openphacts.org/units/Nanomolar,2760557,=,1,1,=,,IC50,nM,,37.15,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,7.43
,,16486673,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4C5CC6CC(C5)CC4C6)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL3771184,,CHEMBL3771184,9.40,0,http://www.openphacts.org/units/Nanomolar,2760558,=,1,1,=,,IC50,nM,,0.3981,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,9.4
,,16486674,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL3770679,,CHEMBL3770679,10.53,0,http://www.openphacts.org/units/Nanomolar,2760560,=,1,1,=,,IC50,nM,,0.02951,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,10.53
,,16486675,[],CHEMBL3772951,Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL3769381,J Med Chem,2016.0,,CHEMBL3770310,,CHEMBL3770310,8.21,0,http://www.openphacts.org/units/Nanomolar,2760561,=,1,1,=,,IC50,nM,,6.166,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.21
,,16501844,[],CHEMBL3779523,Displacement of [3H]DPCPX from human recombinant adenosine A1 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL3774372,Bioorg Med Chem,2016.0,"{'bei': '30.56', 'le': '0.58', 'lle': '6.94', 'sei': '12.80'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,9.30,0,http://www.openphacts.org/units/Nanomolar,2762812,=,1,1,=,,IC50,nM,,0.5,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,10'-10M,UO_0000065,,5.0
,,16580412,[],CHEMBL3802561,Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1Cn1cc2nc(-c3ccco3)nc(N)c2n1,,,CHEMBL3797185,Bioorg Med Chem,2016.0,,CHEMBL3798766,,CHEMBL3798766,6.97,0,http://www.openphacts.org/units/Nanomolar,2774734,=,1,1,=,,IC50,nM,,106.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,106.0
,,16580413,[],CHEMBL3802561,Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2nc(N)c3nn(Cc4ccccc4)cc3n2)o1,,,CHEMBL3797185,Bioorg Med Chem,2016.0,,CHEMBL3798754,,CHEMBL3798754,6.82,0,http://www.openphacts.org/units/Nanomolar,2774736,=,1,1,=,,IC50,nM,,152.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,152.0
,,16580414,[],CHEMBL3802561,Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1Cn1cc2nc(-c3ccc(C)o3)nc(N)c2n1,,,CHEMBL3797185,Bioorg Med Chem,2016.0,,CHEMBL3799351,,CHEMBL3799351,7.68,0,http://www.openphacts.org/units/Nanomolar,2774737,=,1,1,=,,IC50,nM,,21.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,21.0
,,16580415,[],CHEMBL3802561,Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(Cn2cc3nc(-c4ccc(C)o4)nc(N)c3n2)c1,,,CHEMBL3797185,Bioorg Med Chem,2016.0,,CHEMBL3800587,,CHEMBL3800587,6.87,0,http://www.openphacts.org/units/Nanomolar,2774738,=,1,1,=,,IC50,nM,,134.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,134.0
,,16771608,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3ccc(CC(=O)NCCCCCCCN(C)CCO)cc3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3957127,,CHEMBL3957127,7.21,0,http://www.openphacts.org/units/Nanomolar,2804076,=,1,1,=,,IC50,nM,,61.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,61.0
,,16771609,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(CC(=O)NCCCCCCCN(C)CCO)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3896989,,CHEMBL3896989,7.55,0,http://www.openphacts.org/units/Nanomolar,2804075,=,1,1,=,,IC50,nM,,28.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,28.0
,,16771610,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(C(=O)NCCCCCCCN(C)CCO)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3968147,,CHEMBL3968147,7.89,0,http://www.openphacts.org/units/Nanomolar,2804074,=,1,1,=,,IC50,nM,,13.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,13.0
,,16771611,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3ccc(CC(=O)NCCN4CCCCC4)cc3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3905929,,CHEMBL3905929,7.51,0,http://www.openphacts.org/units/Nanomolar,2804073,=,1,1,=,,IC50,nM,,31.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,31.0
,,16771612,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(C(=O)NCCC4CCCN4C)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3918173,,CHEMBL3918173,8.70,0,http://www.openphacts.org/units/Nanomolar,2804072,=,1,1,=,,IC50,nM,,2.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.0
,,16771613,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(C(=O)NCCN4CCOCC4)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3986586,,CHEMBL3986586,7.82,0,http://www.openphacts.org/units/Nanomolar,2804071,=,1,1,=,,IC50,nM,,15.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,15.0
,,16771614,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(C(=O)NCCN4CCNCC4)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3916846,,CHEMBL3916846,8.70,0,http://www.openphacts.org/units/Nanomolar,2804070,=,1,1,=,,IC50,nM,,2.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.0
,,16771615,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(C(=O)NCCN4CCCCC4)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3941513,,CHEMBL3941513,8.22,0,http://www.openphacts.org/units/Nanomolar,2804069,=,1,1,=,,IC50,nM,,6.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,6.0
,,16771616,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(C(=O)NCCN(C)C)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3980193,,CHEMBL3980193,8.70,0,http://www.openphacts.org/units/Nanomolar,2804068,=,1,1,=,,IC50,nM,,2.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.0
,,16771617,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(C(=O)NC4CC4)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3952586,,CHEMBL3952586,8.00,0,http://www.openphacts.org/units/Nanomolar,2804067,=,1,1,=,,IC50,nM,,10.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,10.0
,,16771618,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3ccc(CC(=O)O)cc3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3892121,,CHEMBL3892121,6.74,0,http://www.openphacts.org/units/Nanomolar,2804064,=,1,1,=,,IC50,nM,,184.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,184.0
,,16771619,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(CC(=O)O)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3950249,,CHEMBL3950249,8.30,0,http://www.openphacts.org/units/Nanomolar,2804063,=,1,1,=,,IC50,nM,,5.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.0
,,16771621,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(C(=O)O)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3963331,,CHEMBL3963331,7.77,0,http://www.openphacts.org/units/Nanomolar,2804058,=,1,1,=,,IC50,nM,,17.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,17.0
,,16771646,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cccc(O)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3969954,,CHEMBL3969954,7.06,0,http://www.openphacts.org/units/Nanomolar,2804047,=,1,1,=,,IC50,nM,,87.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,87.0
,,16771647,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cncc(O)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3903604,,CHEMBL3903604,7.96,0,http://www.openphacts.org/units/Nanomolar,2804055,=,1,1,=,,IC50,nM,,11.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,11.0
,,16771681,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cc(OCC4CC4)cc(C(=O)NCCN4CCCCC4)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3903408,,CHEMBL3903408,7.09,0,http://www.openphacts.org/units/Nanomolar,2804083,=,1,1,=,,IC50,nM,,81.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,81.0
,,16771682,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cc(C(=O)NCC[C@H]4CCCN4C)cc(C(=O)NC4CC4)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3945895,,CHEMBL3945895,6.40,0,http://www.openphacts.org/units/Nanomolar,2804082,=,1,1,=,,IC50,nM,,399.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,399.0
,,16771683,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)c1cc(C(=O)NCCCN(C)C)cc(-c2cccc(-c3cc(NC(=O)Nc4c(Cl)cncc4Cl)c(=O)n(CC)n3)c2)c1,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3941862,,CHEMBL3941862,6.27,0,http://www.openphacts.org/units/Nanomolar,2804081,=,1,1,=,,IC50,nM,,537.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,537.0
,,16771684,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cc(C(=O)NCCCN(C)C)cc(C(=O)OC)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3913876,,CHEMBL3913876,7.15,0,http://www.openphacts.org/units/Nanomolar,2804080,=,1,1,=,,IC50,nM,,71.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,71.0
,,16771685,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cc(C(=O)NC4CC4)cc(C(=O)NC4CC4)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3977665,,CHEMBL3977665,6.49,0,http://www.openphacts.org/units/Nanomolar,2804079,=,1,1,=,,IC50,nM,,324.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,324.0
,,16771686,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cc(C(=O)NC2CC2)cc(-c2cccc(-c3cc(NC(=O)Nc4c(Cl)cncc4Cl)c(=O)n(CC)n3)c2)c1,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3948448,,CHEMBL3948448,7.23,0,http://www.openphacts.org/units/Nanomolar,2804078,=,1,1,=,,IC50,nM,,59.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,59.0
,,16771687,[],CHEMBL3863976,Antagonist activity at adenosine A1 receptor (unknown origin),A,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(-c2cccc(-c3cc(C#N)cc(C(=O)NC4CC4)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O,,,CHEMBL3862036,J Med Chem,2016.0,,CHEMBL3985784,,CHEMBL3985784,6.20,0,http://www.openphacts.org/units/Nanomolar,2804077,=,1,1,=,,IC50,nM,,634.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,634.0
,,16838398,[],CHEMBL3876336,Displacement of [3H]DPCPX from human recombinant adenosine receptor A1 expressed in CHO cells measured after 60 mins by scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL3875185,Bioorg Med Chem,2017.0,"{'bei': '30.56', 'le': '0.58', 'lle': '6.94', 'sei': '12.80'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,9.30,1,http://www.openphacts.org/units/Nanomolar,2815507,=,1,1,=,,IC50,nM,,0.5,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,10'-10M,UO_0000065,,5.0
,323805,17702842,[],CHEMBL3887219,"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.",F,,,BAO_0000190,BAO_0000019,assay format,CNc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1,,,CHEMBL3886219,,2015.0,,CHEMBL1077943,,CHEMBL1077943,7.24,0,http://www.openphacts.org/units/Nanomolar,2836973,=,37,1,=,,IC50,nM,,57.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,57.6
,323806,17702843,[],CHEMBL3887219,"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.",F,,,BAO_0000190,BAO_0000019,assay format,CN(C)c1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1,,,CHEMBL3886219,,2015.0,,CHEMBL1081160,,CHEMBL1081160,7.71,0,http://www.openphacts.org/units/Nanomolar,2836974,=,37,1,=,,IC50,nM,,19.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,19.4
,323807,17702844,[],CHEMBL3887219,"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.",F,,,BAO_0000190,BAO_0000019,assay format,CCNc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1,,,CHEMBL3886219,,2015.0,,CHEMBL1080421,,CHEMBL1080421,6.93,0,http://www.openphacts.org/units/Nanomolar,2836975,=,37,1,=,,IC50,nM,,118.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,118.3
,323808,17702845,[],CHEMBL3887219,"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.",F,,,BAO_0000190,BAO_0000019,assay format,Nc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1,,,CHEMBL3886219,,2015.0,,CHEMBL1080241,,CHEMBL1080241,5.96,0,http://www.openphacts.org/units/Nanomolar,2836976,=,37,1,=,,IC50,nM,,1103.5,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1103.5
,323809,17702846,[],CHEMBL3887219,"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.",F,,,BAO_0000190,BAO_0000019,assay format,C=Cc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1,,,CHEMBL3886219,,2015.0,,CHEMBL3973260,,CHEMBL3973260,6.79,0,http://www.openphacts.org/units/Nanomolar,2836977,=,37,1,=,,IC50,nM,,161.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,161.3
,323810,17702847,[],CHEMBL3887219,"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.",F,,,BAO_0000190,BAO_0000019,assay format,CCc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1,,,CHEMBL3886219,,2015.0,,CHEMBL3952824,,CHEMBL3952824,6.67,0,http://www.openphacts.org/units/Nanomolar,2836978,=,37,1,=,,IC50,nM,,216.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,216.0
,323811,17702848,[],CHEMBL3887219,"Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.",F,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cccs1)c1nc(NCc2cccnc2)nc2cc(NCc3cccnc3)sc12,,,CHEMBL3886219,,2015.0,,CHEMBL3922797,,CHEMBL3922797,6.59,0,http://www.openphacts.org/units/Nanomolar,2836979,=,37,1,=,,IC50,nM,,256.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,256.2
,,18286230,[],CHEMBL4121465,Displacement of [3H]-DPCPX from human recombinant adenosine A1 receptor after 60 mins by scintillation counting analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12,,,CHEMBL4118122,Bioorg Med Chem Lett,2018.0,"{'bei': '15.78', 'le': '0.31', 'lle': '3.45', 'sei': '7.34'}",CHEMBL4128926,,CHEMBL4128926,9.21,0,http://www.openphacts.org/units/Nanomolar,3035290,=,1,1,=,,IC50,nM,,0.61,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.61
,,18301001,[],CHEMBL4124839,Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1CNc1nc(N)c2nc(-c3ccccc3)sc2n1,,,CHEMBL4118252,Bioorg Med Chem,2018.0,,CHEMBL4127213,,CHEMBL4127213,7.87,0,http://www.openphacts.org/units/Nanomolar,3038126,=,1,1,=,,IC50,nM,,13.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,13.4
,,18301002,[],CHEMBL4124839,Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(CNc2nc(N)c3nc(-c4ccccc4)sc3n2)c1,,,CHEMBL4118252,Bioorg Med Chem,2018.0,,CHEMBL4128596,,CHEMBL4128596,7.43,0,http://www.openphacts.org/units/Nanomolar,3038127,=,1,1,=,,IC50,nM,,37.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,37.0
,,18301003,[],CHEMBL4124839,Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc(NCc2cccs2)nc2sc(-c3ccccc3)nc12,,,CHEMBL4118252,Bioorg Med Chem,2018.0,,CHEMBL4125975,,CHEMBL4125975,7.29,0,http://www.openphacts.org/units/Nanomolar,3038128,=,1,1,=,,IC50,nM,,51.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,51.0
,,18301004,[],CHEMBL4124839,Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2c(N)nc(NCCc3cccs3)nc2s1,,,CHEMBL4118252,Bioorg Med Chem,2018.0,,CHEMBL4126427,,CHEMBL4126427,6.97,0,http://www.openphacts.org/units/Nanomolar,3038141,=,1,1,=,,IC50,nM,,107.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,107.0
,,18338032,[],CHEMBL4137528,Inhibition of adenosine A1 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H](CCO)Nc1nc(N)nc2cc(OC)ccc12,,,CHEMBL4130635,J Med Chem,2018.0,"{'bei': '19.39', 'le': '0.37', 'lle': '3.45', 'sei': '6.04'}",CHEMBL4171368,,CHEMBL4171368,5.63,0,http://www.openphacts.org/units/Nanomolar,3045031,=,1,1,=,,IC50,nM,,2340.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,2.34
,,18414075,[],CHEMBL4152687,Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCC1CCC(CCC)(n2c(=O)[nH]c3nc[nH]c3c2=O)C1,,,CHEMBL4152191,Eur J Med Chem,2018.0,,CHEMBL4177295,,CHEMBL4177295,8.54,0,http://www.openphacts.org/units/Nanomolar,3056150,=,1,1,=,,IC50,nM,,2.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.9
,,18414076,[],CHEMBL4152687,Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(-c2ccc(O)cc2)nc2c(NC3CCCC3)ncnc21,,,CHEMBL4152191,Eur J Med Chem,2018.0,,CHEMBL4174108,,CHEMBL4174108,7.28,0,http://www.openphacts.org/units/Nanomolar,3056148,=,1,1,=,,IC50,nM,,52.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,52.0
,,18414077,[],CHEMBL4152687,Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(-c2ccc(F)cc2)nc2c(NC3CCCC3)ncnc21,,,CHEMBL4152191,Eur J Med Chem,2018.0,,CHEMBL4177249,,CHEMBL4177249,7.50,0,http://www.openphacts.org/units/Nanomolar,3056146,=,1,1,=,,IC50,nM,,32.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,32.0
,,18414078,[],CHEMBL4152687,Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2nc3c(NC4CCCC4)ncnc3n2C)cc1,,,CHEMBL4152191,Eur J Med Chem,2018.0,,CHEMBL4170460,,CHEMBL4170460,7.21,0,http://www.openphacts.org/units/Nanomolar,3056142,=,1,1,=,,IC50,nM,,61.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,61.0
,,18414079,[],CHEMBL4152687,Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc3c(NC4CCCC4)ncnc3n2C)c1,,,CHEMBL4152191,Eur J Med Chem,2018.0,,CHEMBL4170850,,CHEMBL4170850,7.37,0,http://www.openphacts.org/units/Nanomolar,3056141,=,1,1,=,,IC50,nM,,43.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,43.0
,,18414080,[],CHEMBL4152687,Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(-c2ccccc2)nc2c(NC3CCCC3)ncnc21,,,CHEMBL4152191,Eur J Med Chem,2018.0,,CHEMBL4175366,,CHEMBL4175366,7.85,0,http://www.openphacts.org/units/Nanomolar,3056130,=,1,1,=,,IC50,nM,,14.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,14.0
,,19108412,[],CHEMBL4369949,Agonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL4368904,J Med Chem,2019.0,,CHEMBL4533718,,CHEMBL4533718,9.85,0,http://www.openphacts.org/units/Nanomolar,3188254,=,1,1,=,,IC50,nM,,0.14,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.14
,,19108413,[],CHEMBL4369949,Agonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1ncn([C@H]2[C@H](O)[C@H](O)[C@]3(CO)C[C@H]23)n1,,,CHEMBL4368904,J Med Chem,2019.0,,CHEMBL4473739,,CHEMBL4473739,7.06,0,http://www.openphacts.org/units/Nanomolar,3188287,=,1,1,=,,IC50,nM,,87.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,87.0
,,19274394,[],CHEMBL4407538,Antagonist activity at human A1AR expressed in CHO cells assessed as suppression of CCPA-induced inhibition of forskolin-stimulated cAMP production by alphascreen assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1c(NCc2ccccc2)nc(SCCO)c(C#N)c1-c1ccco1,,,CHEMBL4406810,J Med Chem,2019.0,,CHEMBL4560929,,CHEMBL4560929,7.12,0,http://www.openphacts.org/units/Nanomolar,3218684,=,1,1,=,,IC50,nM,,76.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,76.0
,,19274395,[],CHEMBL4407538,Antagonist activity at human A1AR expressed in CHO cells assessed as suppression of CCPA-induced inhibition of forskolin-stimulated cAMP production by alphascreen assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1c(NC2CC2)nc(SCCO)c(C#N)c1-c1ccco1,,,CHEMBL4406810,J Med Chem,2019.0,,CHEMBL4533472,,CHEMBL4533472,6.93,0,http://www.openphacts.org/units/Nanomolar,3218682,=,1,1,=,,IC50,nM,,118.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,118.0
,,19320166,[],CHEMBL4417611,Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cn1cc(-c2ccccc2)c2ncn(C3CC3)c(=O)c21)NCc1ccc(F)cc1,,,CHEMBL4414680,Eur J Med Chem,2020.0,,CHEMBL4592514,,CHEMBL4592514,5.55,0,http://www.openphacts.org/units/Nanomolar,3226051,=,1,1,=,,IC50,nM,,2818.38,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,5.55
,,19320167,[],CHEMBL4417611,Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1c(N)nc2c(c1-c1ccc3c(c1)OCO3)CCCC2,,,CHEMBL4414680,Eur J Med Chem,2020.0,,CHEMBL4471671,,CHEMBL4471671,6.38,0,http://www.openphacts.org/units/Nanomolar,3226052,=,1,1,=,,IC50,nM,,416.87,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,6.38
,,19320168,[],CHEMBL4417611,Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2cc(-c3cccc(Br)c3)c(C#N)c(N)n2)cc1,,,CHEMBL4414680,Eur J Med Chem,2020.0,,CHEMBL4454608,,CHEMBL4454608,5.90,0,http://www.openphacts.org/units/Nanomolar,3226053,=,1,1,=,,IC50,nM,,1258.93,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,5.9
,,19320169,[],CHEMBL4417611,Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(N2CCCC2)nc2nccc(-c3ccc(Cl)cc3)c12,,,CHEMBL4414680,Eur J Med Chem,2020.0,,CHEMBL4453937,,CHEMBL4453937,5.73,0,http://www.openphacts.org/units/Nanomolar,3226054,=,1,1,=,,IC50,nM,,1862.09,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,5.73
,,19320170,[],CHEMBL4417611,Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(C(=O)Nc2c(C(=O)NC3CCCC3)[nH]c3ccc(C)cc23)cc1,,,CHEMBL4414680,Eur J Med Chem,2020.0,,CHEMBL4455491,,CHEMBL4455491,5.83,0,http://www.openphacts.org/units/Nanomolar,3226055,=,1,1,=,,IC50,nM,,1479.11,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,5.83
,,19320171,[],CHEMBL4417611,Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCn1c(SCc2ccccn2)nc2c([nH]c3ccccc32)c1=O,,,CHEMBL4414680,Eur J Med Chem,2020.0,,CHEMBL4451522,,CHEMBL4451522,5.10,0,http://www.openphacts.org/units/Nanomolar,3226058,=,1,1,=,,IC50,nM,,7943.28,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,5.1
,,19362452,[],CHEMBL4423023,Antagonist activity at recombinant human A1 adenosine receptor expressed in CHO cells after 3 to 4 hrs by luciferase reporter gene assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(=O)c2c(C)c(C(=O)N3CCC(O)CC3)sc2n(CCC(F)(F)F)c1=O,,,CHEMBL4422615,Eur J Med Chem,2019.0,"{'bei': '13.58', 'le': '0.28', 'lle': '3.79', 'sei': '6.96'}",CHEMBL4522981,,CHEMBL4522981,5.89,0,http://www.openphacts.org/units/Nanomolar,3240560,=,1,1,=,,IC50,nM,,1300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,10'-9mol/L,UO_0000065,,1300.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,23172712,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.9167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '55.0'}]",CHEMBL4814788,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO-K1 cell membrane preincubated for 5 mins followed measured after 50 mins by radioligand competition binding assay,B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cccc(-c2cn3c(nc4ccccc43)c(N)n2)c1,,,CHEMBL4813923,Eur J Med Chem,2021.0,"{'bei': '24.17', 'le': '0.44', 'lle': '3.88', 'sei': '10.73'}",CHEMBL4846301,,CHEMBL4846301,7.02,0,http://www.openphacts.org/units/Nanomolar,3603042,=,1,1,=,,IC50,nM,,95.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,95.8
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,23172713,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.9167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '55.0'}]",CHEMBL4814788,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO-K1 cell membrane preincubated for 5 mins followed measured after 50 mins by radioligand competition binding assay,B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(-c2cccc(Br)c2)cn2c1nc1ccccc12,,,CHEMBL4813923,Eur J Med Chem,2021.0,"{'bei': '20.74', 'le': '0.46', 'lle': '3.15', 'sei': '12.52'}",CHEMBL4855390,,CHEMBL4855390,7.04,0,http://www.openphacts.org/units/Nanomolar,3603043,=,1,1,=,,IC50,nM,,92.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,92.1
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,23172714,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.9167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '55.0'}]",CHEMBL4814788,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO-K1 cell membrane preincubated for 5 mins followed measured after 50 mins by radioligand competition binding assay,B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(-c2cn3c(nc4ccccc43)c(N)n2)cc1,,,CHEMBL4813923,Eur J Med Chem,2021.0,"{'bei': '26.23', 'le': '0.47', 'lle': '3.75', 'sei': '12.80'}",CHEMBL4846299,,CHEMBL4846299,7.19,0,http://www.openphacts.org/units/Nanomolar,3603044,=,1,1,=,,IC50,nM,,63.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,63.9
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,23172715,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.9167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '55.0'}]",CHEMBL4814788,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO-K1 cell membrane preincubated for 5 mins followed measured after 50 mins by radioligand competition binding assay,B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(-c2ccc(F)cc2F)cn2c1nc1ccccc12,,,CHEMBL4813923,Eur J Med Chem,2021.0,"{'bei': '28.20', 'le': '0.52', 'lle': '4.95', 'sei': '14.87'}",CHEMBL4876739,,CHEMBL4876739,8.36,0,http://www.openphacts.org/units/Nanomolar,3603050,=,1,1,=,,IC50,nM,,4.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,4.4
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,23172716,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.9167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '55.0'}]",CHEMBL4814788,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO-K1 cell membrane preincubated for 5 mins followed measured after 50 mins by radioligand competition binding assay,B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(-c2ccco2)cn2c1nc1ccccc12,,,CHEMBL4813923,Eur J Med Chem,2021.0,"{'bei': '32.77', 'le': '0.59', 'lle': '5.48', 'sei': '11.83'}",CHEMBL4872721,,CHEMBL4872721,8.20,0,http://www.openphacts.org/units/Nanomolar,3603055,=,1,1,=,,IC50,nM,,6.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,6.3
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,23172717,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.9167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '55.0'}]",CHEMBL4814788,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO-K1 cell membrane preincubated for 5 mins followed measured after 50 mins by radioligand competition binding assay,B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(Cc2ccccc2)cn2c1nc1ccccc12,,,CHEMBL4813923,Eur J Med Chem,2021.0,"{'bei': '22.36', 'le': '0.40', 'lle': '3.07', 'sei': '10.91'}",CHEMBL4849795,,CHEMBL4849795,6.13,0,http://www.openphacts.org/units/Nanomolar,3603056,=,1,1,=,,IC50,nM,,733.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,733.4
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,23172718,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.9167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '55.0'}]",CHEMBL4814788,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO-K1 cell membrane preincubated for 5 mins followed measured after 50 mins by radioligand competition binding assay,B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)Nc1cccc(-c2cn3c(nc4ccccc43)c(N)n2)c1,,,CHEMBL4813923,Eur J Med Chem,2021.0,"{'bei': '24.48', 'le': '0.44', 'lle': '4.68', 'sei': '9.11'}",CHEMBL4858421,,CHEMBL4858421,7.77,0,http://www.openphacts.org/units/Nanomolar,3603058,=,1,1,=,,IC50,nM,,17.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,17.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,23172719,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.9167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '55.0'}]",CHEMBL4814788,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO-K1 cell membrane preincubated for 5 mins followed measured after 50 mins by radioligand competition binding assay,B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cccc(-c2cn3c(nc4cc(F)c(F)cc43)c(N)n2)c1,,,CHEMBL4813923,Eur J Med Chem,2021.0,"{'bei': '19.42', 'le': '0.36', 'lle': '2.92', 'sei': '9.68'}",CHEMBL4862573,,CHEMBL4862573,6.34,0,http://www.openphacts.org/units/Nanomolar,3603063,=,1,1,=,,IC50,nM,,460.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,460.3
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24410664,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5046039,Antagonist activity at human recombinant adenosine A1 receptor transfected in HEK293 cells co-transfected with Galpha15/16 assessed as intracellular calcium change incubated for 10 mins by microplate reader method,F,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(-c2cnc(N)n3nc(-c4ccco4)nc23)ccc1=O,,,CHEMBL5042554,ACS Med Chem Lett,2022.0,,CHEMBL5075422,,CHEMBL5075422,7.59,0,http://www.openphacts.org/units/Nanomolar,3782763,=,1,1,=,,IC50,nM,,25.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,25.9
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717913,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2nc(C#N)cc3cn[nH]c23)cc(OC)c1OC,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5187501,,CHEMBL5187501,7.99,0,http://www.openphacts.org/units/Nanomolar,3855113,=,1,1,=,,IC50,nM,,10.23,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,7.99
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717914,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2nc(C#N)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5181728,,CHEMBL5181728,6.70,0,http://www.openphacts.org/units/Nanomolar,3855114,=,1,1,=,,IC50,nM,,199.53,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,6.7
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717915,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2nc(Cl)cc3c(C(C)C)n[nH]c23)cc(OC)c1OC,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL3927012,,CHEMBL3927012,8.30,0,http://www.openphacts.org/units/Nanomolar,3855115,=,1,1,=,,IC50,nM,,5.012,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.3
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717916,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2nc(C#N)cc3c(C(C)C)n[nH]c23)cc(OC)c1OC,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5173159,,CHEMBL5173159,8.49,0,http://www.openphacts.org/units/Nanomolar,3855116,=,1,1,=,,IC50,nM,,3.236,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.49
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717917,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc2c(-c3ccccc3)n[nH]c2c(Nc2ccccc2)n1,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5180268,,CHEMBL5180268,7.87,0,http://www.openphacts.org/units/Nanomolar,3855117,=,1,1,=,,IC50,nM,,13.49,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,7.87
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717918,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2nc(Cl)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL3929812,,CHEMBL3929812,8.54,0,http://www.openphacts.org/units/Nanomolar,3855118,=,1,1,=,,IC50,nM,,2.884,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.54
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717919,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2nccc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL3929143,,CHEMBL3929143,8.72,0,http://www.openphacts.org/units/Nanomolar,3855119,=,1,1,=,,IC50,nM,,1.905,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.72
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717920,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2nc(CN)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5196781,,CHEMBL5196781,7.64,0,http://www.openphacts.org/units/Nanomolar,3855120,=,1,1,=,,IC50,nM,,22.91,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,7.64
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717921,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2nc(CNCc3ccccc3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5185003,,CHEMBL5185003,8.41,0,http://www.openphacts.org/units/Nanomolar,3855121,=,1,1,=,,IC50,nM,,3.89,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.41
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717922,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2nc(CNCc3cccnc3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5189470,,CHEMBL5189470,7.92,0,http://www.openphacts.org/units/Nanomolar,3855122,=,1,1,=,,IC50,nM,,12.02,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,7.92
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717923,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2nc(CNCC3CCN(C)CC3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5189274,,CHEMBL5189274,8.33,0,http://www.openphacts.org/units/Nanomolar,3855123,=,1,1,=,,IC50,nM,,4.677,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.33
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717924,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,Cn1nc(NC(=O)CNc2ccccc2)c2cc(Nc3ccccc3)ncc21,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5180010,,CHEMBL5180010,8.58,0,http://www.openphacts.org/units/Nanomolar,3855124,=,1,1,=,,IC50,nM,,2.63,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.58
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717925,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CNc1ccccc1)Nc1n[nH]c2cnc(Nc3ccccc3)cc12,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5201810,,CHEMBL5201810,8.16,0,http://www.openphacts.org/units/Nanomolar,3855125,=,1,1,=,,IC50,nM,,6.918,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.16
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717926,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,Cn1nc(NC(=O)c2ccccc2)c2cc(Nc3ccccc3)ncc21,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5186062,,CHEMBL5186062,8.30,0,http://www.openphacts.org/units/Nanomolar,3855126,=,1,1,=,,IC50,nM,,5.012,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.3
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717927,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,Cn1nc(NC(=O)Nc2ccccc2)c2ccnc(NC3CCCCC3)c21,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL5174600,,CHEMBL5174600,8.85,0,http://www.openphacts.org/units/Nanomolar,3855127,=,1,1,=,,IC50,nM,,1.413,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.85
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717928,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1ccccc1)Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL88147,,CHEMBL88147,7.32,0,http://www.openphacts.org/units/Nanomolar,3855128,=,1,1,=,,IC50,nM,,47.86,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,7.32
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24717929,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5111998,Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins,F,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL5108055,J Med Chem,2022.0,,CHEMBL464859,NECA,CHEMBL464859,8.95,0,http://www.openphacts.org/units/Nanomolar,3855129,=,1,1,=,,IC50,nM,,1.122,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,8.95
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24772457,[],CHEMBL5126853,Binding affinity to human adenosine A1A receptor measured by radioligand-based affinity assay,B,,,BAO_0000190,BAO_0000357,single protein format,C#Cc1c(N)nc2c(c1-c1ccc3c(c1)OCO3)CCCC2,,,CHEMBL5126505,Eur J Med Chem,2022.0,"{'bei': '21.82', 'le': '0.40', 'lle': '3.46', 'sei': '11.12'}",CHEMBL5185642,,CHEMBL5185642,6.38,0,http://www.openphacts.org/units/Nanomolar,3865475,=,1,1,=,,IC50,nM,,416.87,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,6.38
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24772458,[],CHEMBL5126853,Binding affinity to human adenosine A1A receptor measured by radioligand-based affinity assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCC2)nc2nccc(-c3ccc(Cl)cc3)c12,,,CHEMBL5126505,Eur J Med Chem,2022.0,"{'bei': '17.84', 'le': '0.35', 'lle': '2.59', 'sei': '9.42'}",CHEMBL4453937,,CHEMBL4453937,5.83,0,http://www.openphacts.org/units/Nanomolar,3865476,=,1,1,=,,IC50,nM,,1479.11,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,5.83
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24772459,[],CHEMBL5126853,Binding affinity to human adenosine A1A receptor measured by radioligand-based affinity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)Nc2c(CC(=O)NC3CCCC3)[nH]c3ccccc23)cc1,,,CHEMBL5126505,Eur J Med Chem,2022.0,"{'bei': '14.67', 'le': '0.27', 'lle': '1.18', 'sei': '7.45'}",CHEMBL5178070,,CHEMBL5178070,5.51,0,http://www.openphacts.org/units/Nanomolar,3865477,=,1,1,=,,IC50,nM,,3090.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,5.51
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24772540,[],CHEMBL5126893,Antagonist activity at human adenosine A1A receptor expressed in CHO cells and measured by AlphaScreencAMP assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(C(=O)n2nc(-c3ccccc3Cl)nc2N)c1,,,CHEMBL5126505,Eur J Med Chem,2022.0,,CHEMBL5176292,,CHEMBL5176292,6.78,0,http://www.openphacts.org/units/Nanomolar,3865478,=,1,1,=,,IC50,nM,,165.96,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,6.78
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24772541,[],CHEMBL5126893,Antagonist activity at human adenosine A1A receptor expressed in CHO cells and measured by AlphaScreencAMP assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc(-c2ccccc2Cl)cn1C(=O)c1cccc(Cl)c1,,,CHEMBL5126505,Eur J Med Chem,2022.0,,CHEMBL5174932,,CHEMBL5174932,6.72,0,http://www.openphacts.org/units/Nanomolar,3865479,=,1,1,=,,IC50,nM,,190.55,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,pIC50,,UO_0000065,,6.72
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24973088,[],CHEMBL5223705,Antagonist activity at human A1 adenosine receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(=O)c2nc(-c3ccccc3)[nH]c2n(C)c1=O,,,CHEMBL5223081,J Med Chem,2021.0,"{'bei': '24.59', 'le': '0.45', 'lle': '5.67', 'sei': '8.67'}",CHEMBL62350,8-PHENYL THEOPHYLLINE,CHEMBL62350,6.30,0,http://www.openphacts.org/units/Nanomolar,3902497,=,1,1,=,,IC50,nM,,500.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,0.5
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24973089,[],CHEMBL5223705,Antagonist activity at human A1 adenosine receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(=O)c2nc(-c3ccccc3)[nH]c2n(CC)c1=O,,,CHEMBL5223081,J Med Chem,2021.0,"{'bei': '21.10', 'le': '0.39', 'lle': '4.41', 'sei': '8.26'}",CHEMBL11348,,CHEMBL11348,6.00,0,http://www.openphacts.org/units/Nanomolar,3902498,=,1,1,=,,IC50,nM,,1000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,uM,UO_0000065,,1.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,25935678,[],CHEMBL5531821,Antagonist activity at human Adenosine A1 receptor overexpressed in HEK293 cells preincubated for 0.5 hrs followed by NECA stimulation by GloSensor cAMP assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(C#N)cccc1-c1cc(-c2cn(Cc3cccc(C(C)(C)O)n3)nn2)nc(N)n1,,,CHEMBL5528085,J Med Chem,2024.0,,CHEMBL4740383,ETRUMADENANT,CHEMBL4740383,7.06,0,http://www.openphacts.org/units/Nanomolar,4074330,=,1,1,=,,IC50,nM,,87.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,87.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,26333169,[],CHEMBL5721231,Inhibition of Adenosine 1 transporter (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL5715956,ACS Chem Biol,2017.0,"{'bei': '28.51', 'le': '0.54', 'lle': '6.32', 'sei': '11.94'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,8.68,0,http://www.openphacts.org/units/Nanomolar,4140766,=,72,1,=,,IC50,nM,,2.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,10^-9M,UO_0000065,,2.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,26333214,[],CHEMBL5721276,Inhibition of A1 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O,,,CHEMBL5715956,ACS Chem Biol,2017.0,"{'bei': '28.90', 'le': '0.55', 'lle': '6.44', 'sei': '12.10'}",CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]",CHEMBL183,8.80,0,http://www.openphacts.org/units/Nanomolar,4140766,=,72,1,=,,IC50,nM,,1.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,10^-9M,UO_0000065,,1.6
,960447,28127282,[],CHEMBL5735827,"Radioligand Binding Competition Assay: For the adenosine A2A receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, 6005174), presoaked in 0.01% Brij for 2 h at room temperature were used. Filters were washed six times with 0.5 mL of ice-cold washing buffer (50 mM Tris pH 7.4) and 50 μL of Microscint 20 (Packard) was added in each well. The plates were then incubated for 15 min on an orbital shaker and then counted with a TopCount for 1 min/well.Another radioligand binding assay was used to evaluate the binding affinity for the adenosine A2A receptor assay was performed in duplicate in the wells of a 384 plate. Assay buffer contained DPBS 500 mM, MgCl2 0.1 mM, and 1% DMSO. Membrane-bead suspension was prepared by mixing 25.98 μL of human adenosine A2A membrane preparation (Perkin Elmer, RBHA2AM400UA) at 33.4 pg/mL, 28 μL of ADA at 20 pg/mL, and 932 μL of SPA beads at 3.33 mg/mL) and incubated the mixture for 20 min at room temperature. Mixed 20 μL of radiotracer (3H-SCH 58261) at 15 nM to each well containing test articles at various concentrations and centrifuge the plate at 1000 rpm for 1 minute. Added 30 μL of the membrane-bead suspension to each well. Sealed the plates and incubated for 1 hr at room temperature with vigorous mixing on a plate mixer. Plates were read on Microbeta2 (Perkin Elmer, 2450-0010).",B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc(-c3cc4c(=O)cc[nH]c4nc3-c3ccccc3)ccc2n1,,,CHEMBL5727999,,2020.0,"{'bei': '17.77', 'le': '0.32', 'lle': '1.93', 'sei': '9.93'}",CHEMBL5929866,,CHEMBL5929866,6.74,0,http://www.openphacts.org/units/Nanomolar,4448684,=,37,1,=,,IC50,nM,,181.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,181.0
,960448,28127285,[],CHEMBL5735827,"Radioligand Binding Competition Assay: For the adenosine A2A receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, 6005174), presoaked in 0.01% Brij for 2 h at room temperature were used. Filters were washed six times with 0.5 mL of ice-cold washing buffer (50 mM Tris pH 7.4) and 50 μL of Microscint 20 (Packard) was added in each well. The plates were then incubated for 15 min on an orbital shaker and then counted with a TopCount for 1 min/well.Another radioligand binding assay was used to evaluate the binding affinity for the adenosine A2A receptor assay was performed in duplicate in the wells of a 384 plate. Assay buffer contained DPBS 500 mM, MgCl2 0.1 mM, and 1% DMSO. Membrane-bead suspension was prepared by mixing 25.98 μL of human adenosine A2A membrane preparation (Perkin Elmer, RBHA2AM400UA) at 33.4 pg/mL, 28 μL of ADA at 20 pg/mL, and 932 μL of SPA beads at 3.33 mg/mL) and incubated the mixture for 20 min at room temperature. Mixed 20 μL of radiotracer (3H-SCH 58261) at 15 nM to each well containing test articles at various concentrations and centrifuge the plate at 1000 rpm for 1 minute. Added 30 μL of the membrane-bead suspension to each well. Sealed the plates and incubated for 1 hr at room temperature with vigorous mixing on a plate mixer. Plates were read on Microbeta2 (Perkin Elmer, 2450-0010).",B,,,BAO_0000190,BAO_0000019,assay format,O=c1cc[nH]c2nc(-c3ccco3)c(-c3ccc4ncccc4c3)cc12,,,CHEMBL5727999,,2020.0,"{'bei': '22.05', 'le': '0.39', 'lle': '3.08', 'sei': '10.42'}",CHEMBL5994156,,CHEMBL5994156,7.48,0,http://www.openphacts.org/units/Nanomolar,4448685,=,37,1,=,,IC50,nM,,33.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,33.0
,983602,28196000,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '20.11', 'le': '0.37', 'lle': '5.96', 'sei': '8.61'}",CHEMBL5993458,,CHEMBL5993458,8.96,0,http://www.openphacts.org/units/Nanomolar,4463931,=,37,1,=,,IC50,nM,,1.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1.1
,983606,28196012,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '20.97', 'le': '0.39', 'lle': '5.95', 'sei': '10.65'}",CHEMBL5756623,,CHEMBL5756623,9.70,0,http://www.openphacts.org/units/Nanomolar,4463932,=,37,1,=,,IC50,nM,,0.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.2
,983608,28196018,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,CN(C)c1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '18.17', 'le': '0.34', 'lle': '4.13', 'sei': '10.14'}",CHEMBL5827075,,CHEMBL5827075,8.64,0,http://www.openphacts.org/units/Nanomolar,4463933,=,37,1,=,,IC50,nM,,2.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.3
,983612,28196030,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4OC(F)F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.02', 'le': '0.32', 'lle': '4.93', 'sei': '7.42'}",CHEMBL5956015,,CHEMBL5956015,8.40,0,http://www.openphacts.org/units/Nanomolar,4463934,=,37,1,=,,IC50,nM,,4.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,4.0
,983616,28196042,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.61', 'le': '0.32', 'lle': '5.52', 'sei': '5.67'}",CHEMBL6007073,,CHEMBL6007073,7.37,0,http://www.openphacts.org/units/Nanomolar,4463935,=,37,1,=,,IC50,nM,,43.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,43.0
,983618,28196048,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '18.76', 'le': '0.35', 'lle': '5.57', 'sei': '6.97'}",CHEMBL5781725,,CHEMBL5781725,8.17,0,http://www.openphacts.org/units/Nanomolar,4463936,=,37,1,=,,IC50,nM,,6.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,6.8
,983620,28196054,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-n3nccn3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '18.61', 'le': '0.35', 'lle': '6.58', 'sei': '6.65'}",CHEMBL5847654,,CHEMBL5847654,8.10,0,http://www.openphacts.org/units/Nanomolar,4463937,=,37,1,=,,IC50,nM,,7.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,7.9
,983622,28196060,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccc3nccn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.06', 'le': '0.29', 'lle': '4.06', 'sei': '5.48'}",CHEMBL6063197,,CHEMBL6063197,6.86,0,http://www.openphacts.org/units/Nanomolar,4463938,=,37,1,=,,IC50,nM,,137.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,137.0
,983624,28196066,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3nccn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '18.64', 'le': '0.34', 'lle': '4.52', 'sei': '8.53'}",CHEMBL5841873,,CHEMBL5841873,8.47,0,http://www.openphacts.org/units/Nanomolar,4463939,=,37,1,=,,IC50,nM,,3.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3.4
,983626,28196072,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '19.80', 'le': '0.37', 'lle': '5.61', 'sei': '8.75'}",CHEMBL5966778,,CHEMBL5966778,9.10,0,http://www.openphacts.org/units/Nanomolar,4463940,=,37,1,=,,IC50,nM,,0.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.8
,983630,28196084,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1cccc(Cc2nc3c(-c4ccc5nccn5c4)c(-c4ccc(F)cc4)nc(N)n3n2)n1,,,CHEMBL5728138,,2020.0,"{'bei': '18.60', 'le': '0.34', 'lle': '5.00', 'sei': '6.70'}",CHEMBL5867675,,CHEMBL5867675,8.40,0,http://www.openphacts.org/units/Nanomolar,4463941,=,37,1,=,,IC50,nM,,4.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,4.0
,983632,28196090,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(C(F)F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '18.13', 'le': '0.34', 'lle': '4.86', 'sei': '8.33'}",CHEMBL5931362,,CHEMBL5931362,8.66,0,http://www.openphacts.org/units/Nanomolar,4463942,=,37,1,=,,IC50,nM,,2.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.2
,983634,28196096,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)n1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '21.12', 'le': '0.39', 'lle': '5.95', 'sei': '9.62'}",CHEMBL5957422,,CHEMBL5957422,10.00,0,http://www.openphacts.org/units/Nanomolar,4463943,=,37,1,=,,IC50,nM,,0.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.1
,983638,28196108,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(-c2nc(N)n3nc(Cc4ncccc4F)nc3c2-c2ccc(=O)n(C)c2)cc1,,,CHEMBL5728138,,2020.0,"{'bei': '19.17', 'le': '0.35', 'lle': '5.90', 'sei': '7.75'}",CHEMBL5988628,,CHEMBL5988628,8.77,0,http://www.openphacts.org/units/Nanomolar,4463944,=,37,1,=,,IC50,nM,,1.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1.7
,983640,28196114,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(C(F)(F)F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '16.74', 'le': '0.31', 'lle': '4.41', 'sei': '7.97'}",CHEMBL6022055,,CHEMBL6022055,8.29,0,http://www.openphacts.org/units/Nanomolar,4463945,=,37,1,=,,IC50,nM,,5.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.1
,983642,28196120,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc(=O)n1C,,,CHEMBL5728138,,2020.0,"{'bei': '15.97', 'le': '0.29', 'lle': '4.03', 'sei': '7.06'}",CHEMBL6044836,,CHEMBL6044836,7.34,0,http://www.openphacts.org/units/Nanomolar,4463946,=,37,1,=,,IC50,nM,,46.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,46.0
,983644,28196126,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3cccc(Cl)c3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '19.69', 'le': '0.38', 'lle': '5.58', 'sei': '8.75'}",CHEMBL6043653,,CHEMBL6043653,9.10,0,http://www.openphacts.org/units/Nanomolar,4463947,=,37,1,=,,IC50,nM,,0.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.8
,983646,28196132,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,COc1cccc(-c2nc(N)n3nc(Cc4ncccc4F)nc3c2-c2ccc(=O)n(C)c2)c1,,,CHEMBL5728138,,2020.0,"{'bei': '19.35', 'le': '0.36', 'lle': '5.98', 'sei': '7.82'}",CHEMBL6030840,,CHEMBL6030840,8.85,0,http://www.openphacts.org/units/Nanomolar,4463948,=,37,1,=,,IC50,nM,,1.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1.4
,983648,28196138,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccnc(OC(F)F)c2)c2nc(Cc3c(F)cccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.54', 'le': '0.33', 'lle': '4.38', 'sei': '7.05'}",CHEMBL5795044,,CHEMBL5795044,8.27,0,http://www.openphacts.org/units/Nanomolar,4463949,=,37,1,=,,IC50,nM,,5.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.4
,983650,28196144,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccnc(OC(F)F)c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.90', 'le': '0.32', 'lle': '4.53', 'sei': '5.90'}",CHEMBL5810207,,CHEMBL5810207,7.68,0,http://www.openphacts.org/units/Nanomolar,4463950,=,37,1,=,,IC50,nM,,21.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,21.0
,983652,28196150,[],CHEMBL5736163,"Binding Affinities to Different Adenosine Receptors: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 L ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [1211]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.50% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 L of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-n2nccn2)c(-c2ccc3nccn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.04', 'le': '0.31', 'lle': '5.55', 'sei': '5.60'}",CHEMBL6062538,,CHEMBL6062538,7.28,0,http://www.openphacts.org/units/Nanomolar,4463951,=,37,1,=,,IC50,nM,,52.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,52.0
,983656,28196162,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '18.12', 'le': '0.33', 'lle': '5.07', 'sei': '7.76'}",CHEMBL5993458,,CHEMBL5993458,8.07,0,http://www.openphacts.org/units/Nanomolar,4463931,=,37,1,=,,IC50,nM,,8.5,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,8.5
,983661,28196177,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '17.79', 'le': '0.33', 'lle': '3.63', 'sei': '8.05'}",CHEMBL6022992,,CHEMBL6022992,7.64,0,http://www.openphacts.org/units/Nanomolar,4463952,=,37,1,=,,IC50,nM,,23.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,23.0
,983666,28196192,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccnc(Cl)c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.40', 'le': '0.31', 'lle': '3.03', 'sei': '7.77'}",CHEMBL5919017,,CHEMBL5919017,7.38,0,http://www.openphacts.org/units/Nanomolar,4463953,=,37,1,=,,IC50,nM,,42.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,42.0
,983671,28196207,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccnc(C(F)(F)F)c2)c2nc(Cc3c(F)cccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '12.57', 'le': '0.24', 'lle': '0.83', 'sei': '7.67'}",CHEMBL5752625,,CHEMBL5752625,6.29,0,http://www.openphacts.org/units/Nanomolar,4463954,=,37,1,=,,IC50,nM,,511.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,511.0
,983677,28196225,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccnnc2)c2nc(Cc3c(F)cccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.72', 'le': '0.33', 'lle': '3.84', 'sei': '8.09'}",CHEMBL5880072,,CHEMBL5880072,7.68,0,http://www.openphacts.org/units/Nanomolar,4463956,=,37,1,=,,IC50,nM,,21.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,21.0
,983682,28196240,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4cscn4)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '18.30', 'le': '0.35', 'lle': '3.71', 'sei': '8.05'}",CHEMBL5743567,,CHEMBL5743567,7.64,0,http://www.openphacts.org/units/Nanomolar,4463957,=,37,1,=,,IC50,nM,,23.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,23.0
,983687,28196255,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4cccc(Cl)c4)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '15.26', 'le': '0.29', 'lle': '1.66', 'sei': '8.28'}",CHEMBL5874081,,CHEMBL5874081,6.79,0,http://www.openphacts.org/units/Nanomolar,4463958,=,37,1,=,,IC50,nM,,162.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,162.0
,983692,28196270,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '16.65', 'le': '0.31', 'lle': '3.95', 'sei': '8.45'}",CHEMBL5756623,,CHEMBL5756623,7.70,0,http://www.openphacts.org/units/Nanomolar,4463932,=,37,1,=,,IC50,nM,,20.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,20.0
,983697,28196285,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,CN(C)c1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '15.51', 'le': '0.29', 'lle': '2.87', 'sei': '8.66'}",CHEMBL5827075,,CHEMBL5827075,7.38,0,http://www.openphacts.org/units/Nanomolar,4463933,=,37,1,=,,IC50,nM,,42.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,42.0
,983702,28196300,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4nccs4)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '19.19', 'le': '0.36', 'lle': '4.08', 'sei': '8.45'}",CHEMBL5999973,,CHEMBL5999973,8.01,0,http://www.openphacts.org/units/Nanomolar,4463959,=,37,1,=,,IC50,nM,,9.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,9.7
,983707,28196315,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(C(C)c4c(F)cccc4F)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '14.48', 'le': '0.27', 'lle': '1.36', 'sei': '8.13'}",CHEMBL5856098,,CHEMBL5856098,6.67,0,http://www.openphacts.org/units/Nanomolar,4463960,=,37,1,=,,IC50,nM,,214.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,214.0
,983712,28196330,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)c(C)cn1,,,CHEMBL5728138,,2020.0,"{'bei': '14.80', 'le': '0.27', 'lle': '1.76', 'sei': '8.31'}",CHEMBL5990931,,CHEMBL5990931,6.82,0,http://www.openphacts.org/units/Nanomolar,4463961,=,37,1,=,,IC50,nM,,153.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,153.0
,983717,28196345,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)cc(C)n1,,,CHEMBL5728138,,2020.0,"{'bei': '15.81', 'le': '0.29', 'lle': '2.69', 'sei': '7.39'}",CHEMBL5760505,,CHEMBL5760505,7.01,0,http://www.openphacts.org/units/Nanomolar,4463962,=,37,1,=,,IC50,nM,,97.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,97.0
,983722,28196360,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4cccc(Cl)n4)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '16.97', 'le': '0.32', 'lle': '3.05', 'sei': '7.98'}",CHEMBL5960960,,CHEMBL5960960,7.57,0,http://www.openphacts.org/units/Nanomolar,4463963,=,37,1,=,,IC50,nM,,27.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,27.0
,983726,28196372,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1nccc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)c1C,,,CHEMBL5728138,,2020.0,"{'bei': '14.53', 'le': '0.27', 'lle': '1.63', 'sei': '8.16'}",CHEMBL5813457,,CHEMBL5813457,6.69,0,http://www.openphacts.org/units/Nanomolar,4463964,=,37,1,=,,IC50,nM,,205.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,205.0
,983730,28196384,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4cccc(N(C)C)n4)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '16.85', 'le': '0.31', 'lle': '3.73', 'sei': '7.80'}",CHEMBL6008177,,CHEMBL6008177,7.66,0,http://www.openphacts.org/units/Nanomolar,4463965,=,37,1,=,,IC50,nM,,22.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,22.0
,983734,28196396,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)cc(Cl)n1,,,CHEMBL5728138,,2020.0,"{'bei': '15.76', 'le': '0.30', 'lle': '2.65', 'sei': '7.70'}",CHEMBL5740360,,CHEMBL5740360,7.31,0,http://www.openphacts.org/units/Nanomolar,4463966,=,37,1,=,,IC50,nM,,49.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,49.0
,983739,28196411,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4cccc(C#N)n4)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '17.50', 'le': '0.32', 'lle': '3.90', 'sei': '6.44'}",CHEMBL5892880,,CHEMBL5892880,7.64,0,http://www.openphacts.org/units/Nanomolar,4463967,=,37,1,=,,IC50,nM,,23.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,23.0
,983744,28196426,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4OC(F)F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '15.14', 'le': '0.28', 'lle': '4.00', 'sei': '6.60'}",CHEMBL5956015,,CHEMBL5956015,7.47,0,http://www.openphacts.org/units/Nanomolar,4463934,=,37,1,=,,IC50,nM,,34.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,34.0
,983749,28196441,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '16.60', 'le': '0.31', 'lle': '5.10', 'sei': '5.34'}",CHEMBL6007073,,CHEMBL6007073,6.95,0,http://www.openphacts.org/units/Nanomolar,4463935,=,37,1,=,,IC50,nM,,113.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,113.0
,983754,28196456,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.46', 'le': '0.32', 'lle': '5.00', 'sei': '6.49'}",CHEMBL5781725,,CHEMBL5781725,7.60,0,http://www.openphacts.org/units/Nanomolar,4463936,=,37,1,=,,IC50,nM,,25.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,25.0
,983758,28196468,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc(=O)n(C3CCOC3)c2)c2nc(Cc3c(F)cccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '14.63', 'le': '0.27', 'lle': '3.42', 'sei': '7.56'}",CHEMBL6008157,,CHEMBL6008157,7.58,0,http://www.openphacts.org/units/Nanomolar,4463968,=,37,1,=,,IC50,nM,,26.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,26.0
,983762,28196480,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-c2nc(N)n3nc(Cc4c(F)cccc4F)nc3c2-c2ccc(=O)n(C)c2)cn1,,,CHEMBL5728138,,2020.0,"{'bei': '17.24', 'le': '0.32', 'lle': '4.61', 'sei': '7.62'}",CHEMBL5912720,,CHEMBL5912720,7.92,0,http://www.openphacts.org/units/Nanomolar,4463969,=,37,1,=,,IC50,nM,,12.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,12.0
,983766,28196492,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-n3nccn3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.63', 'le': '0.33', 'lle': '6.16', 'sei': '6.30'}",CHEMBL5847654,,CHEMBL5847654,7.68,0,http://www.openphacts.org/units/Nanomolar,4463937,=,37,1,=,,IC50,nM,,21.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,21.0
,983770,28196504,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc(-c2nc(N)n3nc(Cc4c(F)cccc4F)nc3c2-c2ccc(=O)n(C)c2)o1,,,CHEMBL5728138,,2020.0,"{'bei': '16.65', 'le': '0.31', 'lle': '4.58', 'sei': '6.39'}",CHEMBL5969196,,CHEMBL5969196,7.48,0,http://www.openphacts.org/units/Nanomolar,4463970,=,37,1,=,,IC50,nM,,33.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,33.0
,983774,28196516,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1coc(-c2nc(N)n3nc(Cc4c(F)cccc4F)nc3c2-c2ccc(=O)n(C)c2)n1,,,CHEMBL5728138,,2020.0,"{'bei': '15.47', 'le': '0.29', 'lle': '4.05', 'sei': '5.93'}",CHEMBL5963502,,CHEMBL5963502,6.95,0,http://www.openphacts.org/units/Nanomolar,4463971,=,37,1,=,,IC50,nM,,112.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,112.0
,983778,28196528,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(Cl)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '14.75', 'le': '0.29', 'lle': '3.35', 'sei': '6.52'}",CHEMBL5802772,,CHEMBL5802772,5.94,0,http://www.openphacts.org/units/Nanomolar,4463972,=,37,1,=,,IC50,nM,,1146.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1146.0
,983782,28196540,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)cn(C)c1=O,,,CHEMBL5728138,,2020.0,"{'bei': '18.21', 'le': '0.34', 'lle': '5.06', 'sei': '8.05'}",CHEMBL5817464,,CHEMBL5817464,8.37,0,http://www.openphacts.org/units/Nanomolar,4463973,=,37,1,=,,IC50,nM,,4.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,4.3
,983786,28196552,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1nc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.46', 'le': '0.32', 'lle': '5.40', 'sei': '6.67'}",CHEMBL5804476,,CHEMBL5804476,7.80,0,http://www.openphacts.org/units/Nanomolar,4463974,=,37,1,=,,IC50,nM,,16.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,16.0
,983790,28196564,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccc3nccn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '15.74', 'le': '0.29', 'lle': '3.93', 'sei': '5.37'}",CHEMBL6063197,,CHEMBL6063197,6.73,0,http://www.openphacts.org/units/Nanomolar,4463938,=,37,1,=,,IC50,nM,,188.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,188.0
,983794,28196576,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3nccn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.62', 'le': '0.30', 'lle': '3.60', 'sei': '7.61'}",CHEMBL5841873,,CHEMBL5841873,7.55,0,http://www.openphacts.org/units/Nanomolar,4463939,=,37,1,=,,IC50,nM,,28.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,28.0
,983798,28196588,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)cc(C)n1,,,CHEMBL5728138,,2020.0,"{'bei': '11.90', 'le': '0.22', 'lle': '1.25', 'sei': '4.78'}",CHEMBL5812643,,CHEMBL5812643,5.16,0,http://www.openphacts.org/units/Nanomolar,4463975,=,37,1,=,,IC50,nM,,6935.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,6935.0
,983802,28196600,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.24', 'le': '0.32', 'lle': '4.43', 'sei': '7.62'}",CHEMBL5966778,,CHEMBL5966778,7.92,0,http://www.openphacts.org/units/Nanomolar,4463940,=,37,1,=,,IC50,nM,,12.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,12.0
,983806,28196612,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4cccc(N)n4)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '16.85', 'le': '0.31', 'lle': '5.01', 'sei': '5.73'}",CHEMBL5952384,,CHEMBL5952384,7.46,0,http://www.openphacts.org/units/Nanomolar,4463976,=,37,1,=,,IC50,nM,,35.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,35.0
,983810,28196624,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc(=O)n(C3CC3)c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '15.58', 'le': '0.29', 'lle': '3.55', 'sei': '7.06'}",CHEMBL5907517,,CHEMBL5907517,7.35,0,http://www.openphacts.org/units/Nanomolar,4463977,=,37,1,=,,IC50,nM,,45.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,45.0
,983814,28196636,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1cccc(Cc2nc3c(-c4ccc5nccn5c4)c(-c4ccc(F)cc4)nc(N)n3n2)n1,,,CHEMBL5728138,,2020.0,"{'bei': '17.54', 'le': '0.32', 'lle': '4.52', 'sei': '6.32'}",CHEMBL5867675,,CHEMBL5867675,7.92,0,http://www.openphacts.org/units/Nanomolar,4463941,=,37,1,=,,IC50,nM,,12.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,12.0
,983818,28196648,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '18.74', 'le': '0.34', 'lle': '4.79', 'sei': '6.67'}",CHEMBL5829088,,CHEMBL5829088,8.07,0,http://www.openphacts.org/units/Nanomolar,4463978,=,37,1,=,,IC50,nM,,8.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,8.6
,983822,28196660,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)c(F)c3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '16.88', 'le': '0.31', 'lle': '4.68', 'sei': '7.52'}",CHEMBL5882686,,CHEMBL5882686,7.82,0,http://www.openphacts.org/units/Nanomolar,4463979,=,37,1,=,,IC50,nM,,15.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,15.0
,983826,28196672,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3cccc(F)c3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.39', 'le': '0.32', 'lle': '4.74', 'sei': '7.45'}",CHEMBL5875672,,CHEMBL5875672,7.75,0,http://www.openphacts.org/units/Nanomolar,4463980,=,37,1,=,,IC50,nM,,18.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,18.0
,983830,28196684,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(C(F)F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '16.27', 'le': '0.30', 'lle': '3.97', 'sei': '7.47'}",CHEMBL5931362,,CHEMBL5931362,7.77,0,http://www.openphacts.org/units/Nanomolar,4463942,=,37,1,=,,IC50,nM,,17.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,17.0
,983834,28196696,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4nccs4)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '18.87', 'le': '0.36', 'lle': '5.25', 'sei': '7.87'}",CHEMBL5916379,,CHEMBL5916379,8.18,0,http://www.openphacts.org/units/Nanomolar,4463981,=,37,1,=,,IC50,nM,,6.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,6.6
,983838,28196708,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,CNc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccn1,,,CHEMBL5728138,,2020.0,"{'bei': '17.14', 'le': '0.32', 'lle': '3.88', 'sei': '7.13'}",CHEMBL5986561,,CHEMBL5986561,7.62,0,http://www.openphacts.org/units/Nanomolar,4463982,=,37,1,=,,IC50,nM,,24.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,24.0
,983842,28196720,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3nccs3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.47', 'le': '0.34', 'lle': '4.83', 'sei': '7.58'}",CHEMBL5787943,,CHEMBL5787943,7.89,0,http://www.openphacts.org/units/Nanomolar,4463983,=,37,1,=,,IC50,nM,,13.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,13.0
,983846,28196732,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)n1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '16.66', 'le': '0.31', 'lle': '3.84', 'sei': '7.58'}",CHEMBL5957422,,CHEMBL5957422,7.89,0,http://www.openphacts.org/units/Nanomolar,4463943,=,37,1,=,,IC50,nM,,13.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,13.0
,983850,28196744,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(Cl)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '16.17', 'le': '0.31', 'lle': '3.95', 'sei': '7.18'}",CHEMBL5774791,,CHEMBL5774791,7.47,0,http://www.openphacts.org/units/Nanomolar,4463984,=,37,1,=,,IC50,nM,,34.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,34.0
,983854,28196756,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(C#N)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '15.73', 'le': '0.29', 'lle': '4.38', 'sei': '5.57'}",CHEMBL5948505,,CHEMBL5948505,7.12,0,http://www.openphacts.org/units/Nanomolar,4463985,=,37,1,=,,IC50,nM,,76.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,76.0
,983858,28196768,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4cscn4)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.54', 'le': '0.33', 'lle': '4.67', 'sei': '7.31'}",CHEMBL5800628,,CHEMBL5800628,7.60,0,http://www.openphacts.org/units/Nanomolar,4463986,=,37,1,=,,IC50,nM,,25.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,25.0
,983862,28196780,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(N)n3nc(Cc4ncccc4F)nc3c2-c2ccc(=O)n(C)c2)cn1,,,CHEMBL5728138,,2020.0,"{'bei': '17.23', 'le': '0.32', 'lle': '5.83', 'sei': '6.10'}",CHEMBL5851570,,CHEMBL5851570,7.43,0,http://www.openphacts.org/units/Nanomolar,4463987,=,37,1,=,,IC50,nM,,37.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,37.0
,983866,28196792,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc(=O)n(C3CS(=O)(=O)C3)c2)c2nc(Cc3c(F)cccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '13.39', 'le': '0.26', 'lle': '4.22', 'sei': '5.91'}",CHEMBL6007054,,CHEMBL6007054,7.40,0,http://www.openphacts.org/units/Nanomolar,4463988,=,37,1,=,,IC50,nM,,40.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,40.0
,983870,28196804,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(-c2nc(N)n3nc(Cc4ncccc4F)nc3c2-c2ccc(=O)n(C)c2)cc1,,,CHEMBL5728138,,2020.0,"{'bei': '16.62', 'le': '0.31', 'lle': '4.73', 'sei': '6.71'}",CHEMBL5988628,,CHEMBL5988628,7.60,0,http://www.openphacts.org/units/Nanomolar,4463944,=,37,1,=,,IC50,nM,,25.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,25.0
,983874,28196816,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(C(F)(F)F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '15.28', 'le': '0.29', 'lle': '3.69', 'sei': '7.28'}",CHEMBL6022055,,CHEMBL6022055,7.57,0,http://www.openphacts.org/units/Nanomolar,4463945,=,37,1,=,,IC50,nM,,27.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,27.0
,983878,28196828,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-n3cccn3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '15.82', 'le': '0.29', 'lle': '5.22', 'sei': '5.42'}",CHEMBL5921476,,CHEMBL5921476,6.60,0,http://www.openphacts.org/units/Nanomolar,4463989,=,37,1,=,,IC50,nM,,250.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,250.0
,983882,28196840,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3F)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '15.13', 'le': '0.28', 'lle': '3.87', 'sei': '6.74'}",CHEMBL5837834,,CHEMBL5837834,7.01,0,http://www.openphacts.org/units/Nanomolar,4463990,=,37,1,=,,IC50,nM,,97.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,97.0
,983886,28196852,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc(=O)n(CCO)c2)c2nc(Cc3c(F)cccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '15.78', 'le': '0.29', 'lle': '4.57', 'sei': '6.98'}",CHEMBL5800386,,CHEMBL5800386,7.77,0,http://www.openphacts.org/units/Nanomolar,4463991,=,37,1,=,,IC50,nM,,17.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,17.0
,983890,28196864,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc(=O)n1C,,,CHEMBL5728138,,2020.0,"{'bei': '15.59', 'le': '0.29', 'lle': '3.85', 'sei': '6.89'}",CHEMBL6044836,,CHEMBL6044836,7.16,0,http://www.openphacts.org/units/Nanomolar,4463946,=,37,1,=,,IC50,nM,,69.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,69.0
,983894,28196876,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncc(F)cc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.02', 'le': '0.32', 'lle': '4.75', 'sei': '7.58'}",CHEMBL5969060,,CHEMBL5969060,7.89,0,http://www.openphacts.org/units/Nanomolar,4463992,=,37,1,=,,IC50,nM,,13.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,13.0
,983898,28196888,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc(Cc2nc3c(-c4ccc5nccn5c4)c(-c4ccc(F)cc4)nc(N)n3n2)cs1,,,CHEMBL5728138,,2020.0,"{'bei': '16.51', 'le': '0.31', 'lle': '3.36', 'sei': '7.59'}",CHEMBL6031624,,CHEMBL6031624,7.54,0,http://www.openphacts.org/units/Nanomolar,4463993,=,37,1,=,,IC50,nM,,29.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,29.0
,983902,28196900,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cnc2ccc(-c3c(-c4ccc(F)cc4)nc(N)n4nc(Cc5ncccc5F)nc34)cc21,,,CHEMBL5728138,,2020.0,"{'bei': '16.35', 'le': '0.30', 'lle': '3.47', 'sei': '7.67'}",CHEMBL5999728,,CHEMBL5999728,7.66,0,http://www.openphacts.org/units/Nanomolar,4463994,=,37,1,=,,IC50,nM,,22.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,22.0
,983906,28196912,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3cccc(Cl)c3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.00', 'le': '0.33', 'lle': '4.33', 'sei': '7.55'}",CHEMBL6043653,,CHEMBL6043653,7.85,0,http://www.openphacts.org/units/Nanomolar,4463947,=,37,1,=,,IC50,nM,,14.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,14.0
,983910,28196924,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4ncccc4OC(F)F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.26', 'le': '0.32', 'lle': '5.74', 'sei': '5.78'}",CHEMBL5896698,,CHEMBL5896698,8.05,0,http://www.openphacts.org/units/Nanomolar,4463995,=,37,1,=,,IC50,nM,,8.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,8.9
,983914,28196936,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3nncn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.59', 'le': '0.32', 'lle': '4.66', 'sei': '7.14'}",CHEMBL5884236,,CHEMBL5884236,8.01,0,http://www.openphacts.org/units/Nanomolar,4463996,=,37,1,=,,IC50,nM,,9.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,9.7
,983918,28196948,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3nncn3c2)c2nc(Cc3ncccc3OC(F)F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '15.81', 'le': '0.29', 'lle': '4.15', 'sei': '6.56'}",CHEMBL5928153,,CHEMBL5928153,7.96,0,http://www.openphacts.org/units/Nanomolar,4463997,=,37,1,=,,IC50,nM,,11.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,11.0
,983922,28196960,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccc3nncn3c2)c2nc(Cc3ncccc3OC(F)F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.71', 'le': '0.31', 'lle': '5.30', 'sei': '5.40'}",CHEMBL5917926,,CHEMBL5917926,7.96,0,http://www.openphacts.org/units/Nanomolar,4463998,=,37,1,=,,IC50,nM,,11.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,11.0
,983926,28196972,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3nc[nH]c3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.52', 'le': '0.30', 'lle': '3.33', 'sei': '6.78'}",CHEMBL5833725,,CHEMBL5833725,7.51,0,http://www.openphacts.org/units/Nanomolar,4463999,=,37,1,=,,IC50,nM,,31.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,31.0
,983930,28196984,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3cc(F)cc(F)c3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.38', 'le': '0.32', 'lle': '4.92', 'sei': '7.75'}",CHEMBL5963481,,CHEMBL5963481,8.06,0,http://www.openphacts.org/units/Nanomolar,4464000,=,37,1,=,,IC50,nM,,8.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,8.8
,983934,28196996,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,COc1cccc(-c2nc(N)n3nc(Cc4ncccc4F)nc3c2-c2ccc(=O)n(C)c2)c1,,,CHEMBL5728138,,2020.0,"{'bei': '17.24', 'le': '0.32', 'lle': '5.02', 'sei': '6.97'}",CHEMBL6030840,,CHEMBL6030840,7.89,0,http://www.openphacts.org/units/Nanomolar,4463948,=,37,1,=,,IC50,nM,,13.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,13.0
,983938,28197008,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccccc3Cl)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '12.85', 'le': '0.25', 'lle': '2.42', 'sei': '5.71'}",CHEMBL5746764,,CHEMBL5746764,5.94,0,http://www.openphacts.org/units/Nanomolar,4464001,=,37,1,=,,IC50,nM,,1157.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1157.0
,983942,28197020,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)n1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '16.30', 'le': '0.30', 'lle': '3.91', 'sei': '6.45'}",CHEMBL6003948,,CHEMBL6003948,7.55,0,http://www.openphacts.org/units/Nanomolar,4464002,=,37,1,=,,IC50,nM,,28.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,28.0
,983946,28197032,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)n1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.03', 'le': '0.31', 'lle': '4.70', 'sei': '5.85'}",CHEMBL5915941,,CHEMBL5915941,7.60,0,http://www.openphacts.org/units/Nanomolar,4464003,=,37,1,=,,IC50,nM,,25.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,25.0
,983950,28197044,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)cc(N)n1,,,CHEMBL5728138,,2020.0,"{'bei': '12.14', 'le': '0.23', 'lle': '2.09', 'sei': '3.93'}",CHEMBL5873125,,CHEMBL5873125,5.27,0,http://www.openphacts.org/units/Nanomolar,4464004,=,37,1,=,,IC50,nM,,5323.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5323.0
,983954,28197056,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4ncccc4F)nc23)cc(Cl)n1,,,CHEMBL5728138,,2020.0,"{'bei': '12.77', 'le': '0.25', 'lle': '2.07', 'sei': '4.61'}",CHEMBL5859012,,CHEMBL5859012,5.58,0,http://www.openphacts.org/units/Nanomolar,4464005,=,37,1,=,,IC50,nM,,2643.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2643.0
,983958,28197068,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)cc(C#N)n1,,,CHEMBL5728138,,2020.0,"{'bei': '13.58', 'le': '0.25', 'lle': '2.56', 'sei': '4.58'}",CHEMBL5767016,,CHEMBL5767016,6.04,0,http://www.openphacts.org/units/Nanomolar,4464006,=,37,1,=,,IC50,nM,,923.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,923.0
,983962,28197080,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)cc(C2CC2)n1,,,CHEMBL5728138,,2020.0,"{'bei': '12.11', 'le': '0.22', 'lle': '1.08', 'sei': '5.15'}",CHEMBL5770581,,CHEMBL5770581,5.57,0,http://www.openphacts.org/units/Nanomolar,4464007,=,37,1,=,,IC50,nM,,2724.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2724.0
,983966,28197092,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccnc(OC(F)F)c2)c2nc(Cc3c(F)cccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.06', 'le': '0.30', 'lle': '3.68', 'sei': '6.46'}",CHEMBL5795044,,CHEMBL5795044,7.57,0,http://www.openphacts.org/units/Nanomolar,4463949,=,37,1,=,,IC50,nM,,27.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,27.0
,983970,28197104,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccnc(OC(F)F)c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '15.91', 'le': '0.30', 'lle': '4.08', 'sei': '5.55'}",CHEMBL5810207,,CHEMBL5810207,7.23,0,http://www.openphacts.org/units/Nanomolar,4463950,=,37,1,=,,IC50,nM,,59.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,59.0
,983974,28197116,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4ncccc4F)nc23)cc(OC(F)F)n1,,,CHEMBL5728138,,2020.0,"{'bei': '11.51', 'le': '0.22', 'lle': '1.93', 'sei': '4.14'}",CHEMBL5897970,,CHEMBL5897970,5.39,0,http://www.openphacts.org/units/Nanomolar,4464008,=,37,1,=,,IC50,nM,,4046.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,4046.0
,983978,28197128,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncsc3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '14.76', 'le': '0.28', 'lle': '2.05', 'sei': '7.33'}",CHEMBL5974806,,CHEMBL5974806,6.96,0,http://www.openphacts.org/units/Nanomolar,4464009,=,37,1,=,,IC50,nM,,110.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,110.0
,983982,28197140,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '14.78', 'le': '0.27', 'lle': '2.03', 'sei': '7.25'}",CHEMBL5847956,,CHEMBL5847956,6.88,0,http://www.openphacts.org/units/Nanomolar,4464010,=,37,1,=,,IC50,nM,,132.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,132.0
,983986,28197152,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cnc2ccc(-c3c(-c4ncco4)nc(N)n4nc(Cc5ncccc5F)nc34)cc21,,,CHEMBL5728138,,2020.0,"{'bei': '16.18', 'le': '0.30', 'lle': '4.10', 'sei': '5.68'}",CHEMBL5882133,,CHEMBL5882133,7.14,0,http://www.openphacts.org/units/Nanomolar,4464011,=,37,1,=,,IC50,nM,,72.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,72.0
,983990,28197164,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cnc2ccc(-c3c(-c4ncco4)nc(N)n4nc(Cc5c(F)cccc5F)nc34)cc21,,,CHEMBL5728138,,2020.0,"{'bei': '14.58', 'le': '0.27', 'lle': '2.91', 'sei': '5.92'}",CHEMBL6041892,,CHEMBL6041892,6.69,0,http://www.openphacts.org/units/Nanomolar,4464012,=,37,1,=,,IC50,nM,,206.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,206.0
,983994,28197176,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccccn3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '17.70', 'le': '0.33', 'lle': '4.89', 'sei': '7.58'}",CHEMBL5974092,,CHEMBL5974092,7.89,0,http://www.openphacts.org/units/Nanomolar,4464013,=,37,1,=,,IC50,nM,,13.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,13.0
,983998,28197188,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-n2ccnn2)c(-c2ccc3nccn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '14.29', 'le': '0.26', 'lle': '4.38', 'sei': '4.70'}",CHEMBL5766823,,CHEMBL5766823,6.11,0,http://www.openphacts.org/units/Nanomolar,4464014,=,37,1,=,,IC50,nM,,779.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,779.0
,984002,28197200,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-n2nccn2)c(-c2ccc3nccn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.28', 'le': '0.32', 'lle': '5.66', 'sei': '5.68'}",CHEMBL6062538,,CHEMBL6062538,7.39,0,http://www.openphacts.org/units/Nanomolar,4463951,=,37,1,=,,IC50,nM,,41.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,41.0
,984006,28197212,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc(=O)n(CCO)c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '15.92', 'le': '0.30', 'lle': '5.11', 'sei': '6.09'}",CHEMBL5854635,,CHEMBL5854635,7.57,0,http://www.openphacts.org/units/Nanomolar,4464015,=,37,1,=,,IC50,nM,,27.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,27.0
,984010,28197224,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3nccnc3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5728138,,2020.0,"{'bei': '13.22', 'le': '0.24', 'lle': '1.92', 'sei': '5.72'}",CHEMBL5865001,,CHEMBL5865001,6.17,0,http://www.openphacts.org/units/Nanomolar,4464016,=,37,1,=,,IC50,nM,,681.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,681.0
,984014,28197236,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc4c(ccn4C)c3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5728138,,2020.0,"{'bei': '16.07', 'le': '0.29', 'lle': '4.36', 'sei': '7.09'}",CHEMBL5903842,,CHEMBL5903842,7.72,0,http://www.openphacts.org/units/Nanomolar,4464017,=,37,1,=,,IC50,nM,,19.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,19.0
,984018,28197248,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,COc1ccccc1-c1nc(N)n2nc(Cc3ncccc3F)nc2c1-c1ccc(=O)n(C)c1,,,CHEMBL5728138,,2020.0,"{'bei': '14.16', 'le': '0.26', 'lle': '3.61', 'sei': '5.72'}",CHEMBL6008951,,CHEMBL6008951,6.48,0,http://www.openphacts.org/units/Nanomolar,4464018,=,37,1,=,,IC50,nM,,333.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,333.0
,984022,28197260,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-c4ncco4)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '19.16', 'le': '0.35', 'lle': '5.35', 'sei': '6.75'}",CHEMBL6057896,,CHEMBL6057896,8.46,0,http://www.openphacts.org/units/Nanomolar,4464019,=,37,1,=,,IC50,nM,,3.5,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3.5
,984026,28197272,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N(C)C)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '18.99', 'le': '0.35', 'lle': '5.41', 'sei': '7.73'}",CHEMBL5765395,,CHEMBL5765395,7.93,0,http://www.openphacts.org/units/Nanomolar,4464020,=,37,1,=,,IC50,nM,,11.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,11.8
,984030,28197284,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCCC4)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '18.45', 'le': '0.34', 'lle': '5.13', 'sei': '7.98'}",CHEMBL5955357,,CHEMBL5955357,8.18,0,http://www.openphacts.org/units/Nanomolar,4464021,=,37,1,=,,IC50,nM,,6.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,6.6
,984034,28197296,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCOCC4)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.46', 'le': '0.30', 'lle': '5.28', 'sei': '6.77'}",CHEMBL5857008,,CHEMBL5857008,7.57,0,http://www.openphacts.org/units/Nanomolar,4464022,=,37,1,=,,IC50,nM,,27.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,27.2
,984038,28197308,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,CN1CCC[C@H]1Cc1nc2c(-c3ccc4ncn(C)c4c3)c(-c3ccc(F)cc3)nc(N)n2n1,,,CHEMBL5728138,,2020.0,"{'bei': '14.41', 'le': '0.26', 'lle': '2.88', 'sei': '7.30'}",CHEMBL5876564,,CHEMBL5876564,6.58,0,http://www.openphacts.org/units/Nanomolar,4464023,=,37,1,=,,IC50,nM,,264.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,264.0
,984042,28197320,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,CN1CCC[C@@H]1Cc1nc2c(-c3ccc4ncn(C)c4c3)c(-c3ccc(F)cc3)nc(N)n2n1,,,CHEMBL5728138,,2020.0,"{'bei': '16.36', 'le': '0.30', 'lle': '3.77', 'sei': '8.28'}",CHEMBL6040445,,CHEMBL6040445,7.47,0,http://www.openphacts.org/units/Nanomolar,4464024,=,37,1,=,,IC50,nM,,34.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,34.1
,984046,28197332,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)nc(N)n4nc(CC5CCOC5)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.71', 'le': '0.33', 'lle': '4.14', 'sei': '8.21'}",CHEMBL5940119,,CHEMBL5940119,7.85,0,http://www.openphacts.org/units/Nanomolar,4464025,=,37,1,=,,IC50,nM,,14.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,14.0
,984050,28197344,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)nc(N)n4nc(C[C@H]5CCOC5)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.88', 'le': '0.33', 'lle': '4.22', 'sei': '8.29'}",CHEMBL5836704,,CHEMBL5836704,7.93,0,http://www.openphacts.org/units/Nanomolar,4464026,=,37,1,=,,IC50,nM,,11.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,11.8
,984052,28197350,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-c4ncco4)nc(N)n4nc(C[C@@H]5CCCO5)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.47', 'le': '0.32', 'lle': '4.56', 'sei': '5.98'}",CHEMBL5742864,,CHEMBL5742864,7.27,0,http://www.openphacts.org/units/Nanomolar,4464027,=,37,1,=,,IC50,nM,,53.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,53.2
,984054,28197356,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-c4ncco4)nc(N)n4nc(C[C@H]5CCCO5)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.91', 'le': '0.33', 'lle': '4.75', 'sei': '6.13'}",CHEMBL6064185,,CHEMBL6064185,7.46,0,http://www.openphacts.org/units/Nanomolar,4464028,=,37,1,=,,IC50,nM,,34.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,34.9
,984058,28197368,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-c4ncco4)nc(N)n4nc(C[C@@H]5CCOC5)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.44', 'le': '0.32', 'lle': '4.70', 'sei': '5.97'}",CHEMBL5778791,,CHEMBL5778791,7.26,0,http://www.openphacts.org/units/Nanomolar,4464029,=,37,1,=,,IC50,nM,,54.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,54.6
,984062,28197380,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-c4ncco4)nc(N)n4nc(C[C@H]5CCOC5)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.92', 'le': '0.33', 'lle': '4.90', 'sei': '6.13'}",CHEMBL5916564,,CHEMBL5916564,7.46,0,http://www.openphacts.org/units/Nanomolar,4464030,=,37,1,=,,IC50,nM,,34.5,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,34.5
,984064,28197386,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCN(C)CC4)nc(N)n4nc(Cc5c(F)cccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '14.06', 'le': '0.26', 'lle': '3.93', 'sei': '7.41'}",CHEMBL5745377,,CHEMBL5745377,6.88,0,http://www.openphacts.org/units/Nanomolar,4464031,=,37,1,=,,IC50,nM,,131.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,131.0
,984066,28197392,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,COC1CN(c2nc(N)n3nc(Cc4c(F)cccc4F)nc3c2-c2ccc3ncc(C)n3c2)C1,,,CHEMBL5728138,,2020.0,"{'bei': '15.77', 'le': '0.29', 'lle': '4.48', 'sei': '7.60'}",CHEMBL5811331,,CHEMBL5811331,7.51,0,http://www.openphacts.org/units/Nanomolar,4464032,=,37,1,=,,IC50,nM,,30.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,30.6
,984070,28197404,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCC5(COC5)C4)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '14.55', 'le': '0.27', 'lle': '4.39', 'sei': '6.32'}",CHEMBL6031846,,CHEMBL6031846,7.07,0,http://www.openphacts.org/units/Nanomolar,4464033,=,37,1,=,,IC50,nM,,85.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,85.9
,984072,28197410,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCO[C@H](C)C4)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '12.70', 'le': '0.23', 'lle': '3.34', 'sei': '5.38'}",CHEMBL5798008,,CHEMBL5798008,6.01,0,http://www.openphacts.org/units/Nanomolar,4464034,=,37,1,=,,IC50,nM,,966.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,966.0
,984074,28197416,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCO[C@@H](C)C4)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '14.62', 'le': '0.27', 'lle': '4.24', 'sei': '6.19'}",CHEMBL5865101,,CHEMBL5865101,6.92,0,http://www.openphacts.org/units/Nanomolar,4464035,=,37,1,=,,IC50,nM,,120.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,120.0
,984076,28197422,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCOC[C@@H]4C)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '11.58', 'le': '0.21', 'lle': '2.80', 'sei': '4.91'}",CHEMBL6012996,,CHEMBL6012996,5.49,0,http://www.openphacts.org/units/Nanomolar,4464036,=,37,1,=,,IC50,nM,,3274.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3274.0
,984082,28197440,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,COCCc1nc2c(-c3ccc4ncc(C)n4c3)c(-c3ccc(F)cc3)nc(N)n2n1,,,CHEMBL5728138,,2020.0,"{'bei': '19.75', 'le': '0.36', 'lle': '4.92', 'sei': '8.62'}",CHEMBL5825227,,CHEMBL5825227,8.24,0,http://www.openphacts.org/units/Nanomolar,4464038,=,37,1,=,,IC50,nM,,5.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.7
,984086,28197452,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-n4ccc(F)n4)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.67', 'le': '0.33', 'lle': '5.32', 'sei': '6.92'}",CHEMBL6007478,,CHEMBL6007478,8.10,0,http://www.openphacts.org/units/Nanomolar,4464039,=,37,1,=,,IC50,nM,,7.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,7.9
,984090,28197464,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-n4cc(F)cn4)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.48', 'le': '0.32', 'lle': '5.23', 'sei': '6.84'}",CHEMBL6057843,,CHEMBL6057843,8.01,0,http://www.openphacts.org/units/Nanomolar,4464040,=,37,1,=,,IC50,nM,,9.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,9.7
,984094,28197476,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCC4)nc(N)n4nc(Cc5ncccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.03', 'le': '0.31', 'lle': '4.65', 'sei': '7.13'}",CHEMBL5964116,,CHEMBL5964116,7.31,0,http://www.openphacts.org/units/Nanomolar,4464042,=,37,1,=,,IC50,nM,,48.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,48.6
,984098,28197488,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)nc(N)n4nc(CCN(C)C)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.67', 'le': '0.31', 'lle': '3.94', 'sei': '8.01'}",CHEMBL5949734,,CHEMBL5949734,7.18,0,http://www.openphacts.org/units/Nanomolar,4464043,=,37,1,=,,IC50,nM,,66.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,66.7
,984102,28197500,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCOCC4)nc(N)n4nc(Cc5c(F)cccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '15.00', 'le': '0.28', 'lle': '4.11', 'sei': '7.23'}",CHEMBL5913092,,CHEMBL5913092,7.15,0,http://www.openphacts.org/units/Nanomolar,4464044,=,37,1,=,,IC50,nM,,71.5,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,71.5
,984106,28197512,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)nc(N)n4nc(C[C@@H]5CCCN5C)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '15.70', 'le': '0.29', 'lle': '3.40', 'sei': '8.00'}",CHEMBL6016827,,CHEMBL6016827,7.17,0,http://www.openphacts.org/units/Nanomolar,4464045,=,37,1,=,,IC50,nM,,67.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,67.7
,984110,28197524,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCCC4)nc(N)n4nc(Cc5c(F)cccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.01', 'le': '0.30', 'lle': '3.57', 'sei': '8.22'}",CHEMBL6055525,,CHEMBL6055525,7.37,0,http://www.openphacts.org/units/Nanomolar,4464046,=,37,1,=,,IC50,nM,,42.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,42.4
,984114,28197536,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(N4CCC4)nc(N)n4nc(Cc5c(F)cccc5F)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '17.46', 'le': '0.32', 'lle': '4.39', 'sei': '8.70'}",CHEMBL5747460,,CHEMBL5747460,7.80,0,http://www.openphacts.org/units/Nanomolar,4464047,=,37,1,=,,IC50,nM,,16.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,16.0
,984116,28197542,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)nc(N)n4nc(C[C@H]5CCCN5C)nc34)cn12,,,CHEMBL5728138,,2020.0,"{'bei': '16.36', 'le': '0.30', 'lle': '3.70', 'sei': '8.33'}",CHEMBL5988700,,CHEMBL5988700,7.47,0,http://www.openphacts.org/units/Nanomolar,4464048,=,37,1,=,,IC50,nM,,34.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,34.1
,984118,28197548,[],CHEMBL5736168,"FLIPR and cAMP Inhibition Assay: hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experiment. On the day of experiment, the supernatant was discard and replaced with 40 L of dye (FLIPR calcium 5 Assay Kit) per well and the plates were incubated for 60 mins at 37° C. plus 5% CO2. Then testing compounds were added at different concentrations for FLIPR inhibition assay. After a 400 s incubation with compound, 10 M adenosine was added into the cells, and the signal was captured by FLIPR.hA2a/CHO, hA2b/CHO and mA2a/CHO (Genscript) were plated at 5×103 cells/well into 384-well polystyrene plates at the day of experiment. Compounds were pre-incubated with cells for 30 min at 37° C., 5% CO2. Then 10 M adenosine was added to the cells and incubated for 30 min at 37° C., 5% CO2. Detection reagent (CISBIO) was added and the plates were incubated for 60 min at room temperature. The signal was captured by Envision.",B,,,BAO_0000190,BAO_0000019,assay format,COCCc1nc2c(-c3ccc4ncc(C)n4c3)c(-c3ncco3)nc(N)n2n1,,,CHEMBL5728138,,2020.0,"{'bei': '18.13', 'le': '0.33', 'lle': '4.91', 'sei': '5.82'}",CHEMBL6033152,,CHEMBL6033152,7.08,0,http://www.openphacts.org/units/Nanomolar,4464049,=,37,1,=,,IC50,nM,,83.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,83.6
,995818,28231031,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(C(=O)NCc3c(F)cccc3F)c(N)nc2-c2ncco2)ccc1=O,,,CHEMBL5728234,,2021.0,"{'bei': '17.78', 'le': '0.33', 'lle': '5.51', 'sei': '6.05'}",CHEMBL5867976,,CHEMBL5867976,7.80,0,http://www.openphacts.org/units/Nanomolar,4472032,=,37,1,=,,IC50,nM,,16.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,16.0
,995821,28231040,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,CN(C)c1cccnc1CNC(=O)c1nc(-c2ccc(=O)n(C)c2)c(-c2ncco2)nc1N,,,CHEMBL5728234,,2021.0,"{'bei': '17.52', 'le': '0.32', 'lle': '6.35', 'sei': '5.39'}",CHEMBL5848745,,CHEMBL5848745,7.82,0,http://www.openphacts.org/units/Nanomolar,4472034,=,37,1,=,,IC50,nM,,15.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,15.0
,995823,28231046,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(C(=O)NCc3ncccc3OC(F)F)c(N)nc2-c2ncco2)ccc1=O,,,CHEMBL5728234,,2021.0,"{'bei': '10.65', 'le': '0.20', 'lle': '2.99', 'sei': '3.31'}",CHEMBL5881276,,CHEMBL5881276,5.00,0,http://www.openphacts.org/units/Nanomolar,4472035,=,37,1,=,,IC50,nM,,10000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,10000.0
,995835,28231082,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccc3nccn3c2)nc1C(=O)NCc1ncccc1F,,,CHEMBL5728234,,2021.0,"{'bei': '15.36', 'le': '0.28', 'lle': '4.12', 'sei': '4.82'}",CHEMBL5911581,,CHEMBL5911581,6.61,0,http://www.openphacts.org/units/Nanomolar,4472045,=,37,1,=,,IC50,nM,,245.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,245.0
,995837,28231088,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccc3[nH]cnc3c2)nc1C(=O)NCc1ncccc1F,,,CHEMBL5728234,,2021.0,"{'bei': '14.31', 'le': '0.26', 'lle': '3.44', 'sei': '4.15'}",CHEMBL6003783,,CHEMBL6003783,6.16,0,http://www.openphacts.org/units/Nanomolar,4472046,=,37,1,=,,IC50,nM,,696.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,696.0
,995839,28231094,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1cccc(CNC(=O)c2nc(-c3ccc4nccn4c3)c(-c3ncco3)nc2N)n1,,,CHEMBL5728234,,2021.0,"{'bei': '16.78', 'le': '0.31', 'lle': '5.23', 'sei': '4.40'}",CHEMBL6019989,,CHEMBL6019989,7.17,0,http://www.openphacts.org/units/Nanomolar,4472047,=,37,1,=,,IC50,nM,,67.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,67.0
,995841,28231100,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(C(=O)NCc3nc(N)ccc3F)c(N)nc2-c2ncco2)ccc1=O,,,CHEMBL5728234,,2021.0,"{'bei': '15.88', 'le': '0.30', 'lle': '5.80', 'sei': '4.13'}",CHEMBL5974116,,CHEMBL5974116,6.93,0,http://www.openphacts.org/units/Nanomolar,4472048,=,37,1,=,,IC50,nM,,117.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,117.0
,995843,28231106,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cnc2ccc(-c3nc(C(=O)NCc4ncccc4F)c(N)nc3-c3ncco3)cc21,,,CHEMBL5728234,,2021.0,"{'bei': '15.99', 'le': '0.29', 'lle': '4.38', 'sei': '5.16'}",CHEMBL5802346,,CHEMBL5802346,7.11,0,http://www.openphacts.org/units/Nanomolar,4472049,=,37,1,=,,IC50,nM,,78.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,78.0
,995845,28231112,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,COc1ccccc1CNC(=O)c1nc(-c2cc(C)nc(C)c2)c(-c2ccc(C)o2)nc1N,,,CHEMBL5728234,,2021.0,"{'bei': '16.42', 'le': '0.30', 'lle': '3.04', 'sei': '6.27'}",CHEMBL5781132,,CHEMBL5781132,7.28,0,http://www.openphacts.org/units/Nanomolar,4472050,=,37,1,=,,IC50,nM,,52.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,52.0
,995848,28231121,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2nc(C(=O)NCc3ccccc3OC(F)(F)F)c(N)nc2-c2ccc(F)cc2)cc(C)n1,,,CHEMBL5728234,,2021.0,"{'bei': '14.71', 'le': '0.28', 'lle': '2.15', 'sei': '7.30'}",CHEMBL6005886,,CHEMBL6005886,7.52,0,http://www.openphacts.org/units/Nanomolar,4472051,=,37,1,=,,IC50,nM,,30.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,30.0
,995850,28231127,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(CNC(=O)c3c(F)cccc3F)c(N)nc2-c2ccc(F)cc2)ccc1=O,,,CHEMBL5728234,,2021.0,"{'bei': '16.69', 'le': '0.31', 'lle': '4.33', 'sei': '7.55'}",CHEMBL6058216,,CHEMBL6058216,7.77,0,http://www.openphacts.org/units/Nanomolar,4472052,=,37,1,=,,IC50,nM,,17.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,17.0
,995852,28231133,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(C(=O)NC(CO)c3c(F)cccc3F)c(N)nc2-c2ncco2)ccc1=O,,,CHEMBL5728234,,2021.0,"{'bei': '17.08', 'le': '0.32', 'lle': '6.18', 'sei': '5.36'}",CHEMBL5769004,,CHEMBL5769004,8.00,0,http://www.openphacts.org/units/Nanomolar,4472053,=,37,1,=,,IC50,nM,,10.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,10.0
,995854,28231139,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccc3ncnn3c2)nc1C(=O)NCc1ncccc1F,,,CHEMBL5728234,,2021.0,"{'bei': '14.29', 'le': '0.26', 'lle': '4.27', 'sei': '4.11'}",CHEMBL5963684,,CHEMBL5963684,6.16,0,http://www.openphacts.org/units/Nanomolar,4472054,=,37,1,=,,IC50,nM,,685.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,685.0
,995856,28231145,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NCc4ncccc4F)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '18.57', 'le': '0.34', 'lle': '5.45', 'sei': '6.02'}",CHEMBL5878949,,CHEMBL5878949,8.25,0,http://www.openphacts.org/units/Nanomolar,4472055,=,37,1,=,,IC50,nM,,5.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.6
,995858,28231151,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-n2nccn2)c(-c2ccc3nccn3c2)nc1C(=O)NCc1ncccc1F,,,CHEMBL5728234,,2021.0,"{'bei': '16.98', 'le': '0.31', 'lle': '5.89', 'sei': '5.16'}",CHEMBL5796037,,CHEMBL5796037,7.31,0,http://www.openphacts.org/units/Nanomolar,4472056,=,37,1,=,,IC50,nM,,49.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,49.0
,995860,28231157,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,CNCCOc1cccnc1CNC(=O)c1nc(-c2ccc3ncn(C)c3c2)c(-c2ccc(F)cc2)nc1N,,,CHEMBL5728234,,2021.0,"{'bei': '17.18', 'le': '0.32', 'lle': '5.71', 'sei': '6.81'}",CHEMBL5772325,,CHEMBL5772325,9.05,0,http://www.openphacts.org/units/Nanomolar,4472057,=,37,1,=,,IC50,nM,,0.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.9
,995862,28231163,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NCC4CCCN4C)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '15.74', 'le': '0.29', 'lle': '4.65', 'sei': '5.34'}",CHEMBL5836132,,CHEMBL5836132,6.81,0,http://www.openphacts.org/units/Nanomolar,4472058,=,37,1,=,,IC50,nM,,156.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,156.0
,995864,28231169,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NCC4CCCN4C)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '16.04', 'le': '0.30', 'lle': '4.78', 'sei': '5.44'}",CHEMBL5836132,,CHEMBL5836132,6.94,0,http://www.openphacts.org/units/Nanomolar,4472058,=,37,1,=,,IC50,nM,,116.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,116.0
,995866,28231175,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@H]4CCCO4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '16.95', 'le': '0.31', 'lle': '4.86', 'sei': '5.33'}",CHEMBL5895809,,CHEMBL5895809,7.11,0,http://www.openphacts.org/units/Nanomolar,4472059,=,37,1,=,,IC50,nM,,78.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,78.0
,995868,28231181,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@@H]4CCCO4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '17.09', 'le': '0.32', 'lle': '4.92', 'sei': '5.37'}",CHEMBL5818042,,CHEMBL5818042,7.17,0,http://www.openphacts.org/units/Nanomolar,4472060,=,37,1,=,,IC50,nM,,68.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,68.0
,995870,28231187,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC(C)C)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '17.40', 'le': '0.32', 'lle': '4.09', 'sei': '5.29'}",CHEMBL6046888,,CHEMBL6046888,6.57,0,http://www.openphacts.org/units/Nanomolar,4472061,=,37,1,=,,IC50,nM,,271.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,271.0
,995872,28231193,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NCC4CCO4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '16.44', 'le': '0.30', 'lle': '4.81', 'sei': '4.99'}",CHEMBL5957693,,CHEMBL5957693,6.67,0,http://www.openphacts.org/units/Nanomolar,4472062,=,37,1,=,,IC50,nM,,216.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,216.0
,995874,28231199,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NCC4CCO4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '16.76', 'le': '0.31', 'lle': '4.93', 'sei': '5.09'}",CHEMBL5957693,,CHEMBL5957693,6.79,0,http://www.openphacts.org/units/Nanomolar,4472062,=,37,1,=,,IC50,nM,,161.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,161.0
,995876,28231205,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@H]4CCOC4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '16.07', 'le': '0.30', 'lle': '4.64', 'sei': '5.05'}",CHEMBL6042158,,CHEMBL6042158,6.74,0,http://www.openphacts.org/units/Nanomolar,4472063,=,37,1,=,,IC50,nM,,182.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,182.0
,995878,28231211,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@@H]4CCOC4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '16.00', 'le': '0.30', 'lle': '4.61', 'sei': '5.03'}",CHEMBL6023556,,CHEMBL6023556,6.71,0,http://www.openphacts.org/units/Nanomolar,4472064,=,37,1,=,,IC50,nM,,195.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,195.0
,995880,28231217,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@H]4CCCN4C)c(N)nc3-c3ccc(F)cc3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '16.91', 'le': '0.31', 'lle': '4.46', 'sei': '7.66'}",CHEMBL5772644,,CHEMBL5772644,7.77,0,http://www.openphacts.org/units/Nanomolar,4472065,=,37,1,=,,IC50,nM,,17.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,17.0
,995882,28231223,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@@H]4CCCN4C)c(N)nc3-c3ccc(F)cc3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '15.63', 'le': '0.29', 'lle': '3.87', 'sei': '7.08'}",CHEMBL5903127,,CHEMBL5903127,7.18,0,http://www.openphacts.org/units/Nanomolar,4472066,=,37,1,=,,IC50,nM,,66.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,66.0
,995884,28231229,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,COCCNC(=O)c1nc(-c2ccc3ncc(C)n3c2)c(-c2ncco2)nc1N,,,CHEMBL5728234,,2021.0,"{'bei': '17.71', 'le': '0.33', 'lle': '5.26', 'sei': '5.22'}",CHEMBL5885393,,CHEMBL5885393,6.97,0,http://www.openphacts.org/units/Nanomolar,4472067,=,37,1,=,,IC50,nM,,108.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,108.0
,995886,28231235,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,COC[C@H](C)NC(=O)c1nc(-c2ccc3ncc(C)n3c2)c(-c2ncco2)nc1N,,,CHEMBL5728234,,2021.0,"{'bei': '15.90', 'le': '0.29', 'lle': '4.38', 'sei': '4.85'}",CHEMBL5959365,,CHEMBL5959365,6.48,0,http://www.openphacts.org/units/Nanomolar,4472068,=,37,1,=,,IC50,nM,,333.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,333.0
,995888,28231241,[],CHEMBL5736347,"Binding Affinity Assay: The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA2b membrane (from PerkinElmer) and [3H]-DPCPX for 60 min at 27° C., and the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount. The compounds at different concentrations were incubate with hA3 membrane (from PerkinElmer) and [125I]-AB-MECA for 60 min at 27° C., the binding reactions were stopped by rapid filtration through 0.5% BSA coated UNIFILTER-96 GF/C plates using cell harvester. The filter plates were then washed three times with ice cold wash buffer, and dried at 37° C. for 120 min. At last, 50 μL of scintillation cocktail was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC4CCC4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5728234,,2021.0,"{'bei': '16.24', 'le': '0.30', 'lle': '3.70', 'sei': '5.09'}",CHEMBL5800748,,CHEMBL5800748,6.32,0,http://www.openphacts.org/units/Nanomolar,4472069,=,37,1,=,,IC50,nM,,475.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,475.0
,1143969,28629140,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NCc2ccccc2)c2sccc2n1)c1cccnc1,,,CHEMBL5728996,,2022.0,"{'bei': '16.75', 'le': '0.32', 'lle': '2.33', 'sei': '8.17'}",CHEMBL5870124,,CHEMBL5870124,6.52,0,http://www.openphacts.org/units/Nanomolar,4556809,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1144149,28629680,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NCc2ccc(OCC3CC3)nc2)c2sccc2n1)c1ccccn1,,,CHEMBL5728996,,2022.0,"{'bei': '14.16', 'le': '0.27', 'lle': '2.15', 'sei': '6.40'}",CHEMBL5939822,,CHEMBL5939822,6.52,0,http://www.openphacts.org/units/Nanomolar,4556874,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1144293,28630112,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NC2CC(O)C2)c2sccc2n1)c1ccccn1,,,CHEMBL5728996,,2022.0,"{'bei': '17.66', 'le': '0.34', 'lle': '4.01', 'sei': '6.52'}",CHEMBL5954665,,CHEMBL5954665,6.52,0,http://www.openphacts.org/units/Nanomolar,4556925,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1144339,28630250,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(CNC(=O)c2nc(N[C@@H](C)c3ccccn3)nc3ccsc23)cn1,,,CHEMBL5728996,,2022.0,"{'bei': '15.01', 'le': '0.29', 'lle': '2.54', 'sei': '6.40'}",CHEMBL5831955,,CHEMBL5831955,6.52,0,http://www.openphacts.org/units/Nanomolar,4556937,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1144343,28630262,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CCC1)c1nc(NCc2cncc(F)c2)nc2ccsc12,,,CHEMBL5728996,,2022.0,"{'bei': '18.25', 'le': '0.36', 'lle': '3.40', 'sei': '8.17'}",CHEMBL5802095,,CHEMBL5802095,6.52,0,http://www.openphacts.org/units/Nanomolar,4556938,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1144365,28630328,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CCC1)c1nc(NCc2cc(F)cc(F)c2)nc2ccsc12,,,CHEMBL5728996,,2022.0,"{'bei': '19.03', 'le': '0.37', 'lle': '3.26', 'sei': '10.65'}",CHEMBL5968802,,CHEMBL5968802,7.12,0,http://www.openphacts.org/units/Nanomolar,4556944,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144373,28630352,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NC2CCCC2)c2sccc2n1)c1ccccn1,,,CHEMBL5728996,,2022.0,"{'bei': '17.75', 'le': '0.34', 'lle': '2.59', 'sei': '8.17'}",CHEMBL5795646,,CHEMBL5795646,6.52,0,http://www.openphacts.org/units/Nanomolar,4556947,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1144415,28630478,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NC2CC2)c2sccc2n1)c1ccccn1,,,CHEMBL5728996,,2022.0,"{'bei': '20.99', 'le': '0.41', 'lle': '3.97', 'sei': '8.93'}",CHEMBL6062375,,CHEMBL6062375,7.12,0,http://www.openphacts.org/units/Nanomolar,4556959,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144441,28630556,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NC(C)(C)C)c2sccc2n1)c1ccccn1,,,CHEMBL5728996,,2022.0,"{'bei': '20.04', 'le': '0.39', 'lle': '3.33', 'sei': '8.93'}",CHEMBL6024674,,CHEMBL6024674,7.12,0,http://www.openphacts.org/units/Nanomolar,4556968,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144573,28630952,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3ccccn3)nc(C(=O)N3CCCC3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '19.39', 'le': '0.37', 'lle': '3.32', 'sei': '10.03'}",CHEMBL5981857,,CHEMBL5981857,7.12,0,http://www.openphacts.org/units/Nanomolar,4557010,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144645,28631168,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)N3CC(O)C3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '18.39', 'le': '0.36', 'lle': '4.60', 'sei': '7.81'}",CHEMBL5980513,,CHEMBL5980513,7.12,0,http://www.openphacts.org/units/Nanomolar,4557032,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144649,28631180,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,COC1CN(C(=O)c2nc(N[C@@H](C)c3cncc(F)c3)nc3cc(C)sc23)C1,,,CHEMBL5728996,,2022.0,"{'bei': '17.75', 'le': '0.35', 'lle': '3.94', 'sei': '8.88'}",CHEMBL5812135,,CHEMBL5812135,7.12,0,http://www.openphacts.org/units/Nanomolar,4557033,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144673,28631252,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)N3CCC3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '19.18', 'le': '0.37', 'lle': '3.57', 'sei': '10.03'}",CHEMBL5931557,,CHEMBL5931557,7.12,0,http://www.openphacts.org/units/Nanomolar,4557041,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144677,28631264,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)NC[C@H](C)O)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '18.29', 'le': '0.36', 'lle': '4.30', 'sei': '7.12'}",CHEMBL5894644,,CHEMBL5894644,7.12,0,http://www.openphacts.org/units/Nanomolar,4557042,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144681,28631276,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)NC[C@@H](C)O)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '18.29', 'le': '0.36', 'lle': '4.30', 'sei': '7.12'}",CHEMBL5883640,,CHEMBL5883640,7.12,0,http://www.openphacts.org/units/Nanomolar,4557043,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144685,28631288,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)N3CCCC3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '18.48', 'le': '0.36', 'lle': '3.18', 'sei': '10.03'}",CHEMBL5943822,,CHEMBL5943822,7.12,0,http://www.openphacts.org/units/Nanomolar,4557044,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144689,28631300,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)NCC(F)(F)F)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '18.20', 'le': '0.37', 'lle': '3.52', 'sei': '9.43'}",CHEMBL5910436,,CHEMBL5910436,7.52,0,http://www.openphacts.org/units/Nanomolar,4557045,=,37,1,=,,IC50,nM,,30.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,30.0
,1144705,28631348,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3ccccn3)nc(C(=O)N3CCC3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '20.16', 'le': '0.39', 'lle': '3.71', 'sei': '10.03'}",CHEMBL5899763,,CHEMBL5899763,7.12,0,http://www.openphacts.org/units/Nanomolar,4557049,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144709,28631360,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3ccccn3)nc(C(=O)N3CC(O)C3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '19.29', 'le': '0.37', 'lle': '4.74', 'sei': '7.81'}",CHEMBL6021840,,CHEMBL6021840,7.12,0,http://www.openphacts.org/units/Nanomolar,4557050,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144729,28631420,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NCCO)c2sccc2n1)c1cncc(Cl)c1,,,CHEMBL5728996,,2022.0,"{'bei': '18.86', 'le': '0.39', 'lle': '4.49', 'sei': '7.12'}",CHEMBL5809555,,CHEMBL5809555,7.12,0,http://www.openphacts.org/units/Nanomolar,4557056,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144733,28631432,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](O)CNC(=O)c1nc(N[C@@H](C)c2cncc(Cl)c2)nc2ccsc12,,,CHEMBL5728996,,2022.0,"{'bei': '18.18', 'le': '0.37', 'lle': '4.10', 'sei': '7.12'}",CHEMBL5874604,,CHEMBL5874604,7.12,0,http://www.openphacts.org/units/Nanomolar,4557057,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144737,28631444,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NC[C@@H](C)O)c2sccc2n1)c1cncc(Cl)c1,,,CHEMBL5728996,,2022.0,"{'bei': '18.18', 'le': '0.37', 'lle': '4.10', 'sei': '7.12'}",CHEMBL5947174,,CHEMBL5947174,7.12,0,http://www.openphacts.org/units/Nanomolar,4557058,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144763,28631522,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,COC1CN(C(=O)c2nc(N[C@@H](C)c3ccccn3)nc3cc(C)sc23)C1,,,CHEMBL5728996,,2022.0,"{'bei': '18.58', 'le': '0.36', 'lle': '4.08', 'sei': '8.88'}",CHEMBL5742168,,CHEMBL5742168,7.12,0,http://www.openphacts.org/units/Nanomolar,4557065,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144787,28631594,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)NCC(C)(C)O)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '17.66', 'le': '0.35', 'lle': '3.91', 'sei': '7.12'}",CHEMBL5886429,,CHEMBL5886429,7.12,0,http://www.openphacts.org/units/Nanomolar,4557073,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144845,28631768,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NC2CC[C@@H](O)C2)c2sccc2n1)c1cncc(F)c1,,,CHEMBL5728996,,2022.0,"{'bei': '17.75', 'le': '0.35', 'lle': '4.08', 'sei': '7.12'}",CHEMBL5849430,,CHEMBL5849430,7.12,0,http://www.openphacts.org/units/Nanomolar,4557093,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144919,28631990,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3ccccn3)nc(C(=O)NC3CCC3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '19.39', 'le': '0.37', 'lle': '3.27', 'sei': '8.93'}",CHEMBL5763363,,CHEMBL5763363,7.12,0,http://www.openphacts.org/units/Nanomolar,4557115,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144923,28632002,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3ccccn3)nc(C(=O)NCCO)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '19.93', 'le': '0.39', 'lle': '4.83', 'sei': '7.12'}",CHEMBL5949836,,CHEMBL5949836,7.12,0,http://www.openphacts.org/units/Nanomolar,4557116,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144955,28632098,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cccnc3)nc(C(=O)NCCO)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '19.93', 'le': '0.39', 'lle': '4.83', 'sei': '7.12'}",CHEMBL5904829,,CHEMBL5904829,7.12,0,http://www.openphacts.org/units/Nanomolar,4557131,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144967,28632134,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)NCCc3ccc(O)cc3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '15.78', 'le': '0.30', 'lle': '2.73', 'sei': '7.12'}",CHEMBL5999152,,CHEMBL5999152,7.12,0,http://www.openphacts.org/units/Nanomolar,4557136,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144971,28632146,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(CNC(=O)c2nc(N[C@@H](C)c3cncc(F)c3)nc3cc(C)sc23)n1,,,CHEMBL5728996,,2022.0,"{'bei': '15.75', 'le': '0.30', 'lle': '3.08', 'sei': '6.99'}",CHEMBL5768228,,CHEMBL5768228,7.12,0,http://www.openphacts.org/units/Nanomolar,4557137,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144977,28632164,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)NCC3CCOCC3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '16.59', 'le': '0.32', 'lle': '3.26', 'sei': '8.00'}",CHEMBL5831847,,CHEMBL5831847,7.12,0,http://www.openphacts.org/units/Nanomolar,4557139,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1144999,28632230,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NCCc2ccc(CO)cc2)c2sccc2n1)c1cncc(F)c1,,,CHEMBL5728996,,2022.0,"{'bei': '15.78', 'le': '0.30', 'lle': '3.26', 'sei': '7.12'}",CHEMBL5884317,,CHEMBL5884317,7.12,0,http://www.openphacts.org/units/Nanomolar,4557147,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145013,28632272,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)NCC3CCOC3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '17.15', 'le': '0.34', 'lle': '3.65', 'sei': '8.00'}",CHEMBL5872636,,CHEMBL5872636,7.12,0,http://www.openphacts.org/units/Nanomolar,4557151,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145017,28632284,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)NCC3CCOC3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '17.15', 'le': '0.34', 'lle': '3.65', 'sei': '8.00'}",CHEMBL5872636,,CHEMBL5872636,7.12,0,http://www.openphacts.org/units/Nanomolar,4557151,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145025,28632308,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](O)CNC(=O)c1nc(N[C@@H](C)c2cncc(F)c2)nc2cc(C(F)(F)F)sc12,,,CHEMBL5728996,,2022.0,"{'bei': '16.07', 'le': '0.32', 'lle': '3.59', 'sei': '7.12'}",CHEMBL5854133,,CHEMBL5854133,7.12,0,http://www.openphacts.org/units/Nanomolar,4557153,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145029,28632320,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NC[C@@H](C)O)c2sc(C(F)(F)F)cc2n1)c1cncc(F)c1,,,CHEMBL5728996,,2022.0,"{'bei': '16.07', 'le': '0.32', 'lle': '3.59', 'sei': '7.12'}",CHEMBL5885136,,CHEMBL5885136,7.12,0,http://www.openphacts.org/units/Nanomolar,4557154,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145051,28632386,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)N[C@@H]2CC[C@H](O)C2)c2sccc2n1)c1cncc(F)c1,,,CHEMBL5728996,,2022.0,"{'bei': '16.25', 'le': '0.32', 'lle': '3.48', 'sei': '6.52'}",CHEMBL6064167,,CHEMBL6064167,6.52,0,http://www.openphacts.org/units/Nanomolar,4557163,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1145073,28632452,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NCCc2cccc(O)c2)c2sccc2n1)c1cncc(F)c1,,,CHEMBL5728996,,2022.0,"{'bei': '16.29', 'le': '0.31', 'lle': '3.04', 'sei': '7.12'}",CHEMBL6029192,,CHEMBL6029192,7.12,0,http://www.openphacts.org/units/Nanomolar,4557170,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145093,28632512,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1csc2c(C(=O)N3CCCC3)nc(N[C@@H](C)c3cncc(F)c3)nc12,,,CHEMBL5728996,,2022.0,"{'bei': '18.48', 'le': '0.36', 'lle': '3.18', 'sei': '10.03'}",CHEMBL5929296,,CHEMBL5929296,7.12,0,http://www.openphacts.org/units/Nanomolar,4557175,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145097,28632524,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1csc2c(C(=O)N3CCC3)nc(N[C@@H](C)c3cncc(F)c3)nc12,,,CHEMBL5728996,,2022.0,"{'bei': '19.18', 'le': '0.37', 'lle': '3.57', 'sei': '10.03'}",CHEMBL6063175,,CHEMBL6063175,7.12,0,http://www.openphacts.org/units/Nanomolar,4557176,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145133,28632632,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(=O)NCCc2cccc(O)c2)c2sccc2n1)c1cccnc1,,,CHEMBL5728996,,2022.0,"{'bei': '15.55', 'le': '0.30', 'lle': '2.58', 'sei': '6.52'}",CHEMBL5887205,,CHEMBL5887205,6.52,0,http://www.openphacts.org/units/Nanomolar,4557188,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1145141,28632656,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)N3CC(NC(=O)OC(C)(C)C)C3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '14.64', 'le': '0.29', 'lle': '3.06', 'sei': '6.52'}",CHEMBL5767757,,CHEMBL5767757,7.12,0,http://www.openphacts.org/units/Nanomolar,4557190,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145157,28632704,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@H](C)Nc2nc(C(=O)NCc3cccnc3)c3sccc3n2)cc1,,,CHEMBL5728996,,2022.0,"{'bei': '15.55', 'le': '0.30', 'lle': '2.32', 'sei': '7.33'}",CHEMBL6001576,,CHEMBL6001576,6.52,0,http://www.openphacts.org/units/Nanomolar,4557196,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1145193,28632812,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1csc2c(C(=O)NCc3ccccn3)nc(N[C@@H](C)c3ccccn3)nc12,,,CHEMBL5728996,,2022.0,"{'bei': '17.61', 'le': '0.34', 'lle': '3.23', 'sei': '7.69'}",CHEMBL5745907,,CHEMBL5745907,7.12,0,http://www.openphacts.org/units/Nanomolar,4557212,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145275,28633058,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CNC(=O)c2nc(N[C@@H](C)c3ccccn3)nc3cc(C)sc23)cc1,,,CHEMBL5728996,,2022.0,"{'bei': '16.43', 'le': '0.31', 'lle': '2.61', 'sei': '8.00'}",CHEMBL5854847,,CHEMBL5854847,7.12,0,http://www.openphacts.org/units/Nanomolar,4557238,=,37,1,=,,IC50,nM,,75.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,75.0
,1145303,28633142,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)NCCC3CN(C(=O)OC(C)(C)C)C3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '12.67', 'le': '0.25', 'lle': '1.83', 'sei': '5.97'}",CHEMBL6054459,,CHEMBL6054459,6.52,0,http://www.openphacts.org/units/Nanomolar,4557246,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1145395,28633418,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)N3CC(NC(=O)C(C)(C)C)C3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '13.86', 'le': '0.27', 'lle': '2.83', 'sei': '6.52'}",CHEMBL6031617,,CHEMBL6031617,6.52,0,http://www.openphacts.org/units/Nanomolar,4557273,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1145485,28633688,[],CHEMBL5737880,Activity Assay: Compounds (Adenosine Receptor modulators) and activity assay.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(N[C@@H](C)c3cncc(F)c3)nc(C(=O)N3CC(NC(=O)C4CCCO4)C3)c2s1,,,CHEMBL5728996,,2022.0,"{'bei': '13.46', 'le': '0.26', 'lle': '3.69', 'sei': '5.97'}",CHEMBL6043817,,CHEMBL6043817,6.52,0,http://www.openphacts.org/units/Nanomolar,4557301,=,37,1,=,,IC50,nM,,300.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,300.0
,1163280,28681208,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccccc2)c(-c2ccc3ncccc3c2)c2nncn12,,,CHEMBL5729079,,2022.0,"{'bei': '22.89', 'le': '0.41', 'lle': '4.15', 'sei': '9.45'}",CHEMBL5815348,,CHEMBL5815348,7.75,0,http://www.openphacts.org/units/Nanomolar,4568576,=,37,1,=,,IC50,nM,,18.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,18.0
,1163283,28681217,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccccc3)nc(N)n3cnnc23)cc(Cl)n1,,,CHEMBL5729079,,2022.0,"{'bei': '22.07', 'le': '0.42', 'lle': '4.03', 'sei': '9.06'}",CHEMBL5888877,,CHEMBL5888877,7.43,0,http://www.openphacts.org/units/Nanomolar,4568577,=,37,1,=,,IC50,nM,,37.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,37.0
,1163286,28681226,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccccc3)nc(N)n3cnnc23)cc2cccnc12,,,CHEMBL5729079,,2022.0,"{'bei': '22.48', 'le': '0.40', 'lle': '4.02', 'sei': '9.66'}",CHEMBL5759493,,CHEMBL5759493,7.92,0,http://www.openphacts.org/units/Nanomolar,4568578,=,37,1,=,,IC50,nM,,12.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,12.0
,1163289,28681235,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccccc2)c(-c2cc(F)c3ncccc3c2)c2nncn12,,,CHEMBL5729079,,2022.0,"{'bei': '21.88', 'le': '0.39', 'lle': '4.07', 'sei': '9.51'}",CHEMBL5938328,,CHEMBL5938328,7.80,0,http://www.openphacts.org/units/Nanomolar,4568580,=,37,1,=,,IC50,nM,,16.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,16.0
,1163292,28681244,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccccc3)nc(N)n3cnnc23)cc(C)n1,,,CHEMBL5729079,,2022.0,"{'bei': '22.10', 'le': '0.40', 'lle': '3.94', 'sei': '8.53'}",CHEMBL5923815,,CHEMBL5923815,6.99,0,http://www.openphacts.org/units/Nanomolar,4568584,=,37,1,=,,IC50,nM,,102.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,102.0
,1163295,28681253,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3F)nc(N)n3cnnc23)cc(C(F)(F)F)n1,,,CHEMBL5729079,,2022.0,"{'bei': '15.72', 'le': '0.30', 'lle': '2.35', 'sei': '7.79'}",CHEMBL6062291,,CHEMBL6062291,6.39,0,http://www.openphacts.org/units/Nanomolar,4568590,=,37,1,=,,IC50,nM,,409.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,409.0
,1163298,28681262,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccccc3F)nc(N)n3cnnc23)cc(C)n1,,,CHEMBL5729079,,2022.0,"{'bei': '20.22', 'le': '0.37', 'lle': '3.57', 'sei': '8.25'}",CHEMBL5934149,,CHEMBL5934149,6.76,0,http://www.openphacts.org/units/Nanomolar,4568591,=,37,1,=,,IC50,nM,,173.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,173.0
,1163301,28681271,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3F)nc(N)n3cnnc23)cc(C(F)F)n1,,,CHEMBL5729079,,2022.0,"{'bei': '16.18', 'le': '0.31', 'lle': '2.32', 'sei': '7.67'}",CHEMBL5887665,,CHEMBL5887665,6.29,0,http://www.openphacts.org/units/Nanomolar,4568592,=,37,1,=,,IC50,nM,,519.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,519.0
,1163304,28681280,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccccc3F)nc(N)n3cnnc23)cc(Cl)n1,,,CHEMBL5729079,,2022.0,"{'bei': '20.15', 'le': '0.39', 'lle': '3.61', 'sei': '8.72'}",CHEMBL5748122,,CHEMBL5748122,7.15,0,http://www.openphacts.org/units/Nanomolar,4568598,=,37,1,=,,IC50,nM,,71.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,71.0
,1163307,28681289,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3cnnc23)cc(C)n1,,,CHEMBL5729079,,2022.0,"{'bei': '21.48', 'le': '0.39', 'lle': '3.99', 'sei': '8.76'}",CHEMBL5945954,,CHEMBL5945954,7.18,0,http://www.openphacts.org/units/Nanomolar,4568599,=,37,1,=,,IC50,nM,,66.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,66.0
,1163310,28681298,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3cnnc23)cc(C(F)F)n1,,,CHEMBL5729079,,2022.0,"{'bei': '17.22', 'le': '0.32', 'lle': '2.56', 'sei': '7.78'}",CHEMBL5745015,,CHEMBL5745015,6.38,0,http://www.openphacts.org/units/Nanomolar,4568613,=,37,1,=,,IC50,nM,,418.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,418.0
,1163313,28681307,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(Cl)cc3)nc(N)n3cnnc23)cc(C(F)F)n1,,,CHEMBL5729079,,2022.0,"{'bei': '19.10', 'le': '0.37', 'lle': '3.06', 'sei': '9.01'}",CHEMBL5805722,,CHEMBL5805722,7.39,0,http://www.openphacts.org/units/Nanomolar,4568614,=,37,1,=,,IC50,nM,,41.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,41.0
,1163316,28681316,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(F)cc3)nc(N)n3cnnc23)cc(CF)n1,,,CHEMBL5729079,,2022.0,"{'bei': '18.88', 'le': '0.35', 'lle': '3.30', 'sei': '8.12'}",CHEMBL6009032,,CHEMBL6009032,6.65,0,http://www.openphacts.org/units/Nanomolar,4568617,=,37,1,=,,IC50,nM,,222.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,222.0
,1163319,28681325,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccccc3F)nc(N)n3cnnc23)cc(C(F)F)n1,,,CHEMBL5729079,,2022.0,"{'bei': '17.84', 'le': '0.33', 'lle': '2.79', 'sei': '8.06'}",CHEMBL5825507,,CHEMBL5825507,6.61,0,http://www.openphacts.org/units/Nanomolar,4568618,=,37,1,=,,IC50,nM,,248.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,248.0
,1163322,28681334,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccccc3F)nc(N)n3cnnc23)cc(CF)n1,,,CHEMBL5729079,,2022.0,"{'bei': '18.50', 'le': '0.34', 'lle': '3.17', 'sei': '7.95'}",CHEMBL5754606,,CHEMBL5754606,6.52,0,http://www.openphacts.org/units/Nanomolar,4568619,=,37,1,=,,IC50,nM,,302.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,302.0
,1163325,28681343,[],CHEMBL5738024,"Adenosine A1 receptor: CHO-K1/A1R cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum and 1 mg/ml G418. The cells were digested with the cell separation buffer during the experiment. The cells were then resuspended in the balanced salt buffer containing 20 mM HEPES and 0.1% bovine serum albumin and counted, and the cell density was adjusted to 5×105 cells/ml. In the 384-well plate, each well was added with 12.5 μl of cell suspension, and 6.25 μl of test compound (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. Each well was then added with 6.25 μl of forskolin and N6-cyclopentyladenosine (4× concentration) formulated with the balanced salt buffer containing 20 mM HEPES, 0.1% bovine serum albumin, 54 μM rolipram and 2.7 U/ml adenosine deaminase, and the plate was incubated at room temperature for 30 minutes. The final concentrations of the compounds were: 100000, 10000, 1000, 100, 10, 1, 0.1 and 0 nM. The final concentration of forskolin was 10 μM. The final concentration of CPA was 10 nM. Intracellular cAMP concentration was detected with the cAMP dynamic 2 kit. cAMP-d2 and Anti-cAMP-Eu-Cryptate were diluted respectively with the cAMP lysis buffer at a ratio of 1:4. Each well was added with 12.5 μl of diluted cAMP-d2, followed by addition of 12.5 μl of diluted Anti-cAMP-Eu-Cryptate, and the plate was incubated at room temperature in the dark for 1 hour. The HTRF signal values were read by the PHERAstar multi-function microplate reader. IC50 values of inhibition activity of the compounds were calculated by Graphpad Prism software.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2c(-c3ccc(Cl)cc3F)nc(N)n3cnnc23)cc(C(F)F)n1,,,CHEMBL5729079,,2022.0,"{'bei': '14.81', 'le': '0.29', 'lle': '1.53', 'sei': '7.31'}",CHEMBL5879357,,CHEMBL5879357,6.00,0,http://www.openphacts.org/units/Nanomolar,4568620,=,37,1,=,,IC50,nM,,1009.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1009.0
,1256054,28938077,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(C(=O)NCc3c(F)cccc3F)c(N)nc2-c2ncco2)ccc1=O,,,CHEMBL5729572,,2023.0,"{'bei': '17.78', 'le': '0.33', 'lle': '5.51', 'sei': '6.05'}",CHEMBL5867976,,CHEMBL5867976,7.80,1,http://www.openphacts.org/units/Nanomolar,4623128,=,37,1,=,,IC50,nM,,16.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,16.0
,1256057,28938086,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,CN(C)c1cccnc1CNC(=O)c1nc(-c2ccc(=O)n(C)c2)c(-c2ncco2)nc1N,,,CHEMBL5729572,,2023.0,"{'bei': '17.52', 'le': '0.32', 'lle': '6.35', 'sei': '5.39'}",CHEMBL5848745,,CHEMBL5848745,7.82,1,http://www.openphacts.org/units/Nanomolar,4623130,=,37,1,=,,IC50,nM,,15.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,15.0
,1256059,28938092,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(C(=O)NCc3ncccc3OC(F)F)c(N)nc2-c2ncco2)ccc1=O,,,CHEMBL5729572,,2023.0,"{'bei': '10.65', 'le': '0.20', 'lle': '2.99', 'sei': '3.31'}",CHEMBL5881276,,CHEMBL5881276,5.00,1,http://www.openphacts.org/units/Nanomolar,4623131,=,37,1,=,,IC50,nM,,10000.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,10000.0
,1256071,28938128,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccc3nccn3c2)nc1C(=O)NCc1ncccc1F,,,CHEMBL5729572,,2023.0,"{'bei': '15.36', 'le': '0.28', 'lle': '4.12', 'sei': '4.82'}",CHEMBL5911581,,CHEMBL5911581,6.61,1,http://www.openphacts.org/units/Nanomolar,4623141,=,37,1,=,,IC50,nM,,245.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,245.0
,1256073,28938134,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccc3[nH]cnc3c2)nc1C(=O)NCc1ncccc1F,,,CHEMBL5729572,,2023.0,"{'bei': '14.31', 'le': '0.26', 'lle': '3.44', 'sei': '4.15'}",CHEMBL6003783,,CHEMBL6003783,6.16,1,http://www.openphacts.org/units/Nanomolar,4623142,=,37,1,=,,IC50,nM,,696.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,696.0
,1256075,28938140,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1cccc(CNC(=O)c2nc(-c3ccc4nccn4c3)c(-c3ncco3)nc2N)n1,,,CHEMBL5729572,,2023.0,"{'bei': '16.78', 'le': '0.31', 'lle': '5.23', 'sei': '4.40'}",CHEMBL6019989,,CHEMBL6019989,7.17,1,http://www.openphacts.org/units/Nanomolar,4623143,=,37,1,=,,IC50,nM,,67.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,67.0
,1256077,28938146,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(C(=O)NCc3nc(N)ccc3F)c(N)nc2-c2ncco2)ccc1=O,,,CHEMBL5729572,,2023.0,"{'bei': '15.88', 'le': '0.30', 'lle': '5.80', 'sei': '4.13'}",CHEMBL5974116,,CHEMBL5974116,6.93,1,http://www.openphacts.org/units/Nanomolar,4623144,=,37,1,=,,IC50,nM,,117.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,117.0
,1256079,28938152,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cnc2ccc(-c3nc(C(=O)NCc4ncccc4F)c(N)nc3-c3ncco3)cc21,,,CHEMBL5729572,,2023.0,"{'bei': '15.99', 'le': '0.29', 'lle': '4.38', 'sei': '5.16'}",CHEMBL5802346,,CHEMBL5802346,7.11,1,http://www.openphacts.org/units/Nanomolar,4623145,=,37,1,=,,IC50,nM,,78.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,78.0
,1256081,28938158,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,COc1ccccc1CNC(=O)c1nc(-c2cc(C)nc(C)c2)c(-c2ccc(C)o2)nc1N,,,CHEMBL5729572,,2023.0,"{'bei': '16.42', 'le': '0.30', 'lle': '3.04', 'sei': '6.27'}",CHEMBL5781132,,CHEMBL5781132,7.28,1,http://www.openphacts.org/units/Nanomolar,4623146,=,37,1,=,,IC50,nM,,52.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,52.0
,1256084,28938167,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(-c2nc(C(=O)NCc3ccccc3OC(F)(F)F)c(N)nc2-c2ccc(F)cc2)cc(C)n1,,,CHEMBL5729572,,2023.0,"{'bei': '14.71', 'le': '0.28', 'lle': '2.15', 'sei': '7.30'}",CHEMBL6005886,,CHEMBL6005886,7.52,1,http://www.openphacts.org/units/Nanomolar,4623147,=,37,1,=,,IC50,nM,,30.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,30.0
,1256086,28938173,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(CNC(=O)c3c(F)cccc3F)c(N)nc2-c2ccc(F)cc2)ccc1=O,,,CHEMBL5729572,,2023.0,"{'bei': '16.69', 'le': '0.31', 'lle': '4.33', 'sei': '7.55'}",CHEMBL6058216,,CHEMBL6058216,7.77,1,http://www.openphacts.org/units/Nanomolar,4623148,=,37,1,=,,IC50,nM,,17.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,17.0
,1256088,28938179,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2nc(C(=O)NC(CO)c3c(F)cccc3F)c(N)nc2-c2ncco2)ccc1=O,,,CHEMBL5729572,,2023.0,"{'bei': '17.08', 'le': '0.32', 'lle': '6.18', 'sei': '5.36'}",CHEMBL5769004,,CHEMBL5769004,8.00,1,http://www.openphacts.org/units/Nanomolar,4623149,=,37,1,=,,IC50,nM,,10.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,10.0
,1256090,28938185,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccc3ncnn3c2)nc1C(=O)NCc1ncccc1F,,,CHEMBL5729572,,2023.0,"{'bei': '14.29', 'le': '0.26', 'lle': '4.27', 'sei': '4.11'}",CHEMBL5963684,,CHEMBL5963684,6.16,1,http://www.openphacts.org/units/Nanomolar,4623150,=,37,1,=,,IC50,nM,,685.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,685.0
,1256092,28938191,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NCc4ncccc4F)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '18.57', 'le': '0.34', 'lle': '5.45', 'sei': '6.02'}",CHEMBL5878949,,CHEMBL5878949,8.25,1,http://www.openphacts.org/units/Nanomolar,4623151,=,37,1,=,,IC50,nM,,5.6,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.6
,1256094,28938197,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-n2nccn2)c(-c2ccc3nccn3c2)nc1C(=O)NCc1ncccc1F,,,CHEMBL5729572,,2023.0,"{'bei': '16.98', 'le': '0.31', 'lle': '5.89', 'sei': '5.16'}",CHEMBL5796037,,CHEMBL5796037,7.31,1,http://www.openphacts.org/units/Nanomolar,4623152,=,37,1,=,,IC50,nM,,49.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,49.0
,1256096,28938203,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,CNCCOc1cccnc1CNC(=O)c1nc(-c2ccc3ncn(C)c3c2)c(-c2ccc(F)cc2)nc1N,,,CHEMBL5729572,,2023.0,"{'bei': '17.18', 'le': '0.32', 'lle': '5.71', 'sei': '6.81'}",CHEMBL5772325,,CHEMBL5772325,9.05,1,http://www.openphacts.org/units/Nanomolar,4623153,=,37,1,=,,IC50,nM,,0.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.9
,1256098,28938209,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NCC4CCCN4C)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '15.74', 'le': '0.29', 'lle': '4.65', 'sei': '5.34'}",CHEMBL5836132,,CHEMBL5836132,6.81,1,http://www.openphacts.org/units/Nanomolar,4623154,=,37,1,=,,IC50,nM,,156.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,156.0
,1256100,28938215,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NCC4CCCN4C)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '16.04', 'le': '0.30', 'lle': '4.78', 'sei': '5.44'}",CHEMBL5836132,,CHEMBL5836132,6.94,1,http://www.openphacts.org/units/Nanomolar,4623154,=,37,1,=,,IC50,nM,,116.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,116.0
,1256102,28938221,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@H]4CCCO4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '16.95', 'le': '0.31', 'lle': '4.86', 'sei': '5.33'}",CHEMBL5895809,,CHEMBL5895809,7.11,1,http://www.openphacts.org/units/Nanomolar,4623155,=,37,1,=,,IC50,nM,,78.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,78.0
,1256104,28938227,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@@H]4CCCO4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '17.09', 'le': '0.32', 'lle': '4.92', 'sei': '5.37'}",CHEMBL5818042,,CHEMBL5818042,7.17,1,http://www.openphacts.org/units/Nanomolar,4623156,=,37,1,=,,IC50,nM,,68.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,68.0
,1256106,28938233,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC(C)C)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '17.40', 'le': '0.32', 'lle': '4.09', 'sei': '5.29'}",CHEMBL6046888,,CHEMBL6046888,6.57,1,http://www.openphacts.org/units/Nanomolar,4623157,=,37,1,=,,IC50,nM,,271.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,271.0
,1256108,28938239,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NCC4CCO4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '16.44', 'le': '0.30', 'lle': '4.81', 'sei': '4.99'}",CHEMBL5957693,,CHEMBL5957693,6.67,1,http://www.openphacts.org/units/Nanomolar,4623158,=,37,1,=,,IC50,nM,,216.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,216.0
,1256110,28938245,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NCC4CCO4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '16.76', 'le': '0.31', 'lle': '4.93', 'sei': '5.09'}",CHEMBL5957693,,CHEMBL5957693,6.79,1,http://www.openphacts.org/units/Nanomolar,4623158,=,37,1,=,,IC50,nM,,161.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,161.0
,1256112,28938251,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@H]4CCOC4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '16.07', 'le': '0.30', 'lle': '4.64', 'sei': '5.05'}",CHEMBL6042158,,CHEMBL6042158,6.74,1,http://www.openphacts.org/units/Nanomolar,4623159,=,37,1,=,,IC50,nM,,182.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,182.0
,1256114,28938257,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@@H]4CCOC4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '16.00', 'le': '0.30', 'lle': '4.61', 'sei': '5.03'}",CHEMBL6023556,,CHEMBL6023556,6.71,1,http://www.openphacts.org/units/Nanomolar,4623160,=,37,1,=,,IC50,nM,,195.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,195.0
,1256116,28938263,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@H]4CCCN4C)c(N)nc3-c3ccc(F)cc3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '16.91', 'le': '0.31', 'lle': '4.46', 'sei': '7.66'}",CHEMBL5772644,,CHEMBL5772644,7.77,1,http://www.openphacts.org/units/Nanomolar,4623161,=,37,1,=,,IC50,nM,,17.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,17.0
,1256118,28938269,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC[C@@H]4CCCN4C)c(N)nc3-c3ccc(F)cc3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '15.63', 'le': '0.29', 'lle': '3.87', 'sei': '7.08'}",CHEMBL5903127,,CHEMBL5903127,7.18,1,http://www.openphacts.org/units/Nanomolar,4623162,=,37,1,=,,IC50,nM,,66.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,66.0
,1256120,28938275,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,COCCNC(=O)c1nc(-c2ccc3ncc(C)n3c2)c(-c2ncco2)nc1N,,,CHEMBL5729572,,2023.0,"{'bei': '17.71', 'le': '0.33', 'lle': '5.26', 'sei': '5.22'}",CHEMBL5885393,,CHEMBL5885393,6.97,1,http://www.openphacts.org/units/Nanomolar,4623163,=,37,1,=,,IC50,nM,,108.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,108.0
,1256122,28938281,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,COC[C@H](C)NC(=O)c1nc(-c2ccc3ncc(C)n3c2)c(-c2ncco2)nc1N,,,CHEMBL5729572,,2023.0,"{'bei': '15.90', 'le': '0.29', 'lle': '4.38', 'sei': '4.85'}",CHEMBL5959365,,CHEMBL5959365,6.48,1,http://www.openphacts.org/units/Nanomolar,4623164,=,37,1,=,,IC50,nM,,333.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,333.0
,1256124,28938287,[],CHEMBL5739003,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characterized with cell member chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopenthyl-1-,3-dipropylxanthine (DPCPX) for 50 min at 25C, meanwhile 100uL 0.5% PEI solution was added into UNFILTER-96 GF/B filter palate for 60 min at 4C then UNFILTER-96 GF/B filter palate was washed twice with 50ml wash buffer, the membrane mix was transferred into UNFILTER-96 GF/B filter palate, and the filter plate was washed 4 times before incubated at 55C for 10 min. At last, 40 uL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc2ccc(-c3nc(C(=O)NC4CCC4)c(N)nc3-c3ncco3)cn12,,,CHEMBL5729572,,2023.0,"{'bei': '16.24', 'le': '0.30', 'lle': '3.70', 'sei': '5.09'}",CHEMBL5800748,,CHEMBL5800748,6.32,1,http://www.openphacts.org/units/Nanomolar,4623165,=,37,1,=,,IC50,nM,,475.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,475.0
,1270918,28982150,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '20.11', 'le': '0.37', 'lle': '5.96', 'sei': '8.61'}",CHEMBL5993458,,CHEMBL5993458,8.96,1,http://www.openphacts.org/units/Nanomolar,4633153,=,37,1,=,,IC50,nM,,1.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1.1
,1270922,28982162,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '20.97', 'le': '0.39', 'lle': '5.95', 'sei': '10.65'}",CHEMBL5756623,,CHEMBL5756623,9.70,1,http://www.openphacts.org/units/Nanomolar,4633154,=,37,1,=,,IC50,nM,,0.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.2
,1270924,28982168,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,CN(C)c1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccn1,,,CHEMBL5729667,,2023.0,"{'bei': '18.17', 'le': '0.34', 'lle': '4.13', 'sei': '10.14'}",CHEMBL5827075,,CHEMBL5827075,8.64,1,http://www.openphacts.org/units/Nanomolar,4633155,=,37,1,=,,IC50,nM,,2.3,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.3
,1270928,28982180,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4OC(F)F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '17.02', 'le': '0.32', 'lle': '4.93', 'sei': '7.42'}",CHEMBL5956015,,CHEMBL5956015,8.40,1,http://www.openphacts.org/units/Nanomolar,4633156,=,37,1,=,,IC50,nM,,4.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,4.0
,1270932,28982192,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '17.61', 'le': '0.32', 'lle': '5.52', 'sei': '5.67'}",CHEMBL6007073,,CHEMBL6007073,7.37,1,http://www.openphacts.org/units/Nanomolar,4633157,=,37,1,=,,IC50,nM,,43.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,43.0
,1270934,28982198,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ncco3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '18.76', 'le': '0.35', 'lle': '5.57', 'sei': '6.97'}",CHEMBL5781725,,CHEMBL5781725,8.17,1,http://www.openphacts.org/units/Nanomolar,4633158,=,37,1,=,,IC50,nM,,6.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,6.8
,1270936,28982204,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-n3nccn3)nc(N)n3nc(Cc4c(F)cccc4F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '18.61', 'le': '0.35', 'lle': '6.58', 'sei': '6.65'}",CHEMBL5847654,,CHEMBL5847654,8.10,1,http://www.openphacts.org/units/Nanomolar,4633159,=,37,1,=,,IC50,nM,,7.9,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,7.9
,1270938,28982210,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccc3nccn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5729667,,2023.0,"{'bei': '16.06', 'le': '0.29', 'lle': '4.06', 'sei': '5.48'}",CHEMBL6063197,,CHEMBL6063197,6.86,1,http://www.openphacts.org/units/Nanomolar,4633160,=,37,1,=,,IC50,nM,,137.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,137.0
,1270940,28982216,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3nccn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5729667,,2023.0,"{'bei': '18.64', 'le': '0.34', 'lle': '4.52', 'sei': '8.53'}",CHEMBL5841873,,CHEMBL5841873,8.47,1,http://www.openphacts.org/units/Nanomolar,4633161,=,37,1,=,,IC50,nM,,3.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,3.4
,1270942,28982222,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '19.80', 'le': '0.37', 'lle': '5.61', 'sei': '8.75'}",CHEMBL5966778,,CHEMBL5966778,9.10,1,http://www.openphacts.org/units/Nanomolar,4633162,=,37,1,=,,IC50,nM,,0.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.8
,1270946,28982234,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1cccc(Cc2nc3c(-c4ccc5nccn5c4)c(-c4ccc(F)cc4)nc(N)n3n2)n1,,,CHEMBL5729667,,2023.0,"{'bei': '18.60', 'le': '0.34', 'lle': '5.00', 'sei': '6.70'}",CHEMBL5867675,,CHEMBL5867675,8.40,1,http://www.openphacts.org/units/Nanomolar,4633163,=,37,1,=,,IC50,nM,,4.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,4.0
,1270948,28982240,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(C(F)F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '18.13', 'le': '0.34', 'lle': '4.86', 'sei': '8.33'}",CHEMBL5931362,,CHEMBL5931362,8.66,1,http://www.openphacts.org/units/Nanomolar,4633164,=,37,1,=,,IC50,nM,,2.2,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,2.2
,1270950,28982246,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,CC(C)n1cc(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '21.12', 'le': '0.39', 'lle': '5.95', 'sei': '9.62'}",CHEMBL5957422,,CHEMBL5957422,10.00,1,http://www.openphacts.org/units/Nanomolar,4633165,=,37,1,=,,IC50,nM,,0.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.1
,1270954,28982258,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(-c2nc(N)n3nc(Cc4ncccc4F)nc3c2-c2ccc(=O)n(C)c2)cc1,,,CHEMBL5729667,,2023.0,"{'bei': '19.17', 'le': '0.35', 'lle': '5.90', 'sei': '7.75'}",CHEMBL5988628,,CHEMBL5988628,8.77,1,http://www.openphacts.org/units/Nanomolar,4633166,=,37,1,=,,IC50,nM,,1.7,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1.7
,1270956,28982264,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3ccc(C(F)(F)F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '16.74', 'le': '0.31', 'lle': '4.41', 'sei': '7.97'}",CHEMBL6022055,,CHEMBL6022055,8.29,1,http://www.openphacts.org/units/Nanomolar,4633167,=,37,1,=,,IC50,nM,,5.1,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.1
,1270958,28982270,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(-c2c(-c3ccc(F)cc3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc(=O)n1C,,,CHEMBL5729667,,2023.0,"{'bei': '15.97', 'le': '0.29', 'lle': '4.03', 'sei': '7.06'}",CHEMBL6044836,,CHEMBL6044836,7.34,1,http://www.openphacts.org/units/Nanomolar,4633168,=,37,1,=,,IC50,nM,,46.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,46.0
,1270960,28982276,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(-c3cccc(Cl)c3)nc(N)n3nc(Cc4ncccc4F)nc23)ccc1=O,,,CHEMBL5729667,,2023.0,"{'bei': '19.69', 'le': '0.38', 'lle': '5.58', 'sei': '8.75'}",CHEMBL6043653,,CHEMBL6043653,9.10,1,http://www.openphacts.org/units/Nanomolar,4633169,=,37,1,=,,IC50,nM,,0.8,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,0.8
,1270962,28982282,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,COc1cccc(-c2nc(N)n3nc(Cc4ncccc4F)nc3c2-c2ccc(=O)n(C)c2)c1,,,CHEMBL5729667,,2023.0,"{'bei': '19.35', 'le': '0.36', 'lle': '5.98', 'sei': '7.82'}",CHEMBL6030840,,CHEMBL6030840,8.85,1,http://www.openphacts.org/units/Nanomolar,4633170,=,37,1,=,,IC50,nM,,1.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,1.4
,1270964,28982288,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccnc(OC(F)F)c2)c2nc(Cc3c(F)cccc3F)nn12,,,CHEMBL5729667,,2023.0,"{'bei': '17.54', 'le': '0.33', 'lle': '4.38', 'sei': '7.05'}",CHEMBL5795044,,CHEMBL5795044,8.27,1,http://www.openphacts.org/units/Nanomolar,4633171,=,37,1,=,,IC50,nM,,5.4,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,5.4
,1270966,28982294,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-c2ncco2)c(-c2ccnc(OC(F)F)c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5729667,,2023.0,"{'bei': '16.90', 'le': '0.32', 'lle': '4.53', 'sei': '5.90'}",CHEMBL5810207,,CHEMBL5810207,7.68,1,http://www.openphacts.org/units/Nanomolar,4633172,=,37,1,=,,IC50,nM,,21.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,21.0
,1270968,28982300,[],CHEMBL5739187,"Binding Affinities to Different Adenosine Receptors: Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characterized with cell membrane chromatography binding analysis. The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for 50 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 times before incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.The compounds at different concentrations were incubate with hA2a membrane (from PerkinElmer) and [3H]-CGS21680 for 90 min at 25° C., meanwhile 100 μL 0.5% PEI solution was added into UNFILTER-96 GF/B filter plate for 60 min at 4° C., then UNIFILTER-96 GF/B filter plate was washed twice with 50 ml wash buffer, the membrane mix was transferred into UNIFILTER-96 GF/B filter plate, and the filter plate was washed 4 timesbefore incubated at 55° C. for 10 min. At last, 40 μL ULTIMA GOLD was added into each well, and CPM was read by TopCount.",B,,,BAO_0000190,BAO_0000019,assay format,Nc1nc(-n2nccn2)c(-c2ccc3nccn3c2)c2nc(Cc3ncccc3F)nn12,,,CHEMBL5729667,,2023.0,"{'bei': '17.04', 'le': '0.31', 'lle': '5.55', 'sei': '5.60'}",CHEMBL6062538,,CHEMBL6062538,7.28,1,http://www.openphacts.org/units/Nanomolar,4633173,=,37,1,=,,IC50,nM,,52.0,CHEMBL226,Homo sapiens,Adenosine receptor A1,9606,,,IC50,nM,UO_0000065,,52.0
